<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chinese herbal medicines for induction of remission in advanced or late gastric cancer - Yang, J - 2013 | Cochrane Library</title> <meta content="Chinese herbal medicines for induction of remission in advanced or late gastric cancer - Yang, J - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005096.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chinese herbal medicines for induction of remission in advanced or late gastric cancer - Yang, J - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005096.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005096.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Chinese herbal medicines for induction of remission in advanced or late gastric cancer" name="citation_title"/> <meta content="Jinlin Yang" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="mouse-577@163.com" name="citation_author_email"/> <meta content="Linlin Zhu" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Zongying Wu" name="citation_author"/> <meta content="Third Hospital of Mianyang" name="citation_author_institution"/> <meta content="Yiping Wang" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD005096.pub4" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/04/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005096.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005096.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005096.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antineoplastic Agents, Phytogenic [*therapeutic use]; Drugs, Chinese Herbal [*therapeutic use]; Quality of Life; Randomized Controlled Trials as Topic; Remission Induction [methods]; Stomach Neoplasms [*drug therapy, mortality, pathology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005096.pub4&amp;doi=10.1002/14651858.CD005096.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005096\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005096\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ja","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005096.pub4",title:"Chinese herbal medicines for induction of remission in advanced or late gastric cancer",firstPublishedDate:"Apr 30, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005096.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005096.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005096.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005096.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005096.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005096.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005096.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005096.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005096.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005096.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6223 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005096.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-sec-0130"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-sec-0124"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/appendices#CD005096-sec-0135"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/table_n/CD005096StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/table_n/CD005096StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chinese herbal medicines for induction of remission in advanced or late gastric cancer</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information#CD005096-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jinlin Yang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information#CD005096-cr-0003">Linlin Zhu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information#CD005096-cr-0004">Zongying Wu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information#CD005096-cr-0005">Yiping Wang</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information/en#CD005096-sec-0143">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 April 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005096.pub4">https://doi.org/10.1002/14651858.CD005096.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005096-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005096-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005096-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005096-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005096-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005096-abs-0002">日本語</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005096-abs-0001" lang="en"> <section id="CD005096-sec-0001"> <h3 class="title" id="CD005096-sec-0001">Background</h3> <p>Gastric cancer is difficult to cure once it progresses to an advanced or late stage. Although some chemotherapies or bio‐therapies have made progress in the remission of this disease, the mortality from gastric cancer remains high. A variety of Chinese medicinal herbs have been used to treat gastric cancer. </p> </section> <section id="CD005096-sec-0002"> <h3 class="title" id="CD005096-sec-0002">Objectives</h3> <p>To assess the effectiveness of Chinese medicinal herbs in the short‐term remission of advanced or late gastric cancer. </p> </section> <section id="CD005096-sec-0003"> <h3 class="title" id="CD005096-sec-0003">Search methods</h3> <p>We searched the <i>The Cochrane Library</i>, MEDLINE, EMBASE, AHMED (Allied and Complementary Medicine Database) and CBM (Chinese Biomedical Database) from the first year of the databases to June 2011. We handsearched a number of journals. </p> </section> <section id="CD005096-sec-0004"> <h3 class="title" id="CD005096-sec-0004">Selection criteria</h3> <p>All randomised clinical trials of Chinese herbs for advanced or late gastric cancer were included. </p> </section> <section id="CD005096-sec-0005"> <h3 class="title" id="CD005096-sec-0005">Data collection and analysis</h3> <p>Two authors independently extracted the data, which were analysed using RevMan 5.1 software (<a href="http://revman 2011" target="_blank">RevMan 2011</a>). For dichotomous data, we estimated the relative risk. For continuous data, we calculated the weighted mean difference. </p> </section> <section id="CD005096-sec-0006"> <h3 class="title" id="CD005096-sec-0006">Main results</h3> <p>Eighty‐five trials with 6857 advanced or late gastric cancer patients were identified for inclusion, most were of low quality and used traditional Chinese medicinal herbs (TCMHs) plus chemotherapy compared with the same chemotherapy alone (65 trials). Apart from 23 trials of four different kinds of TCMHs, we could not pool the results because no more than two used the same intervention or outcomes. </p> <p>TCMHs with or without chemotherapy, in 57 trials, showed statistically significant differences for the improvement of mortality in nine trials, quality of life in 16 trials, rate of remission in 11 trials, and leukopenia in five trials. The pooled results from the four injected TCMHs, Huachansu, Aidi, Fufangkushen, and Shenqifuzheng showed statistically significant differences for the improvement of leukopenia, but no significant difference in the rate of short‐term remission. </p> </section> <section id="CD005096-sec-0007"> <h3 class="title" id="CD005096-sec-0007">Authors' conclusions</h3> <p>This review did not provide assured evidence concerning the effectiveness of TCMHs in improving quality of life or rate of remission, alleviating the toxicity or side effects of chemotherapy, or reducing short‐term mortality. Limited, weak evidence showed that Huachansu, Aidi, Fufangkushen, and Shenqifuzheng improved leukopenia when used together with chemotherapy; and Huachansu, Aidi, and Fufangkushen were of benefit for adverse events in the digestive system caused by chemotherapy. These TCMHs did not improve the rate of short‐term remissions. Large, well designed clinical trials are required urgently before any definite conclusions can be drawn about the value of TCMHs for advanced or late stage gastric cancer. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005096-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005096-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005096-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005096-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005096-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005096-abs-0005">日本語</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005096-abs-0004" lang="en"> <h3>Traditional Chinese medicinal herbs for induction of remission in advanced or late gastric cancer </h3> <p>Gastric cancer, one of the malignant tumours in the gastrointestinal tract and with high morbidity among cancers, can easily lead to death once it progresses to an advanced or late stage. There are few interventions which can postpone or stop the malignant course of the illness. However, some kinds of traditional Chinese medicinal herbs (TCMHs) have been used as an alternative therapeutic measure to treat many gastric cancer patients in China, and might be effective as an auxiliary therapy for this illness in its advanced or late stages. Our primary investigation showed there was no assured evidence concerning the effectiveness of TCMHs in improving the quality of life or rate of remission, alleviating the toxic and side effects caused by the chemotherapy, or reducing short‐term mortality. Limited, weak evidence showed that four injections of the TCMHs Huachansu, Aidi, Fufangkushen, and Shenqifuzheng showed statistically significant differences for the improvement of leukopenia, and Huachansu, Aidi, and Fufangkushen for adverse events in the digestive system, but no significant differences in the rate of short‐term remission. Most of the included studies were of low quality and valid comparisons were scarce, meaning that more trials are needed for meta‐analysis to draw definite conclusions about their benefits. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005096-sec-0130" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005096-sec-0130"></div> <h3 class="title" id="CD005096-sec-0131">Implications for practice</h3> <section id="CD005096-sec-0131"> <p>This review did not provide assured evidence concerning the effectiveness of TCMHs in improving the quality of life or rate of remission, alleviating the toxic and side effects caused by the chemotherapy, delaying the time to progression, prolonging the median survival times, or reducing short‐term mortality. Limited and weak evidence showed that Huachansu, Aidi, Fufangkushen, and Shenqifuzheng, when used together with chemotherapy, improved leukopenia; and Huachansu, Aidi, and Fufangkushen also improved the adverse events in the digestive system caused by chemotherapy but did not improve the rate of short‐term remission (complete remission or partial remission). Limitations were due to most of the included studies being of low quality and the scarcity of valid samples. Large, well designed clinical trials are required urgently before any confident conclusions can be drawn about the value of TCMHs for advanced or late‐stage gastric cancer. </p> <p>At present, the general evidence is insufficient to suggest that clinical practice should be changed on the basis of these results. </p> </section> <h3 class="title" id="CD005096-sec-0132">Implications for research</h3> <section id="CD005096-sec-0132"> <p>A standardised formula of TCMHs should be developed and used for all trials of advanced or late‐stage gastric cancer in China. Data from large, randomised, double blind, multi‐centre trials are required to confirm the benefit and safety of TCMHs for treatment of advanced or late‐stage gastric cancer. These trials should use standardised outcome measures for efficacy and should include an assessment of adverse events. All the trials should provide adequate follow‐up periods so that long‐term efficacy and safety can be assessed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005096-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005096-sec-0029"></div> <div class="table" id="CD005096-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Appraisal of the results of Huachansu in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Huachansu in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Huachansu in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Huachansu in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy (no special data in trial of Zhang 2006)</b> <br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.43</b> <br/> (0.28 to 0.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>388 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>589 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>381 per 1000</b> <br/> (286 to 486) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>523 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>320 per 1000</b> <br/> (235 to 420) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission (Copy)</b> <br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.48</b> <br/> (1.01 to 2.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>448 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>401 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>498 per 1000</b> <br/> (403 to 592) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>367 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>462 per 1000</b> <br/> (369 to 557) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Zhang 2006)</b> <br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.32</b> <br/> (0.21 to 0.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>388 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>583 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (227 to 412) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>539 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>272 per 1000</b> <br/> (197 to 369) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in three studies,quasi‐randomised for three trials,and one simple randomisation study. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the seven study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005096-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Appraisal of the results of Aidi in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Aidi in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Aidi in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Aidi in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission(no special data in trial of Zhang 2009)</b> <br/> Follow‐up: 6‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.51</b> <br/> (0.94 to 2.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>287 <br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>423 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>525 per 1000</b> <br/> (408 to 638) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>409 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>511 per 1000</b> <br/> (394 to 625) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy</b> <br/> Follow‐up: 6‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.33</b> <br/> (0.2 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>354 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>575 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> <br/> (213 to 422) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>574 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> <br/> (212 to 421) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Jia 2003, Zhang 2009)</b> <br/> Follow‐up: median 6‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.43</b> <br/> (0.23 to 0.8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>242 <br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>675 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>472 per 1000</b> <br/> (323 to 624) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>667 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>463 per 1000</b> <br/> (315 to 616) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in all studies. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the five study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005096-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Appraisal of the results of Fufangkushen in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Fufangkushen in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Fufangkushen in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Fufangkushen in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission(no special data in trial of Fu 2011)</b> <br/> Follow‐up: 3‐9 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.22</b> <br/> (0.83 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>423 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>464 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>514 per 1000</b> <br/> (418 to 608) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>454 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>504 per 1000</b> <br/> (408 to 598) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy(no special data in trial of Fu 2011, Liu 2009a, Zhang 2010)</b> <br/> Follow‐up: 3‐9 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.42</b> <br/> (0.26 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>302 <br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>611 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>397 per 1000</b> <br/> (290 to 520) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>628 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>415 per 1000</b> <br/> (305 to 538) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy</b> <br/> Follow‐up: median 3‐9 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.37</b> <br/> (0.25 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>503 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>699 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>462 per 1000</b> <br/> (367 to 565) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>719 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>486 per 1000</b> <br/> (390 to 589) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in five studies,random number table for one trials, and the method of sequence generation was tossed of a coin in one study. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the seven study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005096-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Appraisal of the results of Shenqifuzheng in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Shenqifuzheng in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Shenqifuzheng in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Shenqifuzheng in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission</b> <br/> Follow‐up: 4‐8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.48</b> <br/> (0.78 to 2.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>153 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>493 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>590 per 1000</b> <br/> (432 to 732) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>597 per 1000</b> <br/> (438 to 738) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy</b> <br/> Follow‐up: 4‐8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.13</b> <br/> (0.18 to 7.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>153 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>413 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>443 per 1000</b> <br/> (113 to 836) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>533 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>563 per 1000</b> <br/> (170 to 892) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy</b> <br/> Follow‐up: 4‐8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.37</b> <br/> (0.18 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>153 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>467 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>245 per 1000</b> <br/> (136 to 393) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>182 per 1000</b> <br/> (97 to 307) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in all studies. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the seven study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005096-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005096-sec-0030"></div> <p>In general, therapeutic prescriptions of traditional Chinese medicinal herbs (TCMHs) for gastric cancer consist of a group of herbs (commonly seven to 15 kinds of herbs). Some, such as Rhizoma Curcumae, Herba Hedyotis Diffusae, Rhizoma Paridis, Astragali radix, Radix Clematidis, and Fructus Bruceae, are commonly used as direct anti‐tumour agents and others, such as Tangerine peel, Milk vetch root, Pilose asiabell root, Spatholobus stem, Chinese angelica root, Flos Carthami, and Red sage root, can be added to the main prescription as supporting treatments to decrease the side effects or toxicity of chemotherapy (<a href="./references#CD005096-bbs2-0192" title="NingC , WangG , ZhaoT , YuG , DuanF . The effect of Jianpiyishen prescription on toxic‐side effects caused by chemotherapy in late gastric cancer after operation. Chinese Journal of Intergrated Traditional and Western Medicine1985;5(11):668‐70. ">Ning 1985</a>) or to improve the curative effect. This is described as 'strengthening the body resistance, restoring normal functioning of the body to consolidate the constitution, relieving the depressed liver and soothing the stomach, invigorating qi and enriching the blood, removing the poisonous quality of any substance and resolving the stasis'. These are the terms used in traditional Chinese medical theory (<a href="./references#CD005096-bbs2-0184" title="GuD , ZhangY . The research advancement of clinical dispensatories in treatment of gastric cancer. Information on Traditional Chinese Medicine1995;12(1):8‐10. ">Gu 1995</a>). Unfortunately, there still seems to be no special herbs or recipes that have been found to have special effects on certain kinds of cancers, so these same TCMHs can be used for other malignant tumours such as oesophageal carcinoma, hepatocarcinoma, or pulmonary carcinoma. At present, TCMHs are not recommended to treat benign tumours, such as polyps, because such diseases can be cured effectively by surgery. </p> <p>Medicines in complex prescriptions can be given by oral administration or intravenous drip, and there are many case reports showing that patients have been treated effectively with TCMHs administered either orally or intravenously, or by both methods (<a href="./references#CD005096-bbs2-0183" title="DuanP , HeJ , ZhangM . The effectiveness of invigorating the spleen and removing toxic substances in the treatment of gastric cancer. Sichuan Traditional Chinese Medicine2002;20(1):44. ">Duan 2002</a>). The combination administration is based on the special diagnostic modes of Traditional Chinese Medicine (TCM), such as inspection, listening, smelling, inquiry, and palpation, which mainly depend on the experience of doctors and are very different from western diagnostic methods. Although many trials appear to demonstrate that TCMHs might have some effectiveness on cancer, there is no evidence showing that TCMHs could replace surgery or radio‐chemotherapy for cancer in its early stages. At present, TCMHs are mainly used as an auxiliary therapy and a palliative treatment with routine therapeutic methods for advanced or late cancer, including gastric cancer. </p> <section id="CD005096-sec-0031"> <h3 class="title" id="CD005096-sec-0031">Description of the condition</h3> <p>Although many cancers can be cured in the early stages, once they progress to advanced or late stage (that is once widespread metastasis is confirmed by medical techniques such as X‐ray computed tomography (X‐CT), magnetic resonance imaging (MRI), or histologic examination) there are few interventions which can postpone or stop the malignant illness leading to death. Although bio‐therapies, such as gene therapy, immune therapy, bone‐marrow transplantation, etc, have made some progress in some kinds of advanced or late cancers, the mortality rate of most common late malignancy tumours (such as carcinomas derived from the digestive tract, gastric cancer, hepatocarcinoma) is still high. Both the morbidity and mortality of gastric cancer rank second of all malignant tumours (<a href="./references#CD005096-bbs2-0200" title="TangC . Gastric Carcinoma. Internal Medicine. 6th Edition. Beijing: The People's Hygiene Publishing House of China, 2004:393‐9. ">Tang 2004</a>), varying from 30 per 10⁵ to 80 per 10⁵ and 15.9 per 10⁵ to 32.4 per 10⁵, respectively (<a href="./references#CD005096-bbs2-0209" title="ZhengZ . The morbidity and mortality of gastric cancer. Gastroenterology. 3rd Edition. Beijing: the People's Hygiene Publishing House of China, 2001:12. ">Zheng 2001</a>), in different countries and regions. According to the statistical data, China, Japan, and Chile are countries with high risk of morbidity and mortality, and the United States, Canada, and European countries are those with low risk (<a href="./references#CD005096-bbs2-0200" title="TangC . Gastric Carcinoma. Internal Medicine. 6th Edition. Beijing: The People's Hygiene Publishing House of China, 2004:393‐9. ">Tang 2004</a>). </p> </section> <section id="CD005096-sec-0032"> <h3 class="title" id="CD005096-sec-0032">Description of the intervention</h3> <p>TCM is a common alternative therapy in China for late‐stage cancer, and all the herbs cited in this review can be found in the Traditional Chinese Medicine Dictionary. TCM has its own theories and systems for diagnostic and therapeutic methods for malignant tumours. It is thought that gastric cancer, called ye‐ge (similar to dysphagia) (<a href="./references#CD005096-bbs2-0205" title="YangC . The advancement of Chinese medicine and integrated Chinese medicine and western medicine in treatment of gastric cancer. Journal of New Chinese Medicine1989;21(2):45‐7. ">Yang 1989</a>), is caused mainly by overactive emotions (joy, anger, sorrow, anxiety, and fear) and eating or drinking too much, resulting in internal stasis of Yangqi and consumption of Yin fluid. Yin‐Yang theories of TCM, derived from Taoism, state that there are two substances, Yin and Yang, in the human body and that they should match each other to keep the balance, otherwise the body is at risk of all kinds of diseases. According to matched control research, it is shown that highly differentiated gastric adenocarcinoma (<a href="./references#CD005096-bbs2-0202" title="WangA , LiuB , ZhaoY , SunG . The relation between the classification of syndrome differentiation on Traditional Chinese Medicine and histopathology classification in moderate‐late stage of gastric carcinoma and the therapeutic evaluation. Chinese Journal of Surgery of Integrated Traditional and Western Medicine2000;6(3):165‐6. ">Wang 2000</a>) is similar to insufficiency of the spleen (Yang), or lack of coordination between the liver and the spleen; and poorly differentiated gastric adenocarcinoma is similar to deficiency of both qi and blood, or stagnancy of qi and blood stasis. In TCM, qi means something similar to air. The theories of TCM believe there is a kind of air running throughout the entire human body, not only in the lungs but in every organ of the body, and some people can feel its existence through breathing exercises; though this viewpoint has not been proven by modern western science. </p> <p>In traditional Chinese medicinal theory, therapeutic strategies aimed at late or advanced gastric cancer include three basic principles (<a href="./references#CD005096-bbs2-0187" title="JiG , JiJ . The advancement of Chinese medicine in treatment of gastric cancer. Jiangsu Journal of Traditional Chinese Medicine1989;10(2):40‐2. ">Ji 1989</a>): </p> <p> <ul id="CD005096-list-0001"> <li> <p>replenishing and strengthening the vital‐qi;</p> </li> <li> <p>reducing phlegm and resolving stasis;</p> </li> <li> <p>clearing away heat and toxic material.</p> </li> </ul> </p> </section> <section id="CD005096-sec-0033"> <h3 class="title" id="CD005096-sec-0033">How the intervention might work</h3> <p>According to the principle that treatment of a disease should deal with both the symptoms and causes at the same time, some categories of traditional Chinese medicinal herbs (TCMHs) are used according to the Chinese medicinal typing of advanced or late gastric cancer (<a href="./references#CD005096-bbs2-0185" title="GuoZ , ChengL . A clinical therapeutic effectiveness analyses of gastric carcinoma. Sichuan Traditional Chinese Medicine1997;15(3):7‐8. ">Guo 1997</a>) as alternative interventions. It is generally acknowledged that in its early stages gastric cancer can be cured with surgery, so alternative interventions (including TCMHs) are unnecessary. Once metastasis develops (that is in advanced or late‐stage disease) and the opportunity for surgery is lost, the cancer can not be cured. Therefore alternative interventions, including TCMHs, are used either alone or as auxiliary therapies with radio‐chemotherapy or bio‐therapy (<a href="./references#CD005096-bbs2-0209" title="ZhengZ . The morbidity and mortality of gastric cancer. Gastroenterology. 3rd Edition. Beijing: the People's Hygiene Publishing House of China, 2001:12. ">Zheng 2001</a>). </p> <p>Though the basic research on TCMHs is still weak, and most of the active ingredients are not extracted and confirmed at present, It is believed that some TCM herbs (including Astragulus membranaceus, dandelion herb, cassia twig, Poria, magnolia bark, chaenomeles fruit, costus root, barbat skullcap, lyrate nightshade, Chinese actinidia root, Coix seed, globethistle, hornet nest (<a href="./references#CD005096-bbs2-0210" title="ZhouD . The success and future of Chinese medicine integrated western medicine in treatment of malignant tumor. Chinese Journal of Tumour1999;8(10):455‐7. ">Zhou 1999</a>), and others such as bighead atractylodes rhizome, Oldenlandia diffusa Roxb (<a href="./references#CD005096-bbs2-0203" title="WuM , YaoB . The research advancement of Chinese medicine in treatment of gastric cancer and inducing cellular apoptosis. Journal of Traditional Chinese Medicine2001;42(12):752‐4. ">Wu 2001</a>), Scutellaria baicalensis Georgi, Allium sativum L As2O3) could inhibit the proliferation of gastric tumour cells (<a href="./references#CD005096-bbs2-0199" title="SunW , ZhengX . A clinical report of Aidi injection with chemotherapy for advanced or late gastric cancer. The Thesis Compilation of National Western and Chinese Traditional Medicine Summit Forum of Oncology. Chinese Medical Association, 2002:126‐127. ">Sun 2002</a>; <a href="./references#CD005096-bbs2-0208" title="ZhaoP , TangL , LuoJ . The effect of Aidi Injection with chemotherapy for gastric cancer after operation. the Thesis Compilation of National Western and Chinese Traditional Medicine Summit Forum of Oncology. Chinese Medical Association, 2002:244‐5. ">Zhao 2002</a>). Some basic research showed that isoverbascoside (<a href="./references#CD005096-bbs2-0181" title="ChenR , SuJ , CaiK , FuY , LiL . The effect of natural antioxidant of Isoverbascoside on inducing the differentiation of gastric cancer cell. Journal of Xiamen University (Natural Science)2001;40(4):936‐41. ">Chen 2001</a>), found in Pedicularis strata, has the effect of cleaning up multifarious oxyradicals. This could transfer the growth signal in the gastric cancer cell thus inhibiting the proliferation of gastric cancer. Astragulus membranaceus, a commonly used herb (<a href="./references#CD005096-bbs2-0198" title="ShenH , LiuZ , ZhangK , WangW , GuoQ , YuanS , et al. Effect of Astragulus membranaceus on expression of COX‐1, COX‐2, VEGF, and PEG‐2 in human gastric cancer cell line SGC7901. Tumour2007;27(3):194‐8. ">Shen 2007</a>) can down‐regulate the expression of cyclooxygenase‐2 (COX‐2), vascular endothelial growth factor (VEGF), and polyethylene glycol (PEG)‐2 in the gastric cancer cells. Radix Astragali specifically inhibits the growth of gastric cancer cells in vitro, but it is mainly cytostatic and not cytotoxic and does not induce apoptosis (<a href="./references#CD005096-bbs2-0188" title="LinJ , DongH , OppenheimJ , HowardO . Effects of astragali radix on the growth of different cancer cell lines. World Journal of Gastroenterology2003;9(4):670‐3. ">Lin 2003</a>). Another result from a pilot study suggests that a polysaccharide isolated from Echinacea purpurea herba cell cultures might be effective in reducing chemotherapy‐induced leukopenia (<a href="./references#CD005096-bbs2-0191" title="MelchartD , ClemmC , WeberB , DraczynskiT , WorkuF , LindeK , et al. Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy‐‐a pilot study. Phytotherapy Research2002;16(2):138‐42. ">Melchart 2002</a>); and the extract from Radix Curcumae, obtained by steam distillation, has a chemopreventive effect on gastric cancer induced by N‐methyl‐N'‐nitro‐N‐nitrosoguanidine (MNNG) in rats (<a href="./references#CD005096-bbs2-0190" title="LuB , XuL , YuL , ZhangL . Extract of radix curcumae prevents gastric cancer in rats. Digestion2008;77(2):87‐91. ">Lu 2008</a>). Furthermore, the alkaloid Matrine can inhibit cell proliferation and induce apoptosis of SGC‐7901 cells in vitro; the apoptosis induction appears to be through up‐regulating Fas/FasL expression and activating caspase‐3 enzyme (<a href="./references#CD005096-bbs2-0182" title="DaiZ , GaoJ , JiZ , WangX , RenH , LiuX , et al. Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase‐3. Journal of Ethnopharmacology 2009;123(1):91‐6. ">Dai 2009</a>). Aidi injection, a commonly used TCM recipe in China, appears to have the effect of inhibiting the proliferation of cancer cells, including gastric cancer cells, but the effect is uncertain and needs to be assessed more thoroughly (<a href="./references#CD005096-bbs2-0197" title="SaR . The retrospect and prospect of combination treatment with Traditional Chinese Medicine and Western medicine for cancer. Bulletin of Chinese Cancer2003;12(6):324‐6. ">Sa 2003</a>). Other TCMHs can improve immunity (<a href="./references#CD005096-bbs2-0180" title="BuP , ZhouC , ChenQ . The effects of Recipe of Fuzhenghuayu on inhibiting the metastasis and strengthening immune function of T‐cell in patients with gastric cancer after operation. Journal of Traditional Chinese Medicine2001;42(4):226. ">Bu 2001b</a>; <a href="./references#CD005096-bbs2-0189" title="LuW , SunG , PiaoB . The clinical and laboratory research of Yangweikangliu recipe for gastric cancer. Journal of Traditional Chinese Medicine1996;37(6):350‐2. ">Lu 1996</a>), for example Fuzhenghuayu Recipe can improve the function of T‐cells and inhibit metastasis after surgery in patients with gastric cancer. Some herbal recipes are believed to reduce the incidence of atypical hyperplasia in the gastric mucosa (<a href="./references#CD005096-bbs2-0194" title="QiuJ . Appraisement of the effect of Traditional Chinese medicine herbs on preventing cancer from metastasis. Journal of Traditional Chinese Medicine1993;34(9):560. ">Qiu 1993</a>), and many TCMHs (including Sijunzi decoction, As2O3, Radix Astragali seu Hedysari, Bulbus Alliican) lead to apoptosis of gastric cancer cells (<a href="./references#CD005096-bbs2-0203" title="WuM , YaoB . The research advancement of Chinese medicine in treatment of gastric cancer and inducing cellular apoptosis. Journal of Traditional Chinese Medicine2001;42(12):752‐4. ">Wu 2001</a>) by inducing expression of gene P53, P21. Huoxuehuayu recipe has the same effect, by inducing over‐expression of Bcl‐2 and inhibiting the expression of epidermoid growth factor receptors (EGFR). </p> </section> <section id="CD005096-sec-0034"> <h3 class="title" id="CD005096-sec-0034">Why it is important to do this review</h3> <p>TCMHs have been used widely and for many years to treat gastric cancer. Much clinical experience has been summarised and the first randomised controlled trial (RCT) appeared in 1986 (<a href="./references#CD005096-bbs2-0206" title="ZengX , HuP . MFO chemotherapy randomized with addition of Chinese herb medicine in patients with advanced gastric cancer. Chinese Journal of Clinical Oncology1986;13(3):145‐6. ">Zeng 1986</a>). Most of the literature about TCMH for gastric cancer, especially the RCTs (<a href="./references#CD005096-bbs2-0019" title="HuangX , SongA . Clinical research on elemene combined chemotherapy treating gastric cancer. Chinese Traditonal Medicine2005;5(3):40‐1. ">Huang 2005</a>; <a href="./references#CD005096-bbs2-0028" title="LiuJ , HuD , FanH , NiuL . Clinical observation of Tianlong treating advanced gastric cancer of 30 cases. Hebei Traditional Chinese Medicine2006;28(10):739‐40. [1002‐2619(2006)10‐739‐02] ">Liu 2006a</a>; <a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a>), have concluded that the TCMHs have positive effects on quality of life, prolonging the life span, and alleviating adverse events caused by routine chemotherapy, but the effectiveness and adverse effects of TCMHs have not been assessed systematically. The objective of this review was to assess the effectiveness of TCMHs for eradicating gastric cancerous cells and to determine whether TCMHs can improve the patient's general condition and prolong the average life span compared with routine clinical therapy for late or advanced gastric cancer, such as chemotherapy and radiotherapy. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005096-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005096-sec-0035"></div> <p>1. To appraise the improvement of and remission in patients by comparing the intervention group (TCMHs) with the control group (no TCMHs), including: </p> <p>(i) studies which compared TCMH to placebo (these may be either with or without concomitant treatment); or </p> <p>(ii) studies which compared TCMH to other treatments.</p> <p>The efficacy parameters included mortality and median survival time, time to progression, quality of life. </p> <p>2. To determine adverse events associated with TCMH treatment in patients with advanced or late gastric cancer. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005096-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005096-sec-0036"></div> <section id="CD005096-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005096-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) which compared TCMHs with either placebo or other drugs. </p> </section> <section id="CD005096-sec-0039"> <h4 class="title">Types of participants</h4> <p> <ol id="CD005096-list-0002"> <li> <p>Patients of any age whose final diagnosis was T (tumour) 1 to 4, N (lymph nodes) 1 to 3, M (metastasis) 1, confirmed by the new tumour, node, metastasis (TNM) descriptive stage (<a href="./references#CD005096-bbs2-0201" title="SobinL , WittekindL . UICC, Manual of Clinical Oncology 1990. TNM Classification of Malignant Tumors. Fifth. New York: Wiley‐Liss, 1997. ">UICC 1997</a>) and for whom surgery was not an option. This descriptive stage means that metastasis exists and the cancer has gone into advanced or late stage, that is, III or IV. </p> </li> <li> <p>Patients who have confirmed recurrence of gastric cancer accompanied by distant metastasis after operation. </p> </li> </ol> </p> </section> <section id="CD005096-sec-0040"> <h4 class="title">Types of interventions</h4> <p>RCTs of TCMH (oral or intravenous administration, or both) used for treatment of patients with advanced or late‐stage gastric cancer. This included TCMH treatment studies and clinical trials in which TCMHs were added to the other treatments for patients in advanced or late‐stage gastric cancer. </p> </section> <section id="CD005096-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>Endoscopic, radiographic, clinical, or histological remission as defined by the primary studies and expressed as a percentage of the number of patients randomised (intention‐to‐treat analysis) was the outcome measure of interest. Since definitions of advanced or late‐stage disease can vary from trial to trial, we used the individual definitions from each study. The number of patients with clinical improvement or remission of advanced or late gastric cancer was recorded. The exact definition of improvement and remission also varied from study to study, making exact comparisons across studies difficult or impossible. However, for the purpose of this analysis, we used the definition of improvement or remission as used in each study for extraction of data from the individual studies. </p> <p>Other outcomes of interest included life span, drug adverse effects, withdrawals for toxicity or adverse events, and the effects of drug interactions. </p> <section id="CD005096-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD005096-list-0003"> <li> <p>Mortality</p> </li> </ol> </p> </section> <section id="CD005096-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD005096-list-0004"> <li> <p>Quality of life (QOL): the QOL index was assessed by the Karnofsky score, if the score increased to over 10 at the end of the therapeutic period it was defined as improvement of QOL. </p> </li> <li> <p>Rate of remission (short‐term and long‐term): following the standards of the International Union Against Cancer (UICC), the rate of remission included complete remission (the tumour disappeared in a period of at least three months) and part remission (half of the tumour disappeared over at least three months). </p> </li> <li> <p>Median survival time (MST): MST is the median value for patient survival time.</p> </li> <li> <p>Time to progression (TTP): the time from the stage of remission to the stage of advancing cancer, i.e., the time for tumour relapse. </p> </li> </ol> </p> <p>Adverse events:</p> <p> <ol id="CD005096-list-0005"> <li> <p>life threatening;</p> </li> <li> <p>toxic response;</p> </li> <li> <p>resulting in the discontinuation of treatment.</p> </li> </ol> </p> <p>The side effects were those caused by either Chinese medicinal herbs or the comparator, or both. </p> </section> </section> </section> <section id="CD005096-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <p>See: Cochrane Upper Gastrointestinal and Pancreatic Diseases Group methods used in reviews. </p> <p>We conducted a search to identify all published and unpublished RCTs.</p> <section id="CD005096-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases:</p> <p> <ul id="CD005096-list-0006"> <li> <p><i>The Cochrane Library</i> (Issue 3, 2011) (<a href="./appendices#CD005096-sec-0136">Appendix 1</a>), </p> </li> <li> <p>MEDLINE (from 1950 to June 2011) (<a href="./appendices#CD005096-sec-0137">Appendix 2</a>), </p> </li> <li> <p>EMBASE (from 1980 to June 2011) (<a href="./appendices#CD005096-sec-0138">Appendix 3</a>), </p> </li> <li> <p>AHMED (Allied and Complementary Medicine Database), and</p> </li> <li> <p>CBM (Chinese Biomedical Database) (from 1974 to June 2011) (<a href="./appendices#CD005096-sec-0139">Appendix 4</a>). </p> </li> </ul> </p> <p>The search strategy for the review was constructed by using a combination of MeSH subject headings and text words relating to the use of TCMHs in the treatment of advanced or inoperable gastric cancer. </p> </section> <section id="CD005096-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We handsearched reference lists from trials selected by electronic searching to identify further relevant trials. We contacted authors of identified studies to request any further published or unpublished work. </p> <p>We handsearched the following journals:</p> <p> <ul id="CD005096-list-0007"> <li> <p><i>Acta Medicinae Sinica,</i> </p> </li> <li> <p><i>Cancer Research on Prevention and Treatment,</i> </p> </li> <li> <p><i>China Journal of Chinese Materia Medica,</i> </p> </li> <li> <p><i>China Oncology,</i> </p> </li> <li> <p><i>Chinese Journal of Cancer Research,</i> </p> </li> <li> <p><i>Chinese Journal of Clinical Oncology and Rehabilitation,</i> </p> </li> <li> <p><i>Chinese Journal of Integrated Traditional and Western Medicine on Digestion,</i> </p> </li> <li> <p><i>Chinese Journal of Oncology,</i> </p> </li> <li> <p><i>Chinese Journal of Radiation Oncology,</i> </p> </li> <li> <p><i>Henan Journal of Traditional Chinese Medicine,</i> </p> </li> <li> <p><i>Jiangshu Journal of Tradition Chinese Medicine,</i> </p> </li> <li> <p><i>Journal of Beijing of Tradition Chinese Medicine,</i> </p> </li> <li> <p><i>Journal of Fujian of Traditional Chinese Medicine,</i> </p> </li> <li> <p><i>Journal of Jilin of Traditional Chinese Medicine,</i> </p> </li> <li> <p><i>Journal of Practical Oncology,</i> </p> </li> <li> <p><i>Journal of Nanjing University of Traditional Chinese Medicine,</i> </p> </li> <li> <p><i>Journal of Sichuang of Traditional Chinese Medicine,</i> </p> </li> <li> <p><i>JTCM (Journal of Traditional Chinese Medicine),</i> </p> </li> <li> <p><i>Traditional Chinese Medicinal Research.</i> </p> </li> </ul> </p> <p>In addition, we contacted the World Health Organization, experts in the field, and medicinal herb manufacturers to request details of outstanding clinical trials or any relevant unpublished materials. </p> </section> </section> <section id="CD005096-sec-0047"> <h3 class="title" id="CD005096-sec-0047">Data collection and analysis</h3> <p>Where appropriate, we combined the extracted data (<a href="./references#CD005096-bbs2-0193" title="ParmarM , TorriV , StewartL . Extracting summary statistics to perform meta‐analysis of the published literature for survival endpoints. Statistics in Medicine1998;17:2815‐34. ">Parmar 1998</a>) from the various trials by calculating a pooled estimate of the odds ratio using the method of Mantel‐Haenszel, the relative risk and risk difference, and the 95% confidence intervals for dichotomous data. We used both fixed‐effect and random‐effects models. Where outcomes were measured as continuous data in a standard way across studies, we calculated the weighted mean difference and 95% confidence interval using a random‐effects model. Dropouts were analysed according to the principle of inefficiency in the intervention group and efficiency in the control group, and these conservative results were recorded. </p> <section id="CD005096-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Three authors reviewed potentially relevant studies to determine their eligibility based on the criteria (and mortality, MST, TTP, QOL outcomes) described above. </p> </section> <section id="CD005096-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Three review authors independently appraised each study and recorded the methodological criteria and the results of each study on standard data forms. For crossover studies, only data from the first portion of the study would have been incorporated in order to avoid possible carryover effects of medications into the second part of the study, and to make these studies more comparable to those studies not of crossover design. We determined all results on an intention‐to‐treat basis. </p> </section> <section id="CD005096-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The criteria for assessment of risk of bias included the specific methods of randomisation and allocation concealment, the blinding method, and reporting of dropouts or withdrawal of patients according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, Table 8.5.c (criteria for judging risk of bias in the 'risk of bias' assessment tool) (<a href="./references#CD005096-bbs2-0186" title="HigginsJ , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley &amp; Sons, 2008. ">Higgins 2008</a>). </p> </section> <section id="CD005096-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>If the heterogeneity across the included trials was low the treatment effects were pooled in a meta‐analysis, or a descriptive method was used. </p> </section> <section id="CD005096-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>There was a unit of analysis issue for one study. General information about the included studies is provided in the 'Characteristics of included studies' table. </p> </section> <section id="CD005096-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>Analyses were performed on an intention‐to‐treat basis if data were missing. For dichotomous data, patients in the treatment group with incomplete or missing data were regarded as treatment failures and those in the control group were regarded as treatment successes. According to this principle, a 'worst‐best case' scenario analysis would be carried out. </p> </section> <section id="CD005096-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>The heterogeneity of the included studies mainly resulted from the different recipes of TCHM used, assessed in the <a href="./full#CD005096-sec-0059">Results</a> section. </p> </section> <section id="CD005096-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>No</p> </section> <section id="CD005096-sec-0056"> <h4 class="title">Data synthesis</h4> <p>The dichotomous data were presented as relative risk (RR), and continuous outcomes by weighted mean difference (WMD), if possible, both with 95% confidence intervals (CI). </p> </section> <section id="CD005096-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>No</p> </section> <section id="CD005096-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>Where meta‐analysis was performed, we also carried out a sensitivity analysis.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005096-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005096-sec-0059"></div> <section id="CD005096-sec-0060"> <h3 class="title">Description of studies</h3> <section id="CD005096-sec-0061"> <h4 class="title">Results of the search</h4> <p>Our completed searches (June 2011) identified 179 articles: 172 from the electronic searches and seven from handsearching. After reading titles, abstracts, and the content of the articles we excluded 99 because they had study objectives that were different from those for this review, the reasons for exclusion are listed under <a href="./references#CD005096-sec-0150" title="">Characteristics of excluded studies</a>. The remaining 80 articles were selected for further assessment. </p> </section> <section id="CD005096-sec-0062"> <h4 class="title">Included studies</h4> <section id="CD005096-sec-0063"> <h5 class="title">Design</h5> <p>All of the included studies had a parallel design and no crossover design was used.</p> <p>According to the intervention measures, the 80 articles were subdivided into four types: </p> <p> <ol id="CD005096-list-0008"> <li> <p>TCMHs plus western therapeutic methods in the intervention group versus the same western therapeutic methods in the control group (type I in <a href="#CD005096-tbl-0005">Table 1</a>, 65 articles), </p> </li> <li> <p>TCMHs plus western therapeutic methods in the intervention group versus the same TCMHs in the control group (type II in <a href="#CD005096-tbl-0006">Table 2</a>, six articles), </p> </li> <li> <p>TCMHs in the intervention group versus other TCMHs in the control group (type III in <a href="#CD005096-tbl-0007">Table 3</a>, two articles), </p> </li> <li> <p>TCMHs in the intervention group versus western therapeutic methods in the control group (type IV in <a href="#CD005096-tbl-0008">Table 4</a>, seven articles). </p> </li> </ol> </p> <div class="table" id="CD005096-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs + medicine versus medicine)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0001" title="CaoY , LiN , ZhangL , HuaL , LiZ . Clinical observation about association with Western and Traditional Chinese Medicines treating 70 patients with advanced gastric cancer. Clinical Journal of Traditional Chinese Medicine1992;2(3):8‐9. ">Cao 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Radix Astragali. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0002" title="CaoJ , XiaoX , TangX . Observation of effect about Elemene plus fluorouracil and acupuncturing Shenque treat advanced gastric carcinoma. Chinese Clinic of Oncology1997;24(7):549‐50. ">Cao 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi, No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0003" title="ChenN , JinY , LaiY . Observation of effect Pingxiao capsule combined chemotherapy treats advanced gastric cancer. Straits Pharmacy1997;9(1):66‐7. ">Chen 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Curcumae, Alumen, Natrii Sulphas, Faeces Trogopterorum, Radix Achyranthis Bidentatae, Semen Strychni Pulveratum, Hebra Agrimoniae, No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0005" title="ChenP , GaoH , SongJ , ZhengW . ELF connected with Cidan capsule treat gastric carcinoma of 64 cases. Chinese Clinic of Oncology2005;32(8):466‐7. ">Chen 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rhizoma Curcumae, Pseudobulbus Cremastrae Seu Pleiones, Fructus Bruceae, Semen Strychni Pulveratum, Nidus Vespae, Radix Astragali, Calculus Bovis. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 22 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0006" title="ChenNJ , WuDH , LaiYQ , ChenYY . Combining AIDI and FOLFOX4 treated advanced gastric cancer. Guangming Journal of Chinese Medicine2008;23(11):1768‐9. ">Chen 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0008" title="DengW , GuanC . Elemene plus chemotherapy influence on immunity of older progressive gastric carcinoma. Journal of Guangdong Medical College2001;19(5):350. [1005‐4057(2001)‐05‐0350‐01] ">Deng 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0009" title="DengZJ , CaoHN , GaoTN . Shenfu Injection with PCF chemotherapy for late or advanced gastric cancer in 40 cases. Contemporary Medicine2011;17(12):116‐8. ">Deng 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenfu injecta (Radix Ginseng, Radix aconiti lateralis preparata). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0010" title="DuCJ , WangTL , GuoYS . Clinical observation of quality of life in patients with gastric carcinoma treated by combination of traditional Chinese medicine, chemotherapy and hyperthermia treatment. Hebei Journal of Traditional Chinese Medicine2010;32(9):1299‐301. ">Du 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TCMH fomula (Astragalus Mongholicus 30g, Rhizoma Polygonati 20g, Rhizoma atractylodis macrocephala 10g, Poria 10g, Radix Glycyrrhizae 6g, Fructus Ligustri Lucidi 10g, Rhizoma Sanguisorbae 20g, Caulis Spatholobi 30g, Colla Corii Asini 6g, Pericarpium Citri Reticulatae 10g, Rhizoma Pinelliae 6g, Radix Actinidiae Chinensis 20g) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0011" title="FuJW , DengY , HuangW . Compound matrine injection with chemotherapy in the treatment of pain from advanced or late gastric cancer in 40 patients. Journal of Emergency in Traditional Chinese Medicine2011;20(1):152‐3. ">Fu 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mojisankeli (Astragalus Mongholicus, Radix Codonopsitis, Semen Coicis, Fructus Amomi, Ventriculi Galli Mucosa, Sophora Flavescens, Hedyotis Diffusa, Spica Prunellae Vulgaris, Rhizoma Pinelliae, Rhizoma Arisaematis, Kelp, Rhizoma Curcumae Aeruginosae, Rhizoma Sparganii, Radix Curcumae Longae, Scolopendra). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0013" title="GongL , JiangC , ZhaoY . Aidi combining with chemotherapy treat progressive gastric carcinoma. Journal of Oncology2006;12(5):424‐5. ">Gong 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix ginseng, Radix Astragali, Radix Acanthopanacis Senticosi, Chinese Cantharides. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0014" title="GuanC , HeG , YinZ . Effect of elemene emulsion combined chemotherapy on immunity of gastric cancer patients in progressive stage. Chinese Clinic of Oncology2001;28(2):123‐4. [1000‐8179(2001)‐02‐0123‐02] ">Guan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0015" title="GuoL , ChenG . Observation of efficacy about association with Western and Traditional Chinese Medicines treats 90 patients with advanced gastric carcinoma. Fujian Medicine Journal1999;11(1):19‐20. ">Guo 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Largehead Atractylodes, Rhizome Cuscuta Japonica, fructus psoraleae, Fructus Ligustri Lucidi, Fructus Lycii. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0016" title="HuY , HouAJ , ZhangHW , HuangYL , GuWF . Clinical observation of Fuzheng Xiao'ai prescription I combined with OFL regimen for treatment advanced gastric cancer. Journal of New Chinese Medicine2011;43(2):104‐6. ">Hu 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fuzhengxiao'ai I formula (Poria 10g, Radix angelicae seu hemsley 10g, Radix Saposhnikoviae 10g, Rhizoma atractylodis macrocephala 10g, Rhizoma Rehmanniae 10g, Rhizoma Chuanxiong 10g, Cortex Moutan 10g, Radix Actinidiae Chinensis 10g, Radix Pseudoxtellariae 15g, Astragalus Mongholicus 15g, Radix Ophiopogonis 15g, Pseudobulbus Cremastrae Seu Pleiones 15g, Hedyotis Diffusa 30g, Radix Glycyrrhizae 6g, Scolopendra 2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0017" title="HuaB , WangA , HouW . Clinical study on treatment of mid‐late stage gastric carcinoma by composite Xiansu capsule combined with chemotherapy. Journal of Combination of Traditional Chinese Medicine with Western Medicine1999;19(8):470‐3. ">Hua 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>radix ginseng 20g, Radix Astragali 15g, Largehead Atractylodes Rhizome 15g, Prepared Resina Olibani 10g, Prepared Myrrha 10g, Herba Hedyotis Diffusae 30g, Hebra Agrimoniae 30g, Rhizoma Curcumae 15g, Radix Trichosanthis 20g, Venenum Bufonis 0.3g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0018" title="HuangZ , SiZ , LuoY , HuangN . Clinical efficacy of Toad Venom injection combined with chemotherapy in treating 31 patients with medium and advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine2002;24(3):163‐5. ">Huang 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Injecta of Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0019" title="HuangX , SongA . Clinical research on elemene combined chemotherapy treating gastric cancer. Chinese Traditonal Medicine2005;5(3):40‐1. ">Huang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0020" title="JiaL , ZhuS , LiP , ZhangK , WanD , CaiG , et al. Therapeutic effect observation about Aidi, Cisplatin and Fluorouracil treating gastric carcinoma. Journal of China Oncology2003;25(5):517. ">Jia 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Ginseng, Radix Astragali, Radix Acanthopanacis Senticosi. Chinese Cantharides. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0021" title="JiaJW , LiuYQ . The effect of Shenqi Fuzheng injection combined with FOLFOX4 regimen in the treatment of advanced gastric cancer. The Practical Journal of Cancer2009;24(3):273‐5. ">Jia 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0024" title="LiS , HeL , SongY . A clinical report of Yiqihuoxue Recipe combinating with FAP regimen for improving the living qualities in patients with gastric cancer in advanced or late stage. Journal of Sichuan of Traditional Chinese Medicine2002;20(12):33‐4. ">Li 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 40g, Radix Codonopsis Pilosulae 30g, Radix Salviae Miltiorrhizae 30g, Radix Paeoniae Rubra 30g, Radix Rubiae 30g, Rhizoma Sparganii 30g, Ochra Haematitum 30g, Poria 15g, Largehead Atractylodes Rhizome 10g, Radix Glycyrrhizae 10g, Rhizome of Oldworld Arrowhead 10g, Flos Inulae 6g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0025" title="LinCL , GeJH . Clinical research of gastric cancer at the late stage treated with Compound Spophora Flavescens injection combined with chemotherapy. World Journal of Integrated Traditional and Western Medicine2011;6(4):316‐8. ">Lin 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0027" title="LiuH , ZengB , XuL . Observation of decoction of eight ingredients combined with chemotherapy treating advanced gastric carcinoma. Modern Journal of Integrated Traditional Chinese and Western Medicine2006;15(24):3366. ">Liu 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 30g, Radix Codonopsis Pilosulae 20g, Largehead Atractylodes Rhizome 10g, Poria10g, Radix Paeoniae Alba 15g, Radix Angelicae Sinensis 12g, Prepared Radix Rehmanniae 10g, Rhizoma Ligustici Chuanxiong 10g, Prepared Rhizoma Pinelliae 9g, Percarpiu Citri Reticulatae 6g, Carapax Trionycis 30g, Squama Manitis 15g, Caulis Spathoobi 30g, Panax Notoginseng 6g, Radix Glycyrrhizae 5g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0028" title="LiuJ , HuD , FanH , NiuL . Clinical observation of Tianlong treating advanced gastric cancer of 30 cases. Hebei Traditional Chinese Medicine2006;28(10):739‐40. [1002‐2619(2006)10‐739‐02] ">Liu 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gekko Japonicus Dumeril et Bibron 4g, Herba Rabdosiae 30g, Rhizoma Smilacls Chinensis 30g, Radix Actinidiae Chinensis 30g, Radix Ginseng 30g, Radix Astragali 30g, Poria 20g, Dried Semen Coicis 30g, Fructus Crataegi 15g, Rhizoma Curcumae15g, Akebia Trifoliata Koidz 30g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0029" title="LiuLH , ZhangCX . Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma. China Modern Doctor2009;47(29):16‐7. ">Liu 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0030" title="LiuSL , DingC , GuXX . Compound matrine injection with chemotherapy in the treatment of 29 patients with advanced gastric cancer. Chinese Journal of Coal Industry Medicine2009;12(10):1566‐7. ">Liu 2009a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0031" title="LuoPF . The effect of Shenqi Fuzheng injection combined with chemotherapy for advanced gastric cancer. Modern Medicine &amp; Health2011;27(8):1170‐1. ">Luo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5˜6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0032" title="LvB , YangJ . Analysis of efficacy about association Western and Traditional Chinese medicines treating 48 patients with progressive and advanced gastric cancer. Chinese Traditional Treatment1999;2(2):24‐5. ">Lv 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decoction of Taohongsiwu, Decoction of Maimendong. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0033" title="NiuH , MuY . Complex prescription of the TCM and chemotherapy treat 120 patients with advanced gastric carcinoma. Shanxi Traditional Chinese Medicine2006;26(9):1034‐5. ">Niu 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percarpiu Citri Reticulatae, Cortex Magnoliae Officinalis 12g, Ramulus Cinnamomi, Largehead Atractylodes Rhizome, Rhizoma Alismatis10g, Rhizoma Atractylodis 15g, Poria 15g, Umbellate Pore Fungus 9g, Scorpio 5 to 10g, Scolopendra Subspinipes Mutilans L.koch 1 to 3, Fructus Ziziphi Jujubae 10, Radix Glycyrrhizae 6g, Hebra Agastachis, Semen Coicis, Radix Paeoniae Rubra, Radix Codonopsis Pilosulae, Fructus Hordei Germinatus, Fructus Oryzae Germinatus, Faeces Trogopterorum, Pollen Typhae, Rhizoma Polygonati Odorati, Radix Adenophorae, Cortex Cinnamomi, Fructus Evodiae, Panax Notoginseng, Radix Rubiae. No specific dosage of the partly herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0034" title="PengZ , ZhangY , ChenM . Strengthing‐body‐resistance decoction effect on immunity of gastric cancer patients. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1459. [1000‐1719(2006)11‐1459‐01] ">Peng 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 40g, Radix Paeoniae Alba 24g, Rhizoma Corydalis 15g, Fructus Tsaoko 15g, Os Spepiella Seu Sepiae 15g, Poria 15g, PreparedRadix Glycyrrhizae 15g, Baked Concha Arcae 12g, Radix Panacis Quinquefolii 10g, Faeces Trogopterorum 10g, Myrrha 10g, Radix Angelicae Sinensis 10g, Largehead Atractylodes Rhizome 10g, Endothelium Corneum Gigeriae Galli 10g, Panax Notoginseng 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0035" title="RaoF , YuR , HuY , WangY , JinJ , TianZ . Long‐term effect observation Shengxuetang combined with chemotherapy treats advanced gastric cancer. Chinese Journal of Traditional Chinese Medicine1994;14(6):366. ">Rao 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 30g, Radix Pseudostellariae 30g, Caulis Spathoobi 30g, Largehead Atractylodes Rhizome 10g, Poria10g, Fructus Lycii15g, Fructus Ligustri Lucidi 15g, Cuscuta Jjaponica 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0038" title="SiH , ShangG , LuW . Observation of efficacy about TCM and chemo treating advanced gastric cancer. Jiangsu Journal of Traditional Chinese Medicine2004;35(258):40‐1. ">Si 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percarpiu Citri Reticulatae, Prepared Rhizoma Pinelliae, Poria, Radix Glycyrrhizae, Radix Aucklandiae, Semen Sinapis Albae, Radix Codonopsis Pilosulae, Largehead Atractylodes Rhizome, Radix Adenophorae, Radix Ophiopogonis, Rhizoma Polygonati Odorati, Dried Radix Rehmanniae, Prepared Radix Rehmanniae, Radix Angelicae Sinensis, Fructus Meliae Toosendan, Radix Bupleuri, Rhizoma Cyperi, Pericarpium Citri Reticulatae, Percarpiu Citri Reticulatae, Fructus Citri Sarcodactylis, Radix Angelicae Sinensis, Semen Persicae, Radix Paeoniae Alba, Radix Salviae Miltiorrhizae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0039" title="SunG , LiJ . Clinical and experimental research about Qiao‐Wei‐Kang‐Liu dissolved medicines combined with chemotherapy treating advanced gastric cancer. Medical Research Communication1999;28(6):6‐7. ">Sun 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yangweikangliuchongji. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 to 36 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0040" title="TianR , YangJ , ZhangB , LiG . Clinical observations of gastric cancer patients treated with chemotherapy and Lanxiangxiru as a MDR mediator treated with chemotherapy and Elemene as a MDR mediator. Cancer Research on Prevention and Treatment1999;26(3):215‐6. ">Tian 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0041" title="WangR , WuD , JinY , ChenJ , LiuY , HuangP , et al. The short‐term effects of Jianpijiandu Decoction plus chemotherapy for advanced gastric cancer. Fujian Journal of Traditional Chinese Medicine1993;24(5):23‐6. ">Wang 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 15g, Radix Astragali 15g, Largehead Atractylodes Rhizome 15g, Poria 10g, Percarpiu Citri Reticulatae 6g, Rhizoma Pinelliae 6g, Caulis Spathoobi 30g, Fructus Lycii 15g, Fructus Ligustri Lucidi 15g, Radix Paeoniae Alba 15g, Radix Ophiopogonis 12g, Herba Hedyotis Diffusae 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0043" title="WangX , WangR , DaiH . Invigorating the spleen and removing cancer ingredient combined with chemotherapy treat older advanced gastric carcinoma of 90 cases. Shandong Journal of Chinese Medicine2002;21(9):527‐8. [0257‐358X(2002)09‐0527‐02] ">Wang 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Arisaemacum Bile, Rhizoma Pinelliae, Percarpiu Citri Reticulatae, Fructus Aurantii Immaturus, Bulbus Fritillariae Cirrhosae, Semen Sinapis Albae, Scorpio, Endothelium Corneum Gigeriae Galli, Radix Glycyrrhizae. No specific dosage of the herb. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0044" title="WangP . Observation effect in chemotherapy, radiotherapy and Yadanzi oil treating advanced gastric carcinoma. Journal of Practical Oncology2004;19(1):78‐9. [1001‐1692(2004)01‐0078‐02] ">Wang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fructus Bruceae. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0045" title="WangR , PanY , YeZ . Clinical observation about Invigorating the spleen and dissolving petechia mixtura combined with chemotherapy treating advanced gastric carcinoma of 24 cases. Jiangsu Traditional Chinese Medicine2004;25(11):22‐3. [1672‐397X(2004)11‐0022‐02] ">Wang 2004a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 20g, Radix Codonopsis Pilosulae 15g, Largehead Atractylodes Rhizome 12g, Rhizoma Dioscoreae 12g, Semen Coicis 30g, Percarpiu Citri Reticulatae 6g, Radix Salviae Miltiorrhizae 10g, Rhizoma Curcumae 15g, Herba Salviae Chinensis 10g, Herba Solani Nigri 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0046" title="WangZL , ShenHL , ZhouG , LiZY . The effects of Aidi injection to assist selective infusion chemotherapy in treatment of advanced gastric cancer. Journal of Zhejiang Chinese Medical University2009;33(2):219‐20. ">Wang 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0047" title="WangYH . The effect of Huachansu with chemotherapy for advanced or late gastric cancer. Jaingxi Journal of Traditional Chinese Medicine2009;40(4):31‐2. ">Wang 2009a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0048" title="WangJF . The effect of Shenqi Fuzheng injection combined with chemotherapy and radiotherapy for local advanced gastric cancer. Chinese Journal of Traditional Medical Science and Technology2010;17(6):537‐8. ">Wang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0049" title="WangJ , WangKM , WangZX , LuBB , LiJ . Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma. Chinese Journal of New Drugs2010;19(17):1585‐8. ">Wang 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0050" title="WangWM , LiCF , YaoRJ . The clinical effect of Huachansu with chemotherapy for late gastric cancer. Clinical Journal of Traditional Chinese Medicine2010;22(4):314‐5. ">Wang 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0051" title="WuY , CaiM , ZhuX . Following up of 5 years about Western and Chinese Traditional Medicines treating advanced gastric cancer. Journal of Nanjing University of Traditional Chinese Medicine1999;15(2):124. ">Wu 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Bupleuri 10g, Radix Curcumae 10g, Fructus Aurantii 6g, Rhizoma Cyperi 10g, Radix Codonopsis Pilosulae 20g, Poria 10g, Prepared Radix Rehmanniae 10g, Aspongopus 10g, Nidus Vespae 10g, Herba Scutellariae Barbatae 30g, Rhizoma Zingiberis 6g, Largehead Atractylodes Rhizome 10g, Rhizoma Pinelliae 10g, Chinese Buckeye Seed 10g, Percarpium Citri Reticulatae 6g, Radix Astragali 30g, Radix Paeoniae Alba 10g, Radix Angelicae Sinensis 10g, Pollen Typhae 10g, Faeces Trogopterorum 10g, Rhizoma Ligustici Chuanxiong 6g, Hebra Agrimoniae 30g, Rhizoma Polygonati Odorati 10g, Semen Persicae 10g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0052" title="WuY . Analysis of the therapeutic effect of Fuzhenggongjian capsule on the late gastric carcinoma under chemotherapy. Journal of Zhengjiang Medical College2000;10(4):656‐7. ">Wu 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 300g, Rhizoma Curcumae 150g, Herba Hedyotis Diffusae 150g, Dried Semen Coicis 150g, Herba Salviae Chinensis 150g, Radix Clematidis 100g, Powder of Shark Cartilage 150g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0053" title="WuC , LiQ , ZhaoY , LiQ . Controlled observation on Elemene plus chemotherapy treating advanced gastric cancer. Journal of North Sichuan Medical College2000;15(3):12‐3. [1005‐3697(2000)03‐0012‐02] ">Wu 2000a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Sophorae Subprostratae, Herba Hedyotis Diffusae, Radix Astragali, Pseudobulbus Cremastrae Seu Pleiones, Radix Curcumae, Radix Semiaquilegiae, Spica Prunellae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0055" title="XiongLG . Clinical observation of Yanshu injection combined with paclitaxel and oxaliplatin in the treatment of advanced gastric cancer. The Practical Journal of Cancer2008;23(3):276‐7. ">Xiong 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0057" title="XuD , ZhangX . Clinical observation about Ai‐Fu‐Kang plus chemotherapy treating patients with progressive gastric cancer after operation. Shanxi Traditional Chinese Medicine1993;9(4):14. ">Xu 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mesona Chinensis Benth, DriedPrepared Radix Rehmanniae, Radix Astragali, Radix Codonopsis Pilosulae, Panax Notoginseng, Radix Salviae Miltiorrhizae, Calculus Bovis, Moschus, Hebra Euphorbiae Lunulatae, Herba Solani Nigri, Herba Scutellariae Barbatae £¨No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0058" title="XuY . Clinical efficacy study Fuzhenghuoxue combined with chemotherapy in treating advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine1999;21(6):329‐31. ">Xu 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dried Radix Astragali, Radix Scrophulariae, Fructus Ligustri Lucidi, Umbellate Pore Fungus, Semen Coicis, Hebra Agrimoniae, Caulis Spathoobi, Herba Solani Lyrati, Herba Hedyotis Diffusae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0059" title="YangZ , YuanX , LiG . Shenfu combining with ELFP treat advanced gastric carcinoma of 40 cases. Chinese Medical Science Study2005;18(7):26‐7. ">Yang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Ginseng Rubra, Radix Aconiti Praeparata. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0065" title="ZhangF . Clinic research that Shengyutang treats adverse reaction after advanced gastric cancer patients receive chemotherapy. Journal of Changchun College of Traditional Chinese Medicine1997;13(61):18. ">Zhang 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prepared Radix Rehmanniae 15g, Radix Paeoniae Alba 12g, Rhizoma Ligustici Chuanxiong 15g, Radix Angelicae Sinensis 12g, Radix Codonopsis Pilosulae 15g, Radix Astragali 20g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 22 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0066" title="ZhangC , WangQ . Huachansu combined with chemotherapy treat advanced 35 cases of gastric carcinoma. Journal of Anhui Traditional Chinese Medicine College2001;20(4):18‐9. [1000‐2219(2001)‐04‐0018‐01] ">Zhang 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0067" title="ZhangR , ChenC , ShenB , ZhouD , ZhangG . Clinical observation of Huachansu combined with chemotherapy treating advanced gastric carcinoma. Chinese Clinical Oncology2004;9(3):269‐70. [1009‐0460(2004)‐03‐0269‐02] ">Zhang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0068" title="ZhangY , ZhuM , CaoT , ZhangP , YaoL , HuangH . Observation of curative effect of Huachansu combined with chemotherapy treating progressive and advanced gastric carcinoma. Henan Journal of Oncology2005;18(5):359‐60. [1003‐1464(2005)05‐0359‐02] ">Zhang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0069" title="ZhangJ , WangH , ZhangY . Jinlong capsule combined with HFL treat advanced gastric carcinoma. Capital Medicine2005;9(23):33. ">Zhang 2005a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule of Jinlong</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0070" title="ZhangZ , WangY , RongD . Late effect of Huachansu combined with hydroxy. Practical Journal of Medicine and Pharmaceuticals2006;23(7):794‐5. ">Zhang 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0071" title="ZhangH , SuZX . Curative effect of Shenling Baizhu powder on chemotherapy‐induced toxicity in advanced gastric cancer. Journal of TCM University of Hunan2008;28(2):51‐3, 56. ">Zhang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenlingbaizhusanjiawei (Radix Codonopsitis 20g, Astragalus Mongholicus 30g, Poria 15g, Rhizoma atractylodis macrocephala 15g, Semen Coicis 30g, Dolichos Lablab 10g, Radix Saposhnikoviae 15g, Semen Nelumbinis 10g, Fructus Amomi 9g, Halloysitum Rubrum 20g, Rhizoma Pinelliae 10g, Radix Platycodi 10g,Radix Glycyrrhizae 6g, Red Dates 5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0072" title="ZhangAX . Aidi injection with chemotherapy for advanced or late gastric cancer. Journal of Medical Theory &amp; Practice2009;22(10):1214. ">Zhang 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0074" title="ZhangL , WangYF . The effect and immune function of Kanglaite with chemotherapy for advanced or late gastric cancer. Acta Universitatis Medicinalis Nanjin (Natural Science)2010;30(11):1657‐9. ">Zhang 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kanglaite injecta (Semen Coicis). No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0075" title="ZhangMJ , ZuoCF . Observation of clinical efficacy of Yanshu injection combined with NP chemotherapy in treatment of advanced gastric cancer. Chinese Journal of Clinical Oncology and Rehabilitation2010;17(6):531‐3. ">Zhang 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0077" title="ZhengL , SunK . Research of efficacy about Western and Traditional Chinese Medicines treating progressing and advanced gastric cancer. Heilongjiang Medicine and Pharmacy1999;22(1):86‐7. ">Zheng 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 30g, Radix Salviae Miltiorrhizae 20g, Largehead Atractylodes Rhizome 15g, Prepared Radix Rehmanniae 20g, Placenta Hominis 10g, Fructus Lycii 15g, Caulis Spathoobi 30g, Radix Morindae Officinalis 12g, Colla Plastri Testudinis and Colla Cornus Cervi 20g, Radix Polygoni Multiflori Preparata 20g, Colla Corii Asini 10g, Radix Astragali 30g, Radix Salviae Miltiorrhizae 20g, Largehead Atractylodes Rhizome 15g, Prepared Radix Rehmanniae 20g, Placenta Hominis 10g, Fructus Lycii 15g, Caulis Spathoobi 30g, Radix Morindae Officinalis 12g, Colla Plastri Testudinis and Colla Cornus Cervi 20g, Radix Polygoni Multiflori Preparata 20g, Colla Corii Asini 10g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0079" title="ZhuH , ZhuZ , XuL . White Powder of Three Ingredients Medicine treats progressive gastric cancer of 30 cases. Journal of Nanjing Traditional Chinese Medicine University2005;21(5):284‐5. [1000‐5005(2005)05‐0284‐02] ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Semen Crotonis Pulveratum(º¬10 % oil), Bulbus Fritillariae, Radix Platycodi, Prepared Radix Glycyrrhizae, Eupolyphaga Seu Steleophaga, Rhizoma Zedoariae, Moschus, Dried Panax Notoginseng, Dried Semen Coicis, Radix Bupleuri, Radix Aucklandiae, Scorpio, Nidus Vespae, Parched Radix Paeoniae Alba, Radix Codonopsis Pilosulae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0080" title="ZhuJ , SongM , WangL , SunQ , ZhuL , FangC . Immunoregulation and short‐term therapeutic effect of super‐selective intra‐arteral chemotherapy combined with traditional Chinese drugs on gastric cancer patients. Journal of Chinese Integrative Medicine2006;4(5):478‐81. ">Zhu 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 15g, Largehead Atractylodes Rhizome 20g, Radix Astragali 30g, Semen Coicis 30g, Herba Solani Lyrati20g, Rhizoma Paridis 30g, Herba Hedyotis Diffusae 30g, fructus psoraleae 10g, Herba Salviae Chinensis 30g, PreparedRadix Glycyrrhizae 5g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005096-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs + medicine versus TCMHs)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0004" title="ChenN , JinY , LiuY , ChenY . Observation of effect about hydroxycamptothecin combined with Chinese medicine treating advanced gastric carcinoma of 41 cases. Fujian Journal of Medicine1997;19(2):82. ">Chen 1997a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decoction of Maimendo, Xiaoyao San, Shixiao San, Decoction of Lizhong ‐ No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0026" title="LiuY , ZhouJ . Association with Western and Traditional Chinese Medicines treats 30 patients with advanced gastric cancer. Journal of Shandong Traditional Chinese Medicine2002;21(3):164‐5. [0257‐358X(2002)03‐0164‐02] ">Liu 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DriedPollen Typhae 10g, Faeces Trogopterorum 10g, Herba Solani Nigri 30g, Dried Leaf of Cycasrevoluta 30g, Radix Actinidiae Chinensis 30g, Hebra Agrimoniae 30g, Herba Taraxaci 30g, Rhizoma Corydalis 10g, Radix Paeoniae Rubra 10g, Semen Persicae 10g, Rhizoma PolygonatiOdorati 20g Hebra Chelidonii 20g Nodus Nelumbinis Rhizomatis 20g, Percarpiu Citri Reticulatae 10g, Rhizoma Pinelliae 10g, Radix Curcumae 10g, Sargassum 10g, Thallus Eckloniae 10g, Bulbus Fritillariae 10g, Poria 15g, Full Fructus Trichosanthis 30g, Dried Concha Ostreae 30g, Radix Glycyrrhizae 6g, Radix Codonopsis Pilosulae 20g, Largehead Atractylodes Rhizome 10g, Radix Aconiti Praeparata 10g, Semen Alpiniae Katsumadai 6g, Rhizoma Zingiberis 6g, Umbellate Pore Fungus 15g, fructus psoraleae 15g, Radix Astragali 30g, Radix Angelicae Sinensis 15g, Rhizoma Ligustici Chuanxiong 10g, Radix Paeoniae Alba 10g, Fructus Aurantii 10g, Prepared Radix Rehmanniae 10g, Cortex Cinnamomi 6g, cuscuta japonica 12g, Fructus Lycii 12g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 22 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0042" title="WangG , ZhuJ , XuW , WangY , ZhouA . Clinical and experimental studies on Fuzheng granula combined with chemotherapy in advanced gastric cancer. World Chinese Journal of Digestology1998;6(3):214‐8. [ISSN1007‐9319 CN 14‐1218/R] ">Wang 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Dried Radix Astragali, Dried Largehead Atractylodes Rhizome, Fructus Psoraleae, Herba Salviae Chinensis, Herba Hedyotis Diffusae, Rhizoma Paridis, Dried Semen Coicis ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0056" title="XuY . The effects of Yangxue decoction plus chemotherapy for late gastric cancer after operation. Journal of Practical Oncology1989;3(1):54‐6. ">Xu 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Ginseng, Cuscuta Japonica, Fructus Psoraleae, Colla Corii Asini, Fructus Lycii, Radix Polygoni Multiflori Preparata, Largehead Atractylodes Rhizome, Fructus Ligustri Lucidi, Radix Paeoniae Alba, Radix Paeoniae Alba, Caulis Spatholobi, Massa Medicata Fermentata, Fructus Hordei Germinatus, Fructus Crataegi, Endothelium Corneum Gigeriae Galli, Fructus Aurantii Immaturus, Pericarpium Citri Reticulatae, Rhizoma Pinelliae, Caulis Bambusae In Taeniam, Radix Astragali, Herba Scutellariae Barbatae, Herba Hedyotis Diffusae ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0064" title="YouJ , ZhaoJ , ZhouL . Clinical study about Fuzhenghewei in treating fourth stage gastric cancer. Jiangsu Chinese Medicine2005;26(11):11‐3. ">You 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 540g, Umbellate Pore Fungus 540g, ParchedLargehead Atractylodes Rhizome 180g, Poria 180g, Folium Eriobotryae 180g, Prepared Rhizoma Pinelliae 108g, Semen Coicis 540g, Fructus Hordei Germinatus 180g, DriedRadix Glycyrrhizae 54g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0076" title="ZhaoZ , LiaoZ , ZhaoX . The clinic research of the effect of Sheng Mai injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Modern Oncology2005;13(3):387‐8. [1672‐4992(2005)03‐387‐02] ">Zhao 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix ginseng, Radix Ophiopogonis, Fructus Schisandrae Chinensis ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005096-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs versus TCMHs)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0036" title="ShaoJ . clinical study of compound Zhenjian liquid in treating advanced gastric cancer. Journal of Traditional Chinese Medicine1998;39(8):479‐80. ">Shao 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lysimachia Pentapetala Bunge, Ramulus Euonymi Alatae, Hirudo, Semen Coicis, Radix Sophorae Flavescentis, Dried Lacquer, Faeces Trogopterorum, Radix Curcumae, Alumen, Hebra Agrimoniae, Potassium Nitrate, Prepared Semen Strychni Pulveratum ‐ No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without Blind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0037" title="ShiL , YeY , LuoS , ChenJ , YanX . Effect on life quality and immune about Huachansu combined with Chinese medical differentiation of symptoms and signs in treating gastric carcinoma. Journal of Zhejiang Chinese Medicine College2004;28(6):20‐1. ">Shi 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis ‐ No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without Blind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005096-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs versus medicine)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 15g, Poria 15g, Rhizoma Atractylodis Macrocephalae 12g, Radix Astragali sue Hedysari 20g, Rhizoma Zedoariae 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Cyperi 12g, Rhizoma Pinellinae Praeparata 10g, Herba Scutellariae Barbatae 30g, Herba Hedyotis Diffusae 30g, Paris Polyphylla Smith 30g, Herba Salviae Chinensis 50g, Radix Glycyrrhizae 6g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 5 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Arisaemacum Bile, Rhizoma Pinelliae, Percarpiu Citri Reticulatae, Fructus Aurantii Immaturus, Bulbus Fritillariae Cirrhosae, Semen Sinapis Albae, Scorpio, Endothelium Corneum Gigeriae Galli, Radix Glycyrrhizae ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0062" title="YeSF , YeB , WuM . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Journal of Wenzhou Medical College2009;39(2):172‐3. ">Ye 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Umbellate Pore Fungus, Largehead Atractylodes Rhizome, Rhizoma Dioscoreae, Semen Coicis, Rhizoma Pinelliae, Rhizoma Zingiberis, Endothelium Corneum Gigeriae Galli, Massa Fermentata Medicinalis, Fructus Crataegi, Fructus Hordei Germinatus, Semen Raphani, Prepared Radix Rehmanniae ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Umbellate Pore Fungus 30g, Radix Codonopsis Pilosulae 10g, ParchedLargehead Atractylodes Rhizome 10g, Endothelium Corneum Gigeriae Galli 10g, ParchedFructus Oryzae Germinatus 15g, ParchedFructus Hordei Germinatus 15g, Caulis Perillae 10g, Radix Cynanchi Paniculati 15g, Fructus Aurantii Immaturus 10g, Hydrocotyle Sibthorpioides Lam 10g, Dried Radix Rehmanniae 15g, Prepared Radix Rehmanniae 15g, Radix Polygoni Multiflori Preparata 10g, Fructus Corni 10g, Cortex Moutan Radicis 10g, Rhizoma Alismatis 10g, Rhizoma Anemarrhenae 10g, Cortex Phellodendri 10g, Herba Epimedii 15g, Radix Astragali 30g, Rhizoma Polygonati 30g, Radix Ginseng 10g, Fructus Ligustri Lucidi 10g, Fructus Schisandrae Chinensis 10g, Fructus Gardeniae 10g, Radix Bupleuri 6g, Radix Angelicae Sinensis 6g, Radix Salviae Miltiorrhizae 30g, Radix Paeoniae Rubra 30g, Radix Paeoniae Alba 30g, Rhizoma Sparganii 15g, Rhizoma Curcumae 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0078" title='ZhouR , WuL , NiA , XuZ . Clinical observation of intravenous drip of "Anti‐inflammation1" in treating 24 patients with mid and late gastric carcinoma. Shanghai Journal of Traditional Chinese Medicine2000;34(8):15‐6. [1007‐1334(2000)08‐0015‐02] '>Zhou 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Herba Hedyotis Diffusae, Frucutus Xanthii, Herba Taraxaci ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> </tbody> </table> </div> <p>All the specific herbs used in the articles are listed in Tables 1 to 4 (Additional tables). None of the trials implemented blinding methods. We found no RCTs comparing a single herb with another single herb or herbal compounds. No placebo controlled trials were identified. We excluded another 99 articles because they did not meet our inclusion criteria. The reasons for exclusion, mainly because the selected patients did not have a TNM stage or the study was not a RCT, are listed under <a href="./references#CD005096-sec-0149" title="">Characteristics of included studies</a>. </p> <section id="CD005096-sec-0064"> <h6 class="title">Type I (TCMHs plus western therapeutic methods versus the same western therapeutic methods) </h6> <p>The 65 articles in type I included four kinds of injected TCMHs (a total of 23 trials for meta‐analysis) and reported random allocation of 5483 patients with advanced or late gastric cancer (ALGC) to TCMHs plus western therapeutic methods versus the same western therapeutic methods. Treatment was with non‐patented TCMHs in 24 trials and with patented TCMHs in 41 trials. The commonly used herbs were: </p> <p> <ul id="CD005096-list-0009"> <li> <p>Huachansu, in seven trials (<a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a>; <a href="./references#CD005096-bbs2-0047" title="WangYH . The effect of Huachansu with chemotherapy for advanced or late gastric cancer. Jaingxi Journal of Traditional Chinese Medicine2009;40(4):31‐2. ">Wang 2009a</a>; <a href="./references#CD005096-bbs2-0050" title="WangWM , LiCF , YaoRJ . The clinical effect of Huachansu with chemotherapy for late gastric cancer. Clinical Journal of Traditional Chinese Medicine2010;22(4):314‐5. ">Wang 2010b</a>; <a href="./references#CD005096-bbs2-0066" title="ZhangC , WangQ . Huachansu combined with chemotherapy treat advanced 35 cases of gastric carcinoma. Journal of Anhui Traditional Chinese Medicine College2001;20(4):18‐9. [1000‐2219(2001)‐04‐0018‐01] ">Zhang 2001</a>; <a href="./references#CD005096-bbs2-0067" title="ZhangR , ChenC , ShenB , ZhouD , ZhangG . Clinical observation of Huachansu combined with chemotherapy treating advanced gastric carcinoma. Chinese Clinical Oncology2004;9(3):269‐70. [1009‐0460(2004)‐03‐0269‐02] ">Zhang 2004</a>; <a href="./references#CD005096-bbs2-0068" title="ZhangY , ZhuM , CaoT , ZhangP , YaoL , HuangH . Observation of curative effect of Huachansu combined with chemotherapy treating progressive and advanced gastric carcinoma. Henan Journal of Oncology2005;18(5):359‐60. [1003‐1464(2005)05‐0359‐02] ">Zhang 2005</a>; <a href="./references#CD005096-bbs2-0070" title="ZhangZ , WangY , RongD . Late effect of Huachansu combined with hydroxy. Practical Journal of Medicine and Pharmaceuticals2006;23(7):794‐5. ">Zhang 2006</a>), </p> </li> <li> <p>Injections of Fufangkushen, in seven trials (<a href="./references#CD005096-bbs2-0011" title="FuJW , DengY , HuangW . Compound matrine injection with chemotherapy in the treatment of pain from advanced or late gastric cancer in 40 patients. Journal of Emergency in Traditional Chinese Medicine2011;20(1):152‐3. ">Fu 2011</a>; <a href="./references#CD005096-bbs2-0025" title="LinCL , GeJH . Clinical research of gastric cancer at the late stage treated with Compound Spophora Flavescens injection combined with chemotherapy. World Journal of Integrated Traditional and Western Medicine2011;6(4):316‐8. ">Lin 2011</a>; <a href="./references#CD005096-bbs2-0030" title="LiuSL , DingC , GuXX . Compound matrine injection with chemotherapy in the treatment of 29 patients with advanced gastric cancer. Chinese Journal of Coal Industry Medicine2009;12(10):1566‐7. ">Liu 2009a</a>; <a href="./references#CD005096-bbs2-0049" title="WangJ , WangKM , WangZX , LuBB , LiJ . Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma. Chinese Journal of New Drugs2010;19(17):1585‐8. ">Wang 2010a</a>; <a href="./references#CD005096-bbs2-0055" title="XiongLG . Clinical observation of Yanshu injection combined with paclitaxel and oxaliplatin in the treatment of advanced gastric cancer. The Practical Journal of Cancer2008;23(3):276‐7. ">Xiong 2008</a>; <a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a>; <a href="./references#CD005096-bbs2-0075" title="ZhangMJ , ZuoCF . Observation of clinical efficacy of Yanshu injection combined with NP chemotherapy in treatment of advanced gastric cancer. Chinese Journal of Clinical Oncology and Rehabilitation2010;17(6):531‐3. ">Zhang 2010b</a>), </p> </li> <li> <p>Injections of Aidi, in six trials (<a href="./references#CD005096-bbs2-0006" title="ChenNJ , WuDH , LaiYQ , ChenYY . Combining AIDI and FOLFOX4 treated advanced gastric cancer. Guangming Journal of Chinese Medicine2008;23(11):1768‐9. ">Chen 2008</a>; <a href="./references#CD005096-bbs2-0013" title="GongL , JiangC , ZhaoY . Aidi combining with chemotherapy treat progressive gastric carcinoma. Journal of Oncology2006;12(5):424‐5. ">Gong 2006</a>; <a href="./references#CD005096-bbs2-0020" title="JiaL , ZhuS , LiP , ZhangK , WanD , CaiG , et al. Therapeutic effect observation about Aidi, Cisplatin and Fluorouracil treating gastric carcinoma. Journal of China Oncology2003;25(5):517. ">Jia 2003</a>; <a href="./references#CD005096-bbs2-0029" title="LiuLH , ZhangCX . Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma. China Modern Doctor2009;47(29):16‐7. ">Liu 2009</a>; <a href="./references#CD005096-bbs2-0046" title="WangZL , ShenHL , ZhouG , LiZY . The effects of Aidi injection to assist selective infusion chemotherapy in treatment of advanced gastric cancer. Journal of Zhejiang Chinese Medical University2009;33(2):219‐20. ">Wang 2009</a>; <a href="./references#CD005096-bbs2-0072" title="ZhangAX . Aidi injection with chemotherapy for advanced or late gastric cancer. Journal of Medical Theory &amp; Practice2009;22(10):1214. ">Zhang 2009</a>), and </p> </li> <li> <p>Injections of Shenqifuzheng, in three trials (<a href="./references#CD005096-bbs2-0021" title="JiaJW , LiuYQ . The effect of Shenqi Fuzheng injection combined with FOLFOX4 regimen in the treatment of advanced gastric cancer. The Practical Journal of Cancer2009;24(3):273‐5. ">Jia 2009</a>; <a href="./references#CD005096-bbs2-0031" title="LuoPF . The effect of Shenqi Fuzheng injection combined with chemotherapy for advanced gastric cancer. Modern Medicine &amp; Health2011;27(8):1170‐1. ">Luo 2011</a>; <a href="./references#CD005096-bbs2-0048" title="WangJF . The effect of Shenqi Fuzheng injection combined with chemotherapy and radiotherapy for local advanced gastric cancer. Chinese Journal of Traditional Medical Science and Technology2010;17(6):537‐8. ">Wang 2010</a>). </p> </li> </ul> </p> <p>An emulsion of Lanxiangxi was used in five trials (<a href="./references#CD005096-bbs2-0002" title="CaoJ , XiaoX , TangX . Observation of effect about Elemene plus fluorouracil and acupuncturing Shenque treat advanced gastric carcinoma. Chinese Clinic of Oncology1997;24(7):549‐50. ">Cao 1997</a>; <a href="./references#CD005096-bbs2-0008" title="DengW , GuanC . Elemene plus chemotherapy influence on immunity of older progressive gastric carcinoma. Journal of Guangdong Medical College2001;19(5):350. [1005‐4057(2001)‐05‐0350‐01] ">Deng 2001</a>; <a href="./references#CD005096-bbs2-0014" title="GuanC , HeG , YinZ . Effect of elemene emulsion combined chemotherapy on immunity of gastric cancer patients in progressive stage. Chinese Clinic of Oncology2001;28(2):123‐4. [1000‐8179(2001)‐02‐0123‐02] ">Guan 2001</a>; <a href="./references#CD005096-bbs2-0040" title="TianR , YangJ , ZhangB , LiG . Clinical observations of gastric cancer patients treated with chemotherapy and Lanxiangxiru as a MDR mediator treated with chemotherapy and Elemene as a MDR mediator. Cancer Research on Prevention and Treatment1999;26(3):215‐6. ">Tian 1999</a>; <a href="./references#CD005096-bbs2-0053" title="WuC , LiQ , ZhaoY , LiQ . Controlled observation on Elemene plus chemotherapy treating advanced gastric cancer. Journal of North Sichuan Medical College2000;15(3):12‐3. [1005‐3697(2000)03‐0012‐02] ">Wu 2000a</a>), and others in 17 trials. </p> <p>In the 65 trials the western therapeutic interventions were:</p> <p> <ul id="CD005096-list-0010"> <li> <p>regimen of MFV (mitomycin C 4 mg intravenously (iv) drop factor (gtt) once daily (qd) X 1 day + fluorouracilum 0.5 to 1.0 iv gtt qd X 1 to 5 days + vincristine sulphate 2 mg iv qd X 1 to 2 days per week X 4 to 6) as comparator in 7 trials, </p> </li> <li> <p>regimen of ELF (etoposide 100 mg/m² iv gtt qd X 1 to 5 days + lencovorin 100 mg/m² iv gtt qd X 1 to 5 days + fluorouracilum 500 mg/m² iv gtt qd X 1 to 5 days per week X 2) as comparator in 18 trials, </p> </li> <li> <p>regimen of FAM (fluorouracilum 100 mg/m² iv gtt qd X 1 to 5 days + adriamycinum 30 to 40 mg/m² iv qd X 1 day + mitomycin C 8 to 10 mg/m² iv qd X 1 day per week X 3 to 4) as comparator in 6 trials, </p> </li> <li> <p>regimen of EAP (etoposide 100 mg/m² iv gtt qd X 4 to 6 days + adriamycinum 30 mg/m² iv qd X 1, 7 days + cisplatinum 40 mg/m² iv gtt qd X 2, 8 days per period X 2) as comparator in 3 trials, </p> </li> <li> <p>regimen of OFL (oxaliplatin 70 mg/m² iv gtt day 1 + calcium folinate 400 mg/m² iv gtt day 1 + fluorouracilum 500 mg/m² iv gtt day 1 to 5 per week X 3 to 4) in 4 trials, </p> </li> <li> <p>regimen of FOLFOX4 (oxaliplatin 100mg/m² iv gtt day 1 + calcium folinate 200 mg/m² iv gtt day 1 to 5 + fluorouracilum 500 mg/m² iv gtt day 1 to 5 per week X 6) in 6 trials, </p> </li> <li> <p>regimen of TPF (paclitaxel 175 mg/m² iv gtt day 1 + cisplatinum 200 mg/m² iv gtt day 1 to 5 + fluorouracilum 600 mg/m² iv gtt day 1 to 5 per week X 6) in 3 trials, and </p> </li> <li> <p>others in 19 trials.</p> </li> </ul> </p> <p>The relevant contents are described in the 'Additional tables' (<a href="#CD005096-tbl-0005">Table 1</a>: administration of Chinese medical herbs (TCMHs + medicine versus medicine)). </p> <p>In type I, seven trials (<a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a>; <a href="./references#CD005096-bbs2-0047" title="WangYH . The effect of Huachansu with chemotherapy for advanced or late gastric cancer. Jaingxi Journal of Traditional Chinese Medicine2009;40(4):31‐2. ">Wang 2009a</a>; <a href="./references#CD005096-bbs2-0050" title="WangWM , LiCF , YaoRJ . The clinical effect of Huachansu with chemotherapy for late gastric cancer. Clinical Journal of Traditional Chinese Medicine2010;22(4):314‐5. ">Wang 2010b</a>; <a href="./references#CD005096-bbs2-0066" title="ZhangC , WangQ . Huachansu combined with chemotherapy treat advanced 35 cases of gastric carcinoma. Journal of Anhui Traditional Chinese Medicine College2001;20(4):18‐9. [1000‐2219(2001)‐04‐0018‐01] ">Zhang 2001</a>; <a href="./references#CD005096-bbs2-0067" title="ZhangR , ChenC , ShenB , ZhouD , ZhangG . Clinical observation of Huachansu combined with chemotherapy treating advanced gastric carcinoma. Chinese Clinical Oncology2004;9(3):269‐70. [1009‐0460(2004)‐03‐0269‐02] ">Zhang 2004</a>; <a href="./references#CD005096-bbs2-0068" title="ZhangY , ZhuM , CaoT , ZhangP , YaoL , HuangH . Observation of curative effect of Huachansu combined with chemotherapy treating progressive and advanced gastric carcinoma. Henan Journal of Oncology2005;18(5):359‐60. [1003‐1464(2005)05‐0359‐02] ">Zhang 2005</a>; <a href="./references#CD005096-bbs2-0070" title="ZhangZ , WangY , RongD . Late effect of Huachansu combined with hydroxy. Practical Journal of Medicine and Pharmaceuticals2006;23(7):794‐5. ">Zhang 2006</a>) used the same TCMH (Huachansu) with a similar dosage and therapeutic period. In the seven identified trials, the age ranged from 25 to 82 years in the intervention group and from 23 to 75 years in the control group; the number of cases varied from 20 to 43 in the intervention group and from 23 to 43 in the control group. All five trials except two (<a href="./references#CD005096-bbs2-0050" title="WangWM , LiCF , YaoRJ . The clinical effect of Huachansu with chemotherapy for late gastric cancer. Clinical Journal of Traditional Chinese Medicine2010;22(4):314‐5. ">Wang 2010b</a>; <a href="./references#CD005096-bbs2-0066" title="ZhangC , WangQ . Huachansu combined with chemotherapy treat advanced 35 cases of gastric carcinoma. Journal of Anhui Traditional Chinese Medicine College2001;20(4):18‐9. [1000‐2219(2001)‐04‐0018‐01] ">Zhang 2001</a>), which only contained patients in stage IV, contained patients from both stages III and IV. The Huachansu was given by iv gtt 10 to 30 ml qd X 10 to 28 days in the intervention group during one therapeutic period, so the included participants, interventions, and outcomes were similar enough to allow combination of the data for meta‐analysis. The number of patients in each trial was too small to carry out subgroup analyses. In each trial, the same chemotherapeutic regimen and period were used for patients in the intervention group and the control group: </p> <p> <ul id="CD005096-list-0011"> <li> <p>in the first trial (<a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a>), the regimen was TPF (paclitaxel 175 mg/m² iv gtt day 1 + cisplatinum 200 mg/m² iv gtt day 1 to 5 + fluorouracilum 600 mg/m² iv gtt day 1 to 5 per week X 6); </p> </li> <li> <p>in the second trial (<a href="./references#CD005096-bbs2-0047" title="WangYH . The effect of Huachansu with chemotherapy for advanced or late gastric cancer. Jaingxi Journal of Traditional Chinese Medicine2009;40(4):31‐2. ">Wang 2009a</a>), the regimen was FOLFOX4 (oxaliplatin 85 mg/m² iv gtt day 1 + calcium folinate 100 mg/m² iv gtt day 1 to 2 + fluorouracilum 400 mg/m² iv day 1 to 2 + fluorouracilum 600 mg/m² iv gtt day 1 to 2 per week X 8); </p> </li> <li> <p>in the third trial (<a href="./references#CD005096-bbs2-0050" title="WangWM , LiCF , YaoRJ . The clinical effect of Huachansu with chemotherapy for late gastric cancer. Clinical Journal of Traditional Chinese Medicine2010;22(4):314‐5. ">Wang 2010b</a>), the regimen was FOLFOX4 (oxaliplatin (85 to 100 mg/m² iv gtt day 1 + calcium folinate 200 mg/m² iv gtt day 1 to 2 + fluorouracilum 400 mg/m² iv day 1 to 2 + fluorouracilum 600 mg/m² iv gtt day 1 to 2 per week X 16); </p> </li> <li> <p>in the fourth trial (<a href="./references#CD005096-bbs2-0066" title="ZhangC , WangQ . Huachansu combined with chemotherapy treat advanced 35 cases of gastric carcinoma. Journal of Anhui Traditional Chinese Medicine College2001;20(4):18‐9. [1000‐2219(2001)‐04‐0018‐01] ">Zhang 2001</a>), the regimen was ELF (etoposide 100 mg/m² iv gtt qd X 1 to 5 days + lencovorin 100 mg/m² iv gtt qd X 1 to 5 days + fluorouracilum 500 mg/m² iv gtt qd X 1 to 5 days per week X 2); </p> </li> <li> <p>in the fifth trial (<a href="./references#CD005096-bbs2-0067" title="ZhangR , ChenC , ShenB , ZhouD , ZhangG . Clinical observation of Huachansu combined with chemotherapy treating advanced gastric carcinoma. Chinese Clinical Oncology2004;9(3):269‐70. [1009‐0460(2004)‐03‐0269‐02] ">Zhang 2004</a>), the regimen was HLF (10‐hydroxycamptothecine 7 mg/m² iv gtt qd X 1 to 5 days + lencovorin 200 mg/m² iv gtt qd X 1 to 5 days + fluorouracilum 500 mg/m² iv gtt qd X 1 to 5 days per week X 3); </p> </li> <li> <p>in the sixth trial (<a href="./references#CD005096-bbs2-0068" title="ZhangY , ZhuM , CaoT , ZhangP , YaoL , HuangH . Observation of curative effect of Huachansu combined with chemotherapy treating progressive and advanced gastric carcinoma. Henan Journal of Oncology2005;18(5):359‐60. [1003‐1464(2005)05‐0359‐02] ">Zhang 2005</a>), the regimen was FLO (oxaliplatin 130 mg/m² iv gtt qd X 1 days + lencovorin 200 mg/m² iv gtt qd X 1 to 3 days + fluorouracilum 500 mg/m² iv gtt qd X 1 to 3 days per week X 3); and </p> </li> <li> <p>in the seventh trial (<a href="./references#CD005096-bbs2-0070" title="ZhangZ , WangY , RongD . Late effect of Huachansu combined with hydroxy. Practical Journal of Medicine and Pharmaceuticals2006;23(7):794‐5. ">Zhang 2006</a>), the regimen was HCPT (10‐hydroxycamptothecine 5 mg iv gtt qd X 1 to 5 days per week X 3). </p> </li> </ul> </p> <p>None of the seven trials except one (<a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a>) explained the specific method of randomisation (drew a lot) except to simply mention that randomisation was used. </p> <p>In type I, six trials (<a href="./references#CD005096-bbs2-0006" title="ChenNJ , WuDH , LaiYQ , ChenYY . Combining AIDI and FOLFOX4 treated advanced gastric cancer. Guangming Journal of Chinese Medicine2008;23(11):1768‐9. ">Chen 2008</a>; <a href="./references#CD005096-bbs2-0013" title="GongL , JiangC , ZhaoY . Aidi combining with chemotherapy treat progressive gastric carcinoma. Journal of Oncology2006;12(5):424‐5. ">Gong 2006</a>; <a href="./references#CD005096-bbs2-0020" title="JiaL , ZhuS , LiP , ZhangK , WanD , CaiG , et al. Therapeutic effect observation about Aidi, Cisplatin and Fluorouracil treating gastric carcinoma. Journal of China Oncology2003;25(5):517. ">Jia 2003</a>; <a href="./references#CD005096-bbs2-0029" title="LiuLH , ZhangCX . Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma. China Modern Doctor2009;47(29):16‐7. ">Liu 2009</a>; <a href="./references#CD005096-bbs2-0046" title="WangZL , ShenHL , ZhouG , LiZY . The effects of Aidi injection to assist selective infusion chemotherapy in treatment of advanced gastric cancer. Journal of Zhejiang Chinese Medical University2009;33(2):219‐20. ">Wang 2009</a>; <a href="./references#CD005096-bbs2-0072" title="ZhangAX . Aidi injection with chemotherapy for advanced or late gastric cancer. Journal of Medical Theory &amp; Practice2009;22(10):1214. ">Zhang 2009</a>) used the same TCMH (Aidi) with a similar dosage and therapeutic period. In the six identified trials, the age ranged from 30 to 78 years in the intervention group and from 35 to 85 years in the control group; the number of cases varied from 23 to 35 in the intervention group and from 22 to 34 in the control group. All six trials contained patients in both stage III and IV. The AIdi was given by iv gtt 50 ml qd X 10 to 42 (mostly 10 to 21) days in the intervention group during the therapeutic period, so the included participants, interventions, and outcomes were similar enough to allow the combination of data for meta‐analysis. The number of patients in each trial was too small to carry out subgroup analyses. In each trial, the same chemotherapeutic regimen and period were used for patients in the intervention group and the control group: </p> <p> <ul id="CD005096-list-0012"> <li> <p>in the first trial (<a href="./references#CD005096-bbs2-0006" title="ChenNJ , WuDH , LaiYQ , ChenYY . Combining AIDI and FOLFOX4 treated advanced gastric cancer. Guangming Journal of Chinese Medicine2008;23(11):1768‐9. ">Chen 2008</a>), the regimen was FOLFOX4 (oxaliplatin 85 mg/m² iv gtt day 1+ calcium folinate 200 mg/m² iv gtt day 1 to 2 + fluorouracilum 400 mg/m² iv gtt day 1 + fluorouracilum 600 mg/m² iv gtt day 2 per week X 6); </p> </li> <li> <p>in the second trial (<a href="./references#CD005096-bbs2-0013" title="GongL , JiangC , ZhaoY . Aidi combining with chemotherapy treat progressive gastric carcinoma. Journal of Oncology2006;12(5):424‐5. ">Gong 2006</a>), the regimen was TCF (paclitaxel (Taxol) 135 mg/m² iv, day 1 + fluorouracilum 500 mg/m² iv (4 h) day 1 to 5 + calcium folinate 100 mg/m² iv day 1 to 5 + cisplatinum 30 mg/m² Iv gtt day 1 to 3 per week X 12); </p> </li> <li> <p>in the third trial (<a href="./references#CD005096-bbs2-0020" title="JiaL , ZhuS , LiP , ZhangK , WanD , CaiG , et al. Therapeutic effect observation about Aidi, Cisplatin and Fluorouracil treating gastric carcinoma. Journal of China Oncology2003;25(5):517. ">Jia 2003</a>), the regimen was CF (fluorouracilum 500 mg/m² iv gtt day 1 to 5 + cisplatinum 50 mg iv gtt day 1 to 3 per week X 6); </p> </li> <li> <p>in the fourth trial (<a href="./references#CD005096-bbs2-0029" title="LiuLH , ZhangCX . Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma. China Modern Doctor2009;47(29):16‐7. ">Liu 2009</a>), the regimen was TPF (paclitaxel (Taxol) 175 mg/m² iv gtt day 1+ cisplatinum 20 mg/m² iv gtt day 1 to 5 + fluorouracilum 600 mg/m² iv gtt day 1 to 5 per week X 8); </p> </li> <li> <p>in the fifth trial (<a href="./references#CD005096-bbs2-0046" title="WangZL , ShenHL , ZhouG , LiZY . The effects of Aidi injection to assist selective infusion chemotherapy in treatment of advanced gastric cancer. Journal of Zhejiang Chinese Medical University2009;33(2):219‐20. ">Wang 2009</a>), the regimen was FAM (fluorouracilum 0.5 iv day 1 + adriamycinum 20 mg iv day 1 + mitomycin C 20mg iv day 1 X 12 weeks); </p> </li> <li> <p>in the sixth trial (<a href="./references#CD005096-bbs2-0072" title="ZhangAX . Aidi injection with chemotherapy for advanced or late gastric cancer. Journal of Medical Theory &amp; Practice2009;22(10):1214. ">Zhang 2009</a>), the regimen was FOLFOX4 (L‐OXA 100 mg/m² iv gtt day 1+ LV 200 mg/m² iv gtt day 1 to 2 + 5‐FU 400 mg/m² iv day 1 to 2 + 5‐FU 600mg/m² ) iv day 1 to 2 per week X 9). </p> </li> </ul> </p> <p>None of the six trials except one (<a href="./references#CD005096-bbs2-0029" title="LiuLH , ZhangCX . Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma. China Modern Doctor2009;47(29):16‐7. ">Liu 2009</a>) explained the specific method of randomisation (drew a lot) except to mention simply that randomisation was used. </p> <p>In type I, seven trials (<a href="./references#CD005096-bbs2-0011" title="FuJW , DengY , HuangW . Compound matrine injection with chemotherapy in the treatment of pain from advanced or late gastric cancer in 40 patients. Journal of Emergency in Traditional Chinese Medicine2011;20(1):152‐3. ">Fu 2011</a>; <a href="./references#CD005096-bbs2-0025" title="LinCL , GeJH . Clinical research of gastric cancer at the late stage treated with Compound Spophora Flavescens injection combined with chemotherapy. World Journal of Integrated Traditional and Western Medicine2011;6(4):316‐8. ">Lin 2011</a>; <a href="./references#CD005096-bbs2-0030" title="LiuSL , DingC , GuXX . Compound matrine injection with chemotherapy in the treatment of 29 patients with advanced gastric cancer. Chinese Journal of Coal Industry Medicine2009;12(10):1566‐7. ">Liu 2009a</a>; <a href="./references#CD005096-bbs2-0049" title="WangJ , WangKM , WangZX , LuBB , LiJ . Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma. Chinese Journal of New Drugs2010;19(17):1585‐8. ">Wang 2010a</a>; <a href="./references#CD005096-bbs2-0055" title="XiongLG . Clinical observation of Yanshu injection combined with paclitaxel and oxaliplatin in the treatment of advanced gastric cancer. The Practical Journal of Cancer2008;23(3):276‐7. ">Xiong 2008</a>; <a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a>; <a href="./references#CD005096-bbs2-0075" title="ZhangMJ , ZuoCF . Observation of clinical efficacy of Yanshu injection combined with NP chemotherapy in treatment of advanced gastric cancer. Chinese Journal of Clinical Oncology and Rehabilitation2010;17(6):531‐3. ">Zhang 2010b</a>) used the same TCMH (Fufangkushen) with a similar dosage and therapeutic period. In the seven identified trials, the age ranged from 30 to 73 years in the intervention group and from 32 to 75 years in the control group; the number of cases varied from 25 to 48 in the intervention group and from 25 to 48 in the control group. All seven trials except <a href="./references#CD005096-bbs2-0055" title="XiongLG . Clinical observation of Yanshu injection combined with paclitaxel and oxaliplatin in the treatment of advanced gastric cancer. The Practical Journal of Cancer2008;23(3):276‐7. ">Xiong 2008</a>, which contained patients in stage IV, contained patients in both stage III and IV. The Fufangkushen was given by iv gtt 20 ml qd X 10 to 28 days in the intervention group during the therapeutic period, so the included participants, interventions, and outcomes were similar enough to allow combination of the data for meta‐analysis. The number of patients in each trial was too small to carry out subgroup analyses. In each trial, the same chemotherapeutic regimen and period were given to the patients in the intervention group and the control group: </p> <p> <ul id="CD005096-list-0013"> <li> <p>in the first trial (<a href="./references#CD005096-bbs2-0011" title="FuJW , DengY , HuangW . Compound matrine injection with chemotherapy in the treatment of pain from advanced or late gastric cancer in 40 patients. Journal of Emergency in Traditional Chinese Medicine2011;20(1):152‐3. ">Fu 2011</a>), the regimen was FLO (oxaliplatin 85 mg/m² iv gtt day 1 + calcium folinate 200 mg/m² iv gtt day 1 + fluorouracilum 2600 mg/m² iv gtt day 1 per week X 4); </p> </li> <li> <p>in the second trial (<a href="./references#CD005096-bbs2-0025" title="LinCL , GeJH . Clinical research of gastric cancer at the late stage treated with Compound Spophora Flavescens injection combined with chemotherapy. World Journal of Integrated Traditional and Western Medicine2011;6(4):316‐8. ">Lin 2011</a>), the regimen was FDO (oxaliplatin 130 mg/m² iv gtt day 1 + docetaxe 75 mg/m² iv gtt day 1 + fluorouracilum 1500 mg/m² iv gtt day 1, 8 per week X 9); </p> </li> <li> <p>in the third trial (<a href="./references#CD005096-bbs2-0030" title="LiuSL , DingC , GuXX . Compound matrine injection with chemotherapy in the treatment of 29 patients with advanced gastric cancer. Chinese Journal of Coal Industry Medicine2009;12(10):1566‐7. ">Liu 2009a</a>), the regimen was FOT (oxaliplatin 130 mg/m² iv gtt day 1 + calcium folinate 100 mg/m² iv gtt day 1 to 5 + tegafur 1000 mg/m² iv gtt day 1 to 5 per week X 6); </p> </li> <li> <p>in the fourth trial (<a href="./references#CD005096-bbs2-0049" title="WangJ , WangKM , WangZX , LuBB , LiJ . Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma. Chinese Journal of New Drugs2010;19(17):1585‐8. ">Wang 2010a</a>), the regimen was DCF (docetaxel 30 mg/m² iv gtt day 1, 8 + cisplatinum 20 mg/m² iv gtt day 1 to 5 + fluorouracilum 750 mg/m² iv gtt day 1 to 5 per week X 6); </p> </li> <li> <p>in the fifth trial (<a href="./references#CD005096-bbs2-0055" title="XiongLG . Clinical observation of Yanshu injection combined with paclitaxel and oxaliplatin in the treatment of advanced gastric cancer. The Practical Journal of Cancer2008;23(3):276‐7. ">Xiong 2008</a>), the regimen was TO (paclitaxel (Taxol) 130 mg/m² iv gtt day 1 + oxaliplatin 135 mg/m² iv gtt day 2 per week X 9); </p> </li> <li> <p>in the sixth trial (<a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a>) the regimen was ECF (epirubicin 50 mg/m² iv gtt day 1 + cisplatinum 60 mg/m² iv gtt day 1 + fluorouracilum 600 mg/m² iv day 1 to 5 per week X 3); </p> </li> <li> <p>in the seventh trial (<a href="./references#CD005096-bbs2-0075" title="ZhangMJ , ZuoCF . Observation of clinical efficacy of Yanshu injection combined with NP chemotherapy in treatment of advanced gastric cancer. Chinese Journal of Clinical Oncology and Rehabilitation2010;17(6):531‐3. ">Zhang 2010b</a>), the regimen was FLP (cisplatinum 20 mg/m² iv gtt day 1 to 5 + calcium folinate 200 mg/m² iv gtt day 1 to 5 + fluorouracilum 500 mg/m² iv gtt day 1 to 5 per week X 6 to 8). </p> </li> </ul> </p> <p>None of the seven trials except two trials (<a href="./references#CD005096-bbs2-0049" title="WangJ , WangKM , WangZX , LuBB , LiJ . Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma. Chinese Journal of New Drugs2010;19(17):1585‐8. ">Wang 2010a</a>; <a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a>) explained the specific method of randomisation (drew a lot and random number table, respectively) except to mention simply that randomisation was used. </p> <p>In type I, three trials (<a href="./references#CD005096-bbs2-0021" title="JiaJW , LiuYQ . The effect of Shenqi Fuzheng injection combined with FOLFOX4 regimen in the treatment of advanced gastric cancer. The Practical Journal of Cancer2009;24(3):273‐5. ">Jia 2009</a>; <a href="./references#CD005096-bbs2-0031" title="LuoPF . The effect of Shenqi Fuzheng injection combined with chemotherapy for advanced gastric cancer. Modern Medicine &amp; Health2011;27(8):1170‐1. ">Luo 2011</a>; <a href="./references#CD005096-bbs2-0048" title="WangJF . The effect of Shenqi Fuzheng injection combined with chemotherapy and radiotherapy for local advanced gastric cancer. Chinese Journal of Traditional Medical Science and Technology2010;17(6):537‐8. ">Wang 2010</a>), used the same TCMH (Shenqifuzheng) with a similar dosage and therapeutic period. In the three identified trials, the age ranged from 26 to 75 years in the intervention group and from 33 to 75 years in the control group; the number of cases varied from 22 to 32 in the intervention group and from 21 to 30 in the control group. All three trials except (<a href="./references#CD005096-bbs2-0031" title="LuoPF . The effect of Shenqi Fuzheng injection combined with chemotherapy for advanced gastric cancer. Modern Medicine &amp; Health2011;27(8):1170‐1. ">Luo 2011</a>), which only contained patients in stage IV, contained patients in both stage III and IV. The Shenqifuzheng was given by iv gtt 250 ml once daily (qd) X 10 to 31 days in the intervention group during the therapeutic period, so the included participants, interventions, and outcomes were similar enough to allow combination of the data for meta‐analysis. The number of patients in each trial was too small to carry out subgroup analysis. In each trial, the same chemotherapeutic regimen and period were used for patients in the intervention group and the control group: </p> <p> <ul id="CD005096-list-0014"> <li> <p>in the first trial (<a href="./references#CD005096-bbs2-0021" title="JiaJW , LiuYQ . The effect of Shenqi Fuzheng injection combined with FOLFOX4 regimen in the treatment of advanced gastric cancer. The Practical Journal of Cancer2009;24(3):273‐5. ">Jia 2009</a>), the regimen was FOLFOX4 (oxaliplatin 85 mg/m² iv gtt day 1+ calcium folinate 200 mg/m² iv gtt day 1 to 2 + fluorouracilum 600 mg/m² iv + fluorouracilum 400 mg/m² iv gtt day 1 to 2 per week X 8); </p> </li> <li> <p>in the second trial (<a href="./references#CD005096-bbs2-0031" title="LuoPF . The effect of Shenqi Fuzheng injection combined with chemotherapy for advanced gastric cancer. Modern Medicine &amp; Health2011;27(8):1170‐1. ">Luo 2011</a>), the regimen was FLO (oxaliplatin 130 mg/m² iv gtt day 1+ calcium folinate 100 mg/m² iv gtt day 1 to 5 + fluorouracilum 200 mg/m² iv gtt day 1 to 5 per week X 6); </p> </li> <li> <p>in the third trial (<a href="./references#CD005096-bbs2-0048" title="WangJF . The effect of Shenqi Fuzheng injection combined with chemotherapy and radiotherapy for local advanced gastric cancer. Chinese Journal of Traditional Medical Science and Technology2010;17(6):537‐8. ">Wang 2010</a>), the regimen was LF regimen (day 1 to 4, day 28 to 31, no specific dosage). </p> </li> </ul> </p> <p>None of the three trials explained the specific method of randomisation except to simply mention that randomisation was used. </p> </section> <section id="CD005096-sec-0065"> <h6 class="title">Type II (TCMHs plus western therapeutic methods versus the same TCMHs)</h6> <p>The six articles (<a href="./references#CD005096-bbs2-0004" title="ChenN , JinY , LiuY , ChenY . Observation of effect about hydroxycamptothecin combined with Chinese medicine treating advanced gastric carcinoma of 41 cases. Fujian Journal of Medicine1997;19(2):82. ">Chen 1997a</a>; <a href="./references#CD005096-bbs2-0026" title="LiuY , ZhouJ . Association with Western and Traditional Chinese Medicines treats 30 patients with advanced gastric cancer. Journal of Shandong Traditional Chinese Medicine2002;21(3):164‐5. [0257‐358X(2002)03‐0164‐02] ">Liu 2002</a>; <a href="./references#CD005096-bbs2-0042" title="WangG , ZhuJ , XuW , WangY , ZhouA . Clinical and experimental studies on Fuzheng granula combined with chemotherapy in advanced gastric cancer. World Chinese Journal of Digestology1998;6(3):214‐8. [ISSN1007‐9319 CN 14‐1218/R] ">Wang 1998</a>; <a href="./references#CD005096-bbs2-0056" title="XuY . The effects of Yangxue decoction plus chemotherapy for late gastric cancer after operation. Journal of Practical Oncology1989;3(1):54‐6. ">Xu 1989</a>; <a href="./references#CD005096-bbs2-0064" title="YouJ , ZhaoJ , ZhouL . Clinical study about Fuzhenghewei in treating fourth stage gastric cancer. Jiangsu Chinese Medicine2005;26(11):11‐3. ">You 2005</a>; <a href="./references#CD005096-bbs2-0076" title="ZhaoZ , LiaoZ , ZhaoX . The clinic research of the effect of Sheng Mai injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Modern Oncology2005;13(3):387‐8. [1672‐4992(2005)03‐387‐02] ">Zhao 2005</a>) in type II reported random allocation of 587 patients with advanced or late gastic cancer to TCMHs plus western therapeutic methods versus control (treatment with non‐patented TCMHs in five trials, the commonly used herbs listed). The relevant contents are described in the 'Additional tables' (<a href="#CD005096-tbl-0006">Table 2</a>: administration of Chinese medicinal Herbs (TCMHs plus medicine versus TCMHs)). </p> </section> <section id="CD005096-sec-0066"> <h6 class="title">Type III (TCMHs versus other TCMHs)</h6> <p>The two articles (<a href="./references#CD005096-bbs2-0036" title="ShaoJ . clinical study of compound Zhenjian liquid in treating advanced gastric cancer. Journal of Traditional Chinese Medicine1998;39(8):479‐80. ">Shao 1998</a>; <a href="./references#CD005096-bbs2-0037" title="ShiL , YeY , LuoS , ChenJ , YanX . Effect on life quality and immune about Huachansu combined with Chinese medical differentiation of symptoms and signs in treating gastric carcinoma. Journal of Zhejiang Chinese Medicine College2004;28(6):20‐1. ">Shi 2004</a>) in type III reported random allocation of 194 patients with advanced or late gastric cancer to TCMHs versus control (treatment with non‐patented TCMHs in one trial, the commonly used herbs listed; treatment with patented TCMHs, compound oral fluid Zhenjian in one trial (<a href="./references#CD005096-bbs2-0036" title="ShaoJ . clinical study of compound Zhenjian liquid in treating advanced gastric cancer. Journal of Traditional Chinese Medicine1998;39(8):479‐80. ">Shao 1998</a>)). The relevant contents are described in the 'Additional tables' (<a href="#CD005096-tbl-0007">Table 3</a>: administration of Chinese medicinal herbs (TCMHs versus other TCMHs)). </p> </section> <section id="CD005096-sec-0067"> <h6 class="title">Type IV (TCMHs versus western therapeutic methods)</h6> <p>The seven articles (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>; <a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a>; <a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a>; <a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a>; <a href="./references#CD005096-bbs2-0062" title="YeSF , YeB , WuM . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Journal of Wenzhou Medical College2009;39(2):172‐3. ">Ye 2009</a>; <a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>; <a href="./references#CD005096-bbs2-0078" title='ZhouR , WuL , NiA , XuZ . Clinical observation of intravenous drip of "Anti‐inflammation1" in treating 24 patients with mid and late gastric carcinoma. Shanghai Journal of Traditional Chinese Medicine2000;34(8):15‐6. [1007‐1334(2000)08‐0015‐02] '>Zhou 2000</a>) in type IV reported random allocation of 593 patients with advanced or late gastric cancer to TCMHs versus control (treatment with non‐patented TCMHs in four trials, the commonly used herbs). The relevant contents are described in the 'Additional tables' (<a href="#CD005096-tbl-0008">Table 4</a>: administration of Chinese medicinal herbs (TCMHs versus medicines)). </p> </section> </section> <section id="CD005096-sec-0068"> <h5 class="title">Sample sizes</h5> <p>None of the trials reported a sample size calculation. In type I, the sample sizes varied from 36 to 249 cases, with a mean value of 84. In type II, the sample sizes varied from 41 to 246 cases, with a mean value of 144. In type III, the sample sizes varied from 51 to 143 cases, with a mean value of 97. In type IV, the sample sizes varied from 60 to 176 cases, with a mean value of 85. </p> </section> <section id="CD005096-sec-0069"> <h5 class="title">Setting</h5> <p>Both inpatients and outpatients were Included. In type I, only 33 trials included inpatients and no trial included only outpatients. Three trials included both inpatients and outpatients; the other 29 trials did not specify the status of the patients. In type II, four trials included inpatients and the other trials did not specify the status of the patients. In type III, one trial included inpatients and the other trial did not specify the status of the patients. In type IV, three trials included inpatients and the other trials did not specify the status of the patients. No special medicine was given to patients as primary care. </p> </section> <section id="CD005096-sec-0070"> <h5 class="title">Participants</h5> <p>All the patients in the 80 trials were adults with gastric cancer in stage III or IV (that is T 1‐4, N 1‐3, M1). None of the trials reported the specific ratio of gender for all participants, and the general ratio of male to female was close to 2:1. In type I, the age of the participants varied from 22 to 85 years in 46 trials, another 19 trials did not specify the age range, and the mean age was 54 years. In type II, the age of the participants varied from 28 years to 72 years in six trials, and the mean age was 62 years. In type III, the age of the participants varied from 30 years to 79 years in two trials, and the mean age was 54 years. In type IV, the age of the participants varied from 22 years to 85 years in five trials, and the mean age was 62 years. The other two trials did not give data on the participants' age. </p> </section> <section id="CD005096-sec-0071"> <h5 class="title">Interventions</h5> <p>The intervention (TCMHs) consisted of patented herbal medicine and self‐produced herbal compounds. The method of administration was by the oral route in 40 trials, and by intravenous administration in the other 40 trials. The period of administration varied from two weeks to one year, with a median period of one to three months. The specific dosage (range 10 g to 50 g) of the herbs and the regimens, which commonly consisted of seven to 15 herbs, are listed in <a href="#CD005096-tbl-0005">Table 1</a>; <a href="#CD005096-tbl-0006">Table 2</a>; <a href="#CD005096-tbl-0007">Table 3</a>; <a href="#CD005096-tbl-0008">Table 4</a>, but some authors did not specify the dosage of herbs because of commercial or technological secrecy. In the 80 trials, there were more than 200 categories of herbs used for treating gastric cancer in the advanced or late stage. The frequency (≥ 20%) of the most commonly used TCMHs in the 80 trials was: Radix Astragali seu Hedysari 50.0% (40/80), Rhizoma Atractylodis Macrocephalae 30.0% (24/80), Poria 30.0% (24/80), Radix Codonopsis Pilosulae 30.0% (24/80), Rhizoma Zedoariae 20.0% (16/80), Semen Coicis 20.0% (16/80). </p> <p>Due to the lack of a reliable and recognised standards, it should be emphasised that the definition of TCMHs is non‐specific and the associated concepts are diverse. </p> </section> <section id="CD005096-sec-0072"> <h5 class="title">Outcomes</h5> <p>The commonly reported outcomes were mortality, improvements in quality of life (QOL), rate of remission (short‐term and long‐term), median survival time (MST), time to progression (TTP), as well as adverse effects, such as life threatening and toxic responses, resulting in the discontinuation of treatment. </p> </section> </section> <section id="CD005096-sec-0073"> <h4 class="title">Excluded studies</h4> <p>Most of the excluded studies had no clear TNM stage and the illness of some patients was not in the late or advanced stage. A few of the studies were not related to TCMH or TCMH for gastric cancer, so they were excluded for this reason. </p> </section> </section> <section id="CD005096-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p>The methodological quality of the 80 included studies was very poor (<a href="#CD005096-fig-0001">Figure 1</a>). Other than mentioning that the studies were randomised, none of the trials gave any information that would allow a formal assessment of quality. Most of the articles described the method of randomisation that was used, but none of the trials described double blinding or the methods used for blinding. Only five trials provided a description of withdrawals or dropouts (<a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a>; <a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a>; <a href="./references#CD005096-bbs2-0056" title="XuY . The effects of Yangxue decoction plus chemotherapy for late gastric cancer after operation. Journal of Practical Oncology1989;3(1):54‐6. ">Xu 1989</a>; <a href="./references#CD005096-bbs2-0058" title="XuY . Clinical efficacy study Fuzhenghuoxue combined with chemotherapy in treating advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine1999;21(6):329‐31. ">Xu 1999</a>; <a href="./references#CD005096-bbs2-0065" title="ZhangF . Clinic research that Shengyutang treats adverse reaction after advanced gastric cancer patients receive chemotherapy. Journal of Changchun College of Traditional Chinese Medicine1997;13(61):18. ">Zhang 1997</a>). None of the studies mentioned allocation concealment. In China, the results of clinical trials are given more importance than the methodology, especially if the methodology is known within the academic circle; so the methodology is not described in detail. We contacted the authors of the included studies by letter to request further data, but we received no response. </p> <div class="figure" id="CD005096-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD005096-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> </section> <section id="CD005096-sec-0075"> <h3 class="title" id="CD005096-sec-0075">Effects of interventions</h3> <p>See: <a href="./full#CD005096-tbl-0001"><b>Summary of findings for the main comparison</b> Appraisal of the results of Huachansu in the short term for induction of remission in advanced or late gastric cancer</a>; <a href="./full#CD005096-tbl-0002"><b>Summary of findings 2</b> Appraisal of the results of Aidi in the short term for induction of remission in advanced or late gastric cancer</a>; <a href="./full#CD005096-tbl-0003"><b>Summary of findings 3</b> Appraisal of the results of Fufangkushen in the short term for induction of remission in advanced or late gastric cancer</a>; <a href="./full#CD005096-tbl-0004"><b>Summary of findings 4</b> Appraisal of the results of Shenqifuzheng in the short term for induction of remission in advanced or late gastric cancer</a> </p> <p>1.1 A total of 448 patients were enrolled in the seven trials of Huachansu for gastric cancer: 226 were randomised to the TCMH Huachansu and 222 to the control intervention. After three to four periods of treatment, 113 of 226 patients responded clinically to the Huachansu compared to 89 of 222 who responded to the control intervention. The pooled odds ratio (OR) for clinical complete and partial remission was 1.48 (95% CI 1.01 to 2.17; P = 0.05) using a fixed‐effect model and the result was the same using a random‐effects model. Toxic and side effects on the digestive system were noted in 78/196 patients in the intervention group compared to 113/192 in the control group. The pooled OR of toxic and side effects on the digestive system was 0.43 (95% CI 0.28 to 0.66; P = 0.0001) using a fixed‐effect model and 0.43 (95% CI 0.22 to 0.84; P = 0.01) using a random‐effects model. The toxic and side effects of leukopenia were noted in 67/196 patients in the intervention group compared to 112/192 in the control group. The pooled OR for toxic and side effects of leukopenia was 0.32 (95% CI 0.21 to 0.50; P &lt; 0.00001) using a fixed‐effect model and 0.32 (95% CI 0.21 to 0.51; P &lt; 0.00001) using a random‐effects model. </p> <p>Sensitivity analyses showed that the result for toxic and side effects on the digestive system was sensitive to change with the random‐effects model (risk ratio (RR) 0.82, 95% CI 0.67 to 0.99; P = 0.04) and when the selected patients were in IV stage, the trials included patients with median age &gt; 50 years (RR 0.69, 95% CI 0.49 to 0.97; P = 0.03) using a fixed‐effect model, the trials with samples &gt; 60 cases (RR 0.81, 95% CI 0.66 to 0.98; P = 0.03), and the intervention with dosage of Huachansu equal to 20 ml iv gtt qd (RR 0.67, 95% CI 0.53 to 0.84; P = 0.0007) using a random‐effects model. Sensitivity analyses showed that the toxic and side effects of leukopenia were sensitive to change with the fixed‐effect model (RR 0.62, 95% CI 0.45 to 0.86; P = 0.004) when the selected patients were in stage IV, the trials included patients with median age &gt; 50 years (RR 0.50, 95% CI 0.37 to 0.69; P = 0.0001 using a fixed‐effect model; RR 0.52, 95% CI 0.39 to 0.71; P = 0.0001 using a random‐effects model), the trials with samples &gt; 60 cases (RR 0.63, 95% CI 0.50 to 0.78; P = 0.001 using a fixed‐effect model; RR 0.64, 95% CI 0.49 to 0.83; P = 0.0009 using a random‐effects model), and the intervention with dosage of Huachansu equal to 20 ml iv gtt qd (RR 0.67, 95% CI 0.53 to 0.84; P = 0.0005 using a fixed‐effect model; RR 0.67, 95% CI 0.50 to 0.89; P = 0.0005 using a random‐effects model) (<a href="#CD005096-tbl-0009">Table 5</a>). However, due to lack of specific data (<a href="#CD005096-tbl-0009">Table 5</a>), it was not possible to analyse changes in the inclusion criteria. Because only the general results were presented in the trials, the results for patients in stage III and stage IV were not available separately. </p> <div class="table" id="CD005096-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Summary table of sensitivity analyses for Huachansu</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Huachansu = 20ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with dosage of injection Huachansu = 20ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48 [1.01 to 2.13]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48 [1.01 to 2.13]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.15[0.83 to 1.58]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.15[0.83 to 1.58]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.28[1.01 to1.62]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.29 [1.02 to1.62]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.23 [0.99 to 1.54]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.25 [1.01 to 1.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.24 [0.98 to 1.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.26 [1.00 to 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 [0.28 to 0.66]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 [0.22 to 0.84]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 [0.68 to 1.05]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 [0.67 to 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 [0.49 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 [0.40 to 1.30]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 [0.50 to 0.77]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59 [0.35 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 [0.53 to 0.84]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 [0.32 to 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32 [0.21 to 0.50]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32 [0.21 to 0.51]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 [0.45 to 0.86]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52 [0.24 to 1.12]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 [0.37 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52 [0.39 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63 [0.50 to 0.78]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 [0.49 to 0.83]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 [0.53 to 0.84]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 [0.50 to 0.89]</p> </td> </tr> </tbody> </table> </div> <p>1.2. The authors of the seven trials did not report on side effects. Four trials (<a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a>; <a href="./references#CD005096-bbs2-0050" title="WangWM , LiCF , YaoRJ . The clinical effect of Huachansu with chemotherapy for late gastric cancer. Clinical Journal of Traditional Chinese Medicine2010;22(4):314‐5. ">Wang 2010b</a>; <a href="./references#CD005096-bbs2-0067" title="ZhangR , ChenC , ShenB , ZhouD , ZhangG . Clinical observation of Huachansu combined with chemotherapy treating advanced gastric carcinoma. Chinese Clinical Oncology2004;9(3):269‐70. [1009‐0460(2004)‐03‐0269‐02] ">Zhang 2004</a>; <a href="./references#CD005096-bbs2-0068" title="ZhangY , ZhuM , CaoT , ZhangP , YaoL , HuangH . Observation of curative effect of Huachansu combined with chemotherapy treating progressive and advanced gastric carcinoma. Henan Journal of Oncology2005;18(5):359‐60. [1003‐1464(2005)05‐0359‐02] ">Zhang 2005</a>) followed up the patients for 0.5 to two years. Except for <a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a>, the other trials concluded that there was no statistical difference in life expectancy (MST) between the intervention group and the control group. <a href="./references#CD005096-bbs2-0070" title="ZhangZ , WangY , RongD . Late effect of Huachansu combined with hydroxy. Practical Journal of Medicine and Pharmaceuticals2006;23(7):794‐5. ">Zhang 2006</a> concluded that the patients in the intervention group had improved their QOL and alleviated the cancerous ache following treatment in the short term compared with patients in the control group. Other measures, such as mortality and TTP, were not provided in full so could not be analysed. </p> <p>2.1. A total of 287 patients were enrolled in the six trials of Aidi for gastric cancer: 145 were randomised to the TCMH Aidi and 142 to the control intervention. After three to four periods of treatment, 76 of 145 patients responded clinically to Aidi compared to 60 of 142 who responded to the control intervention. The pooled OR for clinical complete and partial remission was 1.51 (95% CI 0.94 to 2.41; P = 0.09) using a fixed‐effect model and 1.50 (95% CI 0.93 to 2.42; P = 0.09) using a random‐effects model. The toxic and side effects on the digestive system were noted in 62/180 patients in the intervention group compared to 100/174 in the control group. The pooled OR of toxic and side effects on the digestive system was 0.33 (95% CI 0.20 to 0.54; P &lt; 0.00001) using a fixed‐effect model and 0.33 (95% CI 0.20 to 0.55; P &lt; 0.00001) using a random‐effects model. The toxic and side effects of leukopenia were noted in 62/122 patients in the intervention group compared to 81/120 in the control group. The pooled OR for toxic and side effects of leukopenia was 0.43 (95% CI 0.23 to 0.80; P = 0.008) using a fixed‐effect model and the same result using a random‐effects model. </p> <p>Sensitivity analyses could not be done for toxic and side effects on the digestive system of patients in stage IV, because no trials only included that kind of patients, but showed that the result for toxic and side effects on the digestive system was sensitive to the change with a random‐effects model (RR 0.34, 95% CI 0.20 to 0.58; P &lt; 0.0001) and fixed‐effect model (RR 0.33, 95% CI 0.20 to 0.57; P &lt; 0.0001) when the included patients' median age was &gt; 50 years, the trials with samples &gt; 60 cases (RR 0.29, 95% CI 0.15 to 0.57; P = 0.0003) using a random‐effects model and the same results using a fixed‐effect model, and the intervention with dosage of Aidi equal to 50 ml iv gtt qd (RR 0.37, 95% CI 0.20 to 0.66; P = 0.0008 using a random‐effects model; RR 0.36, 95% CI 0.20 to 0.65; P = 0.0006 using a fixed‐effect model). Sensitivity analyses could not give results for toxic and side effects of leukopenia in stage IV because no trials only included that kind of patient, but showed that the result for toxic and side effects of leukopenia was sensitive to change with a random effects model (RR 0.46, 95% CI 0.22 to 0.97; P = 0.04) and fixed‐effect model (RR 0.46, 95% CI 0.22 to 0.96; P = 0.04) when the included patients' median age was &gt; 50 years, for the trials with samples &gt; 60 cases (RR 0.37, 95% CI 0.17 to 0.83; P = 0.02 using a random‐effects model; and the same result using a fixed‐effect model), and the intervention with dosage of Aidi equal to 50 ml IV gtt qd (RR 0.46, 95% CI 0.22 to 0.97; P = 0.04 using a random‐effects model; and the same result using a fixed‐effect model) (<a href="#CD005096-tbl-0010">Table 6</a>). However, due to lack of specific data (<a href="#CD005096-tbl-0010">Table 6</a>), it was not possible to analyse changes in the inclusion criteria. Because only the general results were presented in the trials, the results for patients in stage III stage and stage IV were not available separately. </p> <div class="table" id="CD005096-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Summary table of sensitivity analyses for Aidi</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Aidi = 50ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Aidi = 50ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.51[0.94 to 2.41]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.50[0.93 to 2.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.69[0.99 to 2.87]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68[0.98 to 2.88]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.23[0.61 to 2.48]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.23[0.61 to 2.49]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.88[1.03 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.88[1.03 to 3.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33[0.20 to 0.54]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33[0.20 to 0.55]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33[0.20 to 0.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34[0.20 to 0.58]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29[0.15 to 0.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29[0.15 to 0.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.20 to 0.65]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.37[0.20 to 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.23 to 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.23 to 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46[0.22 to 0.96]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46[0.22 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.17 to 0.83]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.17 to 0.83]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46[0.22 to 0.96]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46[0.22 to 0.97]</p> </td> </tr> </tbody> </table> </div> <p>2.2. The authors of the six trials did not report on side effects. Only one trial (<a href="./references#CD005096-bbs2-0013" title="GongL , JiangC , ZhaoY . Aidi combining with chemotherapy treat progressive gastric carcinoma. Journal of Oncology2006;12(5):424‐5. ">Gong 2006</a>) followed up the patients for 42 months, and the author concluded that there was no statistical difference in life expectancy (MST) between the intervention group and control group. <a href="./references#CD005096-bbs2-0006" title="ChenNJ , WuDH , LaiYQ , ChenYY . Combining AIDI and FOLFOX4 treated advanced gastric cancer. Guangming Journal of Chinese Medicine2008;23(11):1768‐9. ">Chen 2008</a> and <a href="./references#CD005096-bbs2-0072" title="ZhangAX . Aidi injection with chemotherapy for advanced or late gastric cancer. Journal of Medical Theory &amp; Practice2009;22(10):1214. ">Zhang 2009</a> concluded that the patients in the intervention group had improved their QOL and alleviated the cancerous ache following treatment in the short term compared with patients in the control group. Other measures, such as mortality and TTP, were not provided and could not be analysed. </p> <p>3.1. A total of 503 patients were enrolled in the seven trials of Fufangkushen for gastric cancer: 254 were randomised to the TCMH Fufangkushen and 249 to the control intervention. After three to four periods of treatment, 110 of 214 patients responded clinically to Fufangkushen compared to 97 of 209 who responded to the control intervention. The pooled OR for clinical complete and partial remission was 1.22 (95% CI 0.83 to 1.79; P = 0.31) using a fixed‐effect model and the result was the same using a random‐effects model. The toxic and side effects on the digestive system were noted in 63/153 patients in the intervention group compared to 91/149 in the control group. The pooled OR for toxic and side effects on the digestive system was 0.42 (95% CI 0.26 to 0.69; P = 0.0005) using a fixed‐effect model and 0.43 (95% CI 0.26 to 0.69; P = 0.0005) using a random‐effects model. The toxic and side effects of leukopenia were noted in 128/254 patients in the intervention group compared to 174/249 treated in the control group. The pooled OR for toxic and side effects of leukopenia was 0.37 (95% CI 0.25 to 0.56; P &lt; 0.0001) using a fixed‐effect model and the same results using a random‐effects model. </p> <p>Sensitivity analyses showed that the result for toxic and side effects on the digestive system was sensitive to change from a fixed‐effect model to random‐effects model (RR 0.35, 95% CI 0.12 to 0.98; P = 0.05) when the selected patients were in IV stage, for the trials with samples &gt; 60 cases (RR 0.42, 95% CI 0.25 to 0.71; P = 0.001), and the intervention with a dosage of Fufangkushen equal to 20 ml iv gtt qd (day 10 to 14) (RR 0.42, 95% CI 0.25 to 0.71; P = 0.001). Sensitivity analyses showed that the result for toxic and side effects of leukopenia was sensitive to change from fixed‐effect model to random‐effects model (RR 0.36, 95% CI 0.13 to 0.99; P = 0.05) when the selected patients were in IV stage, for the trials with samples &gt; 60 cases (RR 0.37, 95% CI 0.23 to 0.59; P &lt; 0.001), and the intervention with a dosage of Fufangkushen equal to 20 ml (day 10 to 14) iv gtt qd (RR 0.36, 95% CI 0.24 to 0.56; P &lt; 0.0001) (<a href="#CD005096-tbl-0011">Table 7</a>). However, due to lack of specific data (<a href="#CD005096-tbl-0011">Table 7</a>), it was not possible to analyse changes in the inclusion criteria. Because only the general results were presented in the trials, the results for patients in stage III and stage IV were not available separately. </p> <div class="table" id="CD005096-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Summary table of sensitivity analyses for Fufangkushen</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Fufangkushen = 20ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Fufangkeshen = 20ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06[0.42 to 2.68]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06[0.42 to 2.68]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.16[0.75 to 1.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.16[0.75 to 1.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.30[0.86 to 1.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30[0.86 to 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.25 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.25 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.25 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42[0.25 to 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.13 to 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.13 to 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.23 to 0.59]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.23 to 0.59]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.24 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36[0.24 to 0.56]</p> </td> </tr> </tbody> </table> </div> <p>3.2. The authors of the seven trials did not report on side effects. Only one trial (<a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a>) followed up the patients for 0.5 to two years, and they concluded that there was no statistical difference in life expectancy (MST) between the intervention group and control group. <a href="./references#CD005096-bbs2-0025" title="LinCL , GeJH . Clinical research of gastric cancer at the late stage treated with Compound Spophora Flavescens injection combined with chemotherapy. World Journal of Integrated Traditional and Western Medicine2011;6(4):316‐8. ">Lin 2011</a> and <a href="./references#CD005096-bbs2-0070" title="ZhangZ , WangY , RongD . Late effect of Huachansu combined with hydroxy. Practical Journal of Medicine and Pharmaceuticals2006;23(7):794‐5. ">Zhang 2006</a> concluded that the patients in the intervention group had improved their QOL and alleviated the cancerous ache following treatment in the short term compared with patients in the control group. Other measures such as mortality and TTP were not provided and could not be analysed. </p> <p>4.1. A total of 153 patients were enrolled in the three trials of Shenqifuzheng for gastric cancer: 78 were randomised to the TCMH Shenqifuzheng and 75 to the control intervention. After three to four periods of treatment, 46 of 78 patients responded clinically to Shenqifuzheng compared to 37 of 75 who responded to the control intervention. The pooled OR for clinical complete and partial remission was 1.48 (95% CI 0.78 to 2.81; P = 0.23) using a fixed‐effect model and the result was the same using a random‐effects model. The toxic and side effects on the digestive system were noted in 30/78 patients in the intervention group compared to 31/75 in the control group. The pooled OR for toxic and side effects on the digestive system was 0.90 (95% CI 0.48 to 1.67; P = 0.74) using a fixed‐effect model and the same using a random‐effects model. The toxic and side effects of leukopenia were noted in 20/78 patients in the intervention group compared to 35/75 in the control group. The pooled OR for toxic and side effects of leukopenia was 0.37 (95% CI 0.18 to 0.74; P = 0.005) using a fixed‐effect model and the same using a random‐effects model. </p> <p>Sensitivity analyses showed that the result for toxic and side effects on the digestive system was sensitive to the change in the fixed‐effect model and random‐effects model (RR 11.40, 95% CI 2.12 to 61.25; P = 0.005) when the selected patients were in IV stage, for the trials with included patients' median age &gt; 50 years (RR 1.63, 95% CI 0.72 to 3.69; P = 0.24 using a fixed‐effect model; and RR 2.26, 95% CI 0.11 to 48.60; P = 0.60 using a random‐effects model), the trials with samples &gt; 60 cases (RR 0.34, 95% CI 0.12 to 0.98; P = 0.05 using a fixed‐effect model and a random‐effects model), and the intervention with dosage of Shenqifuzheng equal to 250 ml (day 10 to 14) iv gtt qd (RR 1.63, 95% CI 0.72 to 3.69; P = 0.24 using a fixed‐effect model; and RR 2.26, 95% CI 0.11 to 48.60; P = 0.60 using a random‐effects model). Sensitivity analyses showed that the result for toxic and side effects of leukopenia was sensitive to change in the fixed‐effect model and random‐effects model (RR 0.32, 95% CI 0.07 to 1.44; P = 0.14) when the selected patients were in IV stage, for the trials with included patients' median age &gt; 50 years (RR 0.38, 95% CI 0.14 to 1.02; P = 0.05), the trials with samples &gt; 60 cases (RR 0.35, 95% CI 0.12 to 0.97; P = 0.04), and the intervention with dosage of Shenqifuzheng equal to 250 ml (day 10 to 14) iv gtt qd (RR 0.38, 95% CI 0.14 to 1.02; P = 0.05) (<a href="#CD005096-tbl-0012">Table 8</a>). However, due to lack of specific data (<a href="#CD005096-tbl-0012">Table 8</a>), it was not possible to analyse changes in the inclusion criteria. Because only the general results were presented in the trials, the results for patients in stage III stage and stage IV were not available separately. </p> <div class="table" id="CD005096-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Summary table of sensitivity analyses for Shenqifuzheng</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Shenqifuzheng = 250ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Shenqifuzheng = 250ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48[0.78 to 2.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48[0.78 to 2.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.31[0.39 to 4.39]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.31[0.39 to 4.39]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.49[0.65 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.49[0.65 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47[0.54 to 4.00]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47[0.54 to 4.00]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.49[0.65 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.49[0.65 to 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90[0.48 to 1.67]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13[0.18 to 7.24]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.40[2.12 to 61.25]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.40[2.12 to 61.25]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.63[0.72 to 3.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.26[0.11 to 48.60]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.63[0.72 to 3.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.26[0.11 to 48.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.18 to 0.74]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.18 to 0.74]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12[0.07 to 1.44]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12[0.07 to 1.44]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38[0.14 to 1.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38[0.14 to 1.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.14 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.14 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38[0.14 to 1.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38[0.14 to 1.02]</p> </td> </tr> </tbody> </table> </div> <p>4.2. The authors of the three trials did not report on side effects. No trials followed up the patients, and no trials concluded that there was a statistical difference in life expectancy (MST) between the intervention group and control group. Two trials (<a href="./references#CD005096-bbs2-0031" title="LuoPF . The effect of Shenqi Fuzheng injection combined with chemotherapy for advanced gastric cancer. Modern Medicine &amp; Health2011;27(8):1170‐1. ">Luo 2011</a>; <a href="./references#CD005096-bbs2-0048" title="WangJF . The effect of Shenqi Fuzheng injection combined with chemotherapy and radiotherapy for local advanced gastric cancer. Chinese Journal of Traditional Medical Science and Technology2010;17(6):537‐8. ">Wang 2010</a>) concluded that the patients in the intervention group had improved their QOL and alleviated the cancerous ache following treatment in the short term compared with patients in the control group. Other measures such as mortality and TTP were not provided and could not be analysed. </p> <p>In the other 57 trials, the different intervention measures prevented pooling of data in a meta‐analysis, and subgroup analysis on the herbs could not be performed. There were four types of clinical trials included: formulas of TCMHs with western medicine versus the same western medicine in the intervention group (type I group, 42 trials), western medicine with formulas of TCMHs versus the same formulas of TCMHs (type II group, six trials), formulas of TCMHs versus another formula of TCMHs (type III group, two trials), formulas of TCMHs versus western medicine (type IV group, seven trials). </p> <section id="CD005096-sec-0076"> <h4 class="title">Type I (TCMHs with western medicine versus the same western medicine)</h4> <section id="CD005096-sec-0077"> <h5 class="title">Mortality</h5> <p>In the 42 trials, which could not be pooled for meta‐analysis, three trials showed a significant difference in mortality at one year between the intervention group and the control group, and the comparison result was the following:13 patients had died in the intervention group (30 patients) and 20 patients in the control group (28 patients) (<a href="./references#CD005096-bbs2-0003" title="ChenN , JinY , LaiY . Observation of effect Pingxiao capsule combined chemotherapy treats advanced gastric cancer. Straits Pharmacy1997;9(1):66‐7. ">Chen 1997</a>; <a href="./references#CD005096-fig-0014" title="">Analysis 5.1</a>) (RR 0.61, 95% CI 0.38 to 0.97); 10 patients had died in the intervention group (77 patients) and 26 patients in the control group (46 patients) (<a href="./references#CD005096-bbs2-0039" title="SunG , LiJ . Clinical and experimental research about Qiao‐Wei‐Kang‐Liu dissolved medicines combined with chemotherapy treating advanced gastric cancer. Medical Research Communication1999;28(6):6‐7. ">Sun 1999</a>; <a href="./references#CD005096-fig-0017" title="">Analysis 5.4</a>) (RR 0.23, 95% CI 0.12 to 0.43); 67 patients had died in the intervention group (90 patients) and 20 patients in the control group (40 patients) (<a href="./references#CD005096-bbs2-0043" title="WangX , WangR , DaiH . Invigorating the spleen and removing cancer ingredient combined with chemotherapy treat older advanced gastric carcinoma of 90 cases. Shandong Journal of Chinese Medicine2002;21(9):527‐8. [0257‐358X(2002)09‐0527‐02] ">Wang 2002</a>; <a href="./references#CD005096-fig-0018" title="">Analysis 5.5</a>) (RR 1.49, 95% CI 1.07 to 2.08). </p> <p>Three trials showed a significant difference in mortality at two years between the intervention group and the control group, and the comparison result was the following:13 patients had died in the intervention group (57 patients) and 20 patients in the control group (46 patients) (<a href="./references#CD005096-bbs2-0051" title="WuY , CaiM , ZhuX . Following up of 5 years about Western and Chinese Traditional Medicines treating advanced gastric cancer. Journal of Nanjing University of Traditional Chinese Medicine1999;15(2):124. ">Wu 1999</a>; <a href="./references#CD005096-fig-0019" title="">Analysis 5.6</a>) (RR 0.52, 95% CI 0.29 to 0.94). There was no significant difference in mortality at three years and five years, the comparison result was the following, respectively: 38 patients had died in the intervention group (57 patients) and 38 patients in the control group (46 patients) (<a href="./references#CD005096-bbs2-0051" title="WuY , CaiM , ZhuX . Following up of 5 years about Western and Chinese Traditional Medicines treating advanced gastric cancer. Journal of Nanjing University of Traditional Chinese Medicine1999;15(2):124. ">Wu 1999</a>; <a href="./references#CD005096-fig-0020" title="">Analysis 5.7</a>) (RR 0.81, 95% CI 0.64 to 1.01); 50 patients had died in the intervention group (57 patients) and 43 patients in the control group (46 patients) (<a href="./references#CD005096-bbs2-0051" title="WuY , CaiM , ZhuX . Following up of 5 years about Western and Chinese Traditional Medicines treating advanced gastric cancer. Journal of Nanjing University of Traditional Chinese Medicine1999;15(2):124. ">Wu 1999</a>; <a href="./references#CD005096-fig-0021" title="">Analysis 5.8</a>) (RR 0.94, 95% CI 0.83 to 1.07). </p> <p>One trial showed no significant difference in mortality at one year between the intervention group and the control group, and the comparison result was the following: 26 patients had died in the intervention group (50 patients) and 23 patients in the control group (40 patients) (<a href="./references#CD005096-bbs2-0015" title="GuoL , ChenG . Observation of efficacy about association with Western and Traditional Chinese Medicines treats 90 patients with advanced gastric carcinoma. Fujian Medicine Journal1999;11(1):19‐20. ">Guo 1989</a>; <a href="./references#CD005096-fig-0016" title="">Analysis 5.3</a>) (RR 0.90, 95% CI 0.62 to 1.32). </p> <p>Three trials showed no significant difference in mortality at six months between the intervention group and the control group, and the comparison result was the following: five patients had died in the intervention group (32 patients) and 10 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0052" title="WuY . Analysis of the therapeutic effect of Fuzhenggongjian capsule on the late gastric carcinoma under chemotherapy. Journal of Zhengjiang Medical College2000;10(4):656‐7. ">Wu 2000</a>; <a href="./references#CD005096-fig-0022" title="">Analysis 5.9</a>) (RR 0.47, 95% CI 0.18 to 1.21). There was a significant difference in mortality at one year and two years, the comparison results were the following, respectively: 10 patients had died in the intervention group (32 patients) and 21 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0052" title="WuY . Analysis of the therapeutic effect of Fuzhenggongjian capsule on the late gastric carcinoma under chemotherapy. Journal of Zhengjiang Medical College2000;10(4):656‐7. ">Wu 2000</a>; <a href="./references#CD005096-fig-0023" title="">Analysis 5.10</a>) (RR 0.45, 95% CI 0.25 to 0.79); 21 patients had died in the intervention group (32 patients) and 27 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0052" title="WuY . Analysis of the therapeutic effect of Fuzhenggongjian capsule on the late gastric carcinoma under chemotherapy. Journal of Zhengjiang Medical College2000;10(4):656‐7. ">Wu 2000</a>; <a href="./references#CD005096-fig-0024" title="">Analysis 5.11</a>) (RR 0.73, 95% CI 0.55 to 0.96). </p> <p>Another trial showed no significant difference in mortality at six months and one year between the intervention group and the control group, and the comparison result was the following, respectively: 12 patients had died in the intervention group (51 patients) and 12 patients in the control group (45 patients) (<a href="./references#CD005096-bbs2-0057" title="XuD , ZhangX . Clinical observation about Ai‐Fu‐Kang plus chemotherapy treating patients with progressive gastric cancer after operation. Shanxi Traditional Chinese Medicine1993;9(4):14. ">Xu 1993</a>; <a href="./references#CD005096-fig-0025" title="">Analysis 5.12</a>) (RR 0.88, 95% CI 0.44 to 1.76); 19 patients had died in the intervention group (51 patients) and 22 patients in the control group (45 patients) (<a href="./references#CD005096-bbs2-0057" title="XuD , ZhangX . Clinical observation about Ai‐Fu‐Kang plus chemotherapy treating patients with progressive gastric cancer after operation. Shanxi Traditional Chinese Medicine1993;9(4):14. ">Xu 1993</a>; <a href="./references#CD005096-fig-0026" title="">Analysis 5.13</a>) (RR 0.76, 95% CI 0.48 to 1.21). There was a significant difference in mortality at two years, the comparison result was the following: 25 patients had died in the intervention group (51 patients) and 32 patients in the control group (45 patients) (<a href="./references#CD005096-bbs2-0057" title="XuD , ZhangX . Clinical observation about Ai‐Fu‐Kang plus chemotherapy treating patients with progressive gastric cancer after operation. Shanxi Traditional Chinese Medicine1993;9(4):14. ">Xu 1993</a>; <a href="./references#CD005096-fig-0027" title="">Analysis 5.14</a>) (RR 0.69, 95% CI 0.49 to 0.96). </p> </section> <section id="CD005096-sec-0078"> <h5 class="title">Quality of life (QOL) (&lt; six months)</h5> <p>Of the 42 individual trials, 11 trials showed a significant difference in Karnofsky score (&gt; 60 points) between the intervention group and the control group after the trial, and the comparison result was the following: 21 patients kept their score &gt; 60 points in the intervention group (30 patients) compared with 11 patients in the control group (28 patients) at two months (<a href="./references#CD005096-bbs2-0003" title="ChenN , JinY , LaiY . Observation of effect Pingxiao capsule combined chemotherapy treats advanced gastric cancer. Straits Pharmacy1997;9(1):66‐7. ">Chen 1997</a>; <a href="./references#CD005096-fig-0028" title="">Analysis 5.15</a>) (RR 1.78, 95% CI 1.06 to 2.99). Twenty‐seven patients kept their score &gt; 60 points in the intervention group (31 patients) compared with 16 patients in the control group (28 patients) at one month (<a href="./references#CD005096-bbs2-0018" title="HuangZ , SiZ , LuoY , HuangN . Clinical efficacy of Toad Venom injection combined with chemotherapy in treating 31 patients with medium and advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine2002;24(3):163‐5. ">Huang 2002</a>; <a href="./references#CD005096-fig-0032" title="">Analysis 5.19</a>) (RR 1.52, 95% CI 1.08 to 2.16). Nineteen patients had increased their score (an increase &gt; 10 points) in the intervention group (35 patients) compared with 7 patients in the control group (33 patients) at six weeks (<a href="./references#CD005096-bbs2-0024" title="LiS , HeL , SongY . A clinical report of Yiqihuoxue Recipe combinating with FAP regimen for improving the living qualities in patients with gastric cancer in advanced or late stage. Journal of Sichuan of Traditional Chinese Medicine2002;20(12):33‐4. ">Li 2002</a>; <a href="./references#CD005096-fig-0033" title="">Analysis 5.20</a>) (RR 2.56, 95% CI 1.24 to 5.28). Twelve patients had increased their score (an increase &gt; 10 points) in the intervention group (38 patients) compared with three patients in the control group (36 patients) at nine weeks (<a href="./references#CD005096-bbs2-0027" title="LiuH , ZengB , XuL . Observation of decoction of eight ingredients combined with chemotherapy treating advanced gastric carcinoma. Modern Journal of Integrated Traditional Chinese and Western Medicine2006;15(24):3366. ">Liu 2006</a>; <a href="./references#CD005096-fig-0034" title="">Analysis 5.21</a>) (RR 3.79, 95% CI 1.16 to 12.33). Twenty‐seven patients had increased their score (an increase &gt; 10 points) in the intervention group (48 patients) compared with seven patients in the control group (34 patients) at nine weeks (<a href="./references#CD005096-bbs2-0032" title="LvB , YangJ . Analysis of efficacy about association Western and Traditional Chinese medicines treating 48 patients with progressive and advanced gastric cancer. Chinese Traditional Treatment1999;2(2):24‐5. ">Lv 1999</a>; <a href="./references#CD005096-fig-0036" title="">Analysis 5.23</a>) (RR 2.73, 95% CI 1.35 to 5.53). Twenty‐five patients had increased their score (an increase &gt; 10 points) in the intervention group (31 patients) compared with 10 patients in the control group at three months (31 patients) (<a href="./references#CD005096-bbs2-0038" title="SiH , ShangG , LuW . Observation of efficacy about TCM and chemo treating advanced gastric cancer. Jiangsu Journal of Traditional Chinese Medicine2004;35(258):40‐1. ">Si 2004</a>; <a href="./references#CD005096-fig-0037" title="">Analysis 5.24</a>) (RR 2.50, 95% CI 1.46 to 4.28). Twenty‐eight patients had increased their score (an increase &gt; 10 points) in the intervention group (38 patients) compared with 13 patients in the control group (30 patients) at three months (<a href="./references#CD005096-bbs2-0044" title="WangP . Observation effect in chemotherapy, radiotherapy and Yadanzi oil treating advanced gastric carcinoma. Journal of Practical Oncology2004;19(1):78‐9. [1001‐1692(2004)01‐0078‐02] ">Wang 2004</a>; <a href="./references#CD005096-fig-0040" title="">Analysis 5.27</a>) (RR 1.70, 95% CI 1.08 to 2.67). Twenty‐four patients had increased their score (an increase &gt; 10 points) in the intervention group (32 patients) compared with 18 patients in the control group (36 patients) at six to eight weeks (<a href="./references#CD005096-bbs2-0053" title="WuC , LiQ , ZhaoY , LiQ . Controlled observation on Elemene plus chemotherapy treating advanced gastric cancer. Journal of North Sichuan Medical College2000;15(3):12‐3. [1005‐3697(2000)03‐0012‐02] ">Wu 2000a</a>; <a href="./references#CD005096-fig-0042" title="">Analysis 5.29</a>) (RR 1.50, 95% CI 1.02 to 2.20). Twenty‐four patients had increased their score (an increase &gt; 10 points) in the intervention group (30 patients) compared with 16 patients in the control group (30 patients) four weeks after the therapeutic period (<a href="./references#CD005096-bbs2-0079" title="ZhuH , ZhuZ , XuL . White Powder of Three Ingredients Medicine treats progressive gastric cancer of 30 cases. Journal of Nanjing Traditional Chinese Medicine University2005;21(5):284‐5. [1000‐5005(2005)05‐0284‐02] ">Zhu 2005</a>; <a href="./references#CD005096-fig-0045" title="">Analysis 5.32</a>) (RR 1.50, 95% CI 1.03 to 2.19). The Karnofsky score was 83.33 ± 6.18 (30 patients) in the intervention group and 77.94 ± 6.14 months (30 patients) in the control group at six to nine weeks (<a href="./references#CD005096-bbs2-0016" title="HuY , HouAJ , ZhangHW , HuangYL , GuWF . Clinical observation of Fuzheng Xiao'ai prescription I combined with OFL regimen for treatment advanced gastric cancer. Journal of New Chinese Medicine2011;43(2):104‐6. ">Hu 2011</a>) (WMD 5.39, 95% CI 2.27 to 8.51); the Karnofsky score was 85.26 ± 4.21 (36 patients) in the intervention group and 71.19 ± 4.38 (36 patients) in the control group at 15 days (<a href="./references#CD005096-bbs2-0071" title="ZhangH , SuZX . Curative effect of Shenling Baizhu powder on chemotherapy‐induced toxicity in advanced gastric cancer. Journal of TCM University of Hunan2008;28(2):51‐3, 56. ">Zhang 2008</a>) (WMD 14.07, 95% CI 12.09 to 16.05). </p> <p>Eleven trials showed no significant difference in Karnofsky score (&gt; 60 points) between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0015"> <li> <p>56 patients had kept their score &gt; 60 points in the intervention group (64 patients) and 52 patients in the control group (64 patients) at three months (<a href="./references#CD005096-bbs2-0005" title="ChenP , GaoH , SongJ , ZhengW . ELF connected with Cidan capsule treat gastric carcinoma of 64 cases. Chinese Clinic of Oncology2005;32(8):466‐7. ">Chen 2005</a>; <a href="./references#CD005096-fig-0029" title="">Analysis 5.16</a>) (RR 1.08, 95% CI 0.93 to 1.25); </p> </li> <li> <p>30 patients had kept their score &gt; 60 points in the intervention group (61 patients) and 8 patients in the control group (30 patients) at three months (<a href="./references#CD005096-bbs2-0017" title="HuaB , WangA , HouW . Clinical study on treatment of mid‐late stage gastric carcinoma by composite Xiansu capsule combined with chemotherapy. Journal of Combination of Traditional Chinese Medicine with Western Medicine1999;19(8):470‐3. ">Hua 1999</a>; <a href="./references#CD005096-fig-0031" title="">Analysis 5.18</a>) (RR 1.84, 95% CI 0.97 to 3.52); </p> </li> <li> <p>16 patients had increased their score (an increase &gt; 10 points) in the intervention group (30 patients) and 12 patients in the control group (30 patients) at six weeks (<a href="./references#CD005096-bbs2-0028" title="LiuJ , HuD , FanH , NiuL . Clinical observation of Tianlong treating advanced gastric cancer of 30 cases. Hebei Traditional Chinese Medicine2006;28(10):739‐40. [1002‐2619(2006)10‐739‐02] ">Liu 2006a</a>; <a href="./references#CD005096-fig-0035" title="">Analysis 5.22</a>) (RR 1.33, 95% CI 0.77 to 2.31); </p> </li> <li> <p>35 patients had increased their score (an increase &gt; 10 points) in the intervention group (77 patients) and 13 patients in the control group (46 patients) at three months (<a href="./references#CD005096-bbs2-0039" title="SunG , LiJ . Clinical and experimental research about Qiao‐Wei‐Kang‐Liu dissolved medicines combined with chemotherapy treating advanced gastric cancer. Medical Research Communication1999;28(6):6‐7. ">Sun 1999</a>; <a href="./references#CD005096-fig-0038" title="">Analysis 5.25</a>) (RR 1.61, 95% CI 0.95 to 2.71); </p> </li> <li> <p>22 patients had increased their score (an increase &gt; 10 points) in the intervention group (90 patients) and 9 patients in the control group (40 patients) at 9 to 12 weeks (<a href="./references#CD005096-bbs2-0043" title="WangX , WangR , DaiH . Invigorating the spleen and removing cancer ingredient combined with chemotherapy treat older advanced gastric carcinoma of 90 cases. Shandong Journal of Chinese Medicine2002;21(9):527‐8. [0257‐358X(2002)09‐0527‐02] ">Wang 2002</a>; <a href="./references#CD005096-fig-0039" title="">Analysis 5.26</a>) (RR 1.09, 95% CI 0.55 to 2.14); </p> </li> <li> <p>18 patients had increased their score (an increase &gt; 10 points) in the intervention group (32 patients) and 12 patients in the control group (30 patients) at six to eight weeks (<a href="./references#CD005096-bbs2-0052" title="WuY . Analysis of the therapeutic effect of Fuzhenggongjian capsule on the late gastric carcinoma under chemotherapy. Journal of Zhengjiang Medical College2000;10(4):656‐7. ">Wu 2000</a>; <a href="./references#CD005096-fig-0041" title="">Analysis 5.28</a>) (RR 1.41, 95% CI 0.82 to 2.40); </p> </li> <li> <p>78 patients had increased their score (an increase &gt; 10 points) in the intervention group (90 patients) and 65 patients in the control group (82 patients) at 12 weeks (<a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a>; <a href="./references#CD005096-fig-0043" title="">Analysis 5.30</a>) (RR 1.09, 95% CI 0.95 to 1.25); </p> </li> <li> <p>11 patients had increased their score (an increase &gt; 10 points) in the intervention group (40 patients) and 2 patients in the control group (30 patients) at two months (<a href="./references#CD005096-bbs2-0058" title="XuY . Clinical efficacy study Fuzhenghuoxue combined with chemotherapy in treating advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine1999;21(6):329‐31. ">Xu 1999</a>; <a href="./references#CD005096-fig-0044" title="">Analysis 5.31</a>) (RR 4.13, 95% CI 0.99 to 17.24); </p> </li> <li> <p>20 patients had increased their score (an increase &gt; 10 points) in the intervention group (40 patients) and 14 patients in the control group (40 patients) at four weeks (<a href="./references#CD005096-bbs2-0080" title="ZhuJ , SongM , WangL , SunQ , ZhuL , FangC . Immunoregulation and short‐term therapeutic effect of super‐selective intra‐arteral chemotherapy combined with traditional Chinese drugs on gastric cancer patients. Journal of Chinese Integrative Medicine2006;4(5):478‐81. ">Zhu 2006</a>; <a href="./references#CD005096-fig-0046" title="">Analysis 5.33</a>) (RR 1.25, 95% CI 0.77 to 2.04). </p> </li> <li> <p>The Karnofsky score was 77.50 ± 11. 73 (40 patients) in the intervention group and 72.00 ± 11.39 months (40 patients) in the control group at six weeks (<a href="./references#CD005096-bbs2-0010" title="DuCJ , WangTL , GuoYS . Clinical observation of quality of life in patients with gastric carcinoma treated by combination of traditional Chinese medicine, chemotherapy and hyperthermia treatment. Hebei Journal of Traditional Chinese Medicine2010;32(9):1299‐301. ">Du 2010</a>; <a href="./references#CD005096-fig-0033" title="">Analysis 5.20</a>) (MD 5.50, 95% CI 0.43 to 10.57); </p> </li> <li> <p>15 patients had increased their score (an increase &gt; 10 points) in the intervention group (24 patients) and 12 patients in the control group (23 patients) at three months (<a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a>; <a href="./references#CD005096-fig-0016" title="">Analysis 5.3</a>) (RR 1.53, 95% CI 0.48 to 4.89). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0079"> <h5 class="title">Rate of short‐term remission</h5> <p>Of the 37 individual trials, nine trials showed a significant difference in the rate of short‐term remission between the intervention group and the control group after the trial, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0016"> <li> <p>18 patients in the intervention group (30 patients) and 9 patients in the control group (28 patients) at six weeks (<a href="./references#CD005096-bbs2-0003" title="ChenN , JinY , LaiY . Observation of effect Pingxiao capsule combined chemotherapy treats advanced gastric cancer. Straits Pharmacy1997;9(1):66‐7. ">Chen 1997</a>; <a href="./references#CD005096-fig-0047" title="">Analysis 5.34</a>) (RR 1.87, 95% CI 1.01 to 3.44); </p> </li> <li> <p>26 patients in the intervention group (38 patients) and 15 patients in the control group (36 patients) at nine weeks (<a href="./references#CD005096-bbs2-0027" title="LiuH , ZengB , XuL . Observation of decoction of eight ingredients combined with chemotherapy treating advanced gastric carcinoma. Modern Journal of Integrated Traditional Chinese and Western Medicine2006;15(24):3366. ">Liu 2006</a>; <a href="./references#CD005096-fig-0054" title="">Analysis 5.41</a>) (RR 1.64, 95% CI 1.05 to 2.56); </p> </li> <li> <p>45 patients in the intervention group (60 patients) and 31 patients in the control group (60 patients) at 40 days (<a href="./references#CD005096-bbs2-0033" title="NiuH , MuY . Complex prescription of the TCM and chemotherapy treat 120 patients with advanced gastric carcinoma. Shanxi Traditional Chinese Medicine2006;26(9):1034‐5. ">Niu 2006</a>; <a href="./references#CD005096-fig-0057" title="">Analysis 5.44</a>) (RR 1.45, 95% CI 1.09 to 1.93); </p> </li> <li> <p>24 patients in the intervention group (31 patients) and 15 patients in the control group (31 patients) at nine weeks (<a href="./references#CD005096-bbs2-0038" title="SiH , ShangG , LuW . Observation of efficacy about TCM and chemo treating advanced gastric cancer. Jiangsu Journal of Traditional Chinese Medicine2004;35(258):40‐1. ">Si 2004</a>; <a href="./references#CD005096-fig-0058" title="">Analysis 5.45</a>) (RR 1.60, 95% CI 1.06 to 2.41); </p> </li> <li> <p>17 patients in the intervention group (30 patients) and 6 patients in the control (30 patients) group at 45 days (<a href="./references#CD005096-bbs2-0041" title="WangR , WuD , JinY , ChenJ , LiuY , HuangP , et al. The short‐term effects of Jianpijiandu Decoction plus chemotherapy for advanced gastric cancer. Fujian Journal of Traditional Chinese Medicine1993;24(5):23‐6. ">Wang 1993</a>; <a href="./references#CD005096-fig-0060" title="">Analysis 5.47</a>) (RR 2.83, 95% CI 1.30 to 6.19); </p> </li> <li> <p>23 patients in the intervention group (40 patients) and 11 patients in the control (40 patients) group at eight weeks (<a href="./references#CD005096-bbs2-0059" title="YangZ , YuanX , LiG . Shenfu combining with ELFP treat advanced gastric carcinoma of 40 cases. Chinese Medical Science Study2005;18(7):26‐7. ">Yang 2005</a>; <a href="./references#CD005096-fig-0068" title="">Analysis 5.55</a>) (RR 2.09, 95% CI 1.18 to 3.69); </p> </li> <li> <p>30 patients in the intervention group (35 patients) and 17 patients in the control group (35 patients) at four to six weeks (<a href="./references#CD005096-bbs2-0065" title="ZhangF . Clinic research that Shengyutang treats adverse reaction after advanced gastric cancer patients receive chemotherapy. Journal of Changchun College of Traditional Chinese Medicine1997;13(61):18. ">Zhang 1997</a>; <a href="./references#CD005096-fig-0069" title="">Analysis 5.56</a>) (RR 1.76, 95% CI 1.12 to 2.55); </p> </li> <li> <p>21 patients in the intervention group (28 patients) and 10 patients in the control group (22 patients) at six to eight weeks (<a href="./references#CD005096-bbs2-0077" title="ZhengL , SunK . Research of efficacy about Western and Traditional Chinese Medicines treating progressing and advanced gastric cancer. Heilongjiang Medicine and Pharmacy1999;22(1):86‐7. ">Zheng 1999</a>; <a href="./references#CD005096-fig-0071" title="">Analysis 5.58</a>) (RR 1.65, 95% CI 1.00 to 2.73). </p> </li> </ol> </p> <p>Twenty trials showed no significant difference in the rate of short‐term remission between the intervention group and the control group after the trial, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0017"> <li> <p>42 patients in the intervention group (64 patients) compared with 34 patients in the control group (64 patients) at three months (<a href="./references#CD005096-bbs2-0005" title="ChenP , GaoH , SongJ , ZhengW . ELF connected with Cidan capsule treat gastric carcinoma of 64 cases. Chinese Clinic of Oncology2005;32(8):466‐7. ">Chen 2005</a>; <a href="./references#CD005096-fig-0048" title="">Analysis 5.35</a>) (RR 1.24, 95% CI 0.92 to 1.65); </p> </li> <li> <p>20 patients in the intervention group (61 patients) compared with 4 patients in the control group (30 patients) at three months (<a href="./references#CD005096-bbs2-0017" title="HuaB , WangA , HouW . Clinical study on treatment of mid‐late stage gastric carcinoma by composite Xiansu capsule combined with chemotherapy. Journal of Combination of Traditional Chinese Medicine with Western Medicine1999;19(8):470‐3. ">Hua 1999</a>; <a href="./references#CD005096-fig-0050" title="">Analysis 5.37</a>) (RR 2.46, 95% CI 0.92 to 6.56); </p> </li> <li> <p>9 patients in the intervention group (31 patients) compared with 5 patients in the control group (28 patients) at four weeks (<a href="./references#CD005096-bbs2-0018" title="HuangZ , SiZ , LuoY , HuangN . Clinical efficacy of Toad Venom injection combined with chemotherapy in treating 31 patients with medium and advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine2002;24(3):163‐5. ">Huang 2002</a>; <a href="./references#CD005096-fig-0051" title="">Analysis 5.38</a>) (RR 1.63, 95% CI 0.62 to 4.27); </p> </li> <li> <p>15 patients in the intervention group (34 patients) compared with 10 patients in the control group (34 patients) at nine weeks (<a href="./references#CD005096-bbs2-0019" title="HuangX , SongA . Clinical research on elemene combined chemotherapy treating gastric cancer. Chinese Traditonal Medicine2005;5(3):40‐1. ">Huang 2005</a>; <a href="./references#CD005096-fig-0052" title="">Analysis 5.39</a>) (RR 1.50, 95% CI 0.79 to 2.86); </p> </li> <li> <p>14 patients in the intervention group (30 patients) compared with 11 patients in the control group (30 patients) at six weeks (<a href="./references#CD005096-bbs2-0028" title="LiuJ , HuD , FanH , NiuL . Clinical observation of Tianlong treating advanced gastric cancer of 30 cases. Hebei Traditional Chinese Medicine2006;28(10):739‐40. [1002‐2619(2006)10‐739‐02] ">Liu 2006a</a>; <a href="./references#CD005096-fig-0055" title="">Analysis 5.42</a>) (RR 1.27, 95% CI 0.69 to 2.33); </p> </li> <li> <p>20 patients in the intervention group (48 patients) compared with 13 patients in the control group (34 patients) (treatment period unspecified) (<a href="./references#CD005096-bbs2-0032" title="LvB , YangJ . Analysis of efficacy about association Western and Traditional Chinese medicines treating 48 patients with progressive and advanced gastric cancer. Chinese Traditional Treatment1999;2(2):24‐5. ">Lv 1999</a>; <a href="./references#CD005096-fig-0056" title="">Analysis 5.43</a>) (RR 1.09, 95% CI 0.63 to 1.88); </p> </li> <li> <p>20 patients in the intervention group (77 patients) compared with 29 patients in the control group (49 patients) (treatment period unspecified) (<a href="./references#CD005096-bbs2-0039" title="SunG , LiJ . Clinical and experimental research about Qiao‐Wei‐Kang‐Liu dissolved medicines combined with chemotherapy treating advanced gastric cancer. Medical Research Communication1999;28(6):6‐7. ">Sun 1999</a>; <a href="./references#CD005096-fig-0059" title="">Analysis 5.46</a>) (RR 0.44, 95% CI 0.28 to 0.68); </p> </li> <li> <p>42 patients in the intervention group (90 patients) compared with 15 patients in the control group (40 patients) at three months (<a href="./references#CD005096-bbs2-0043" title="WangX , WangR , DaiH . Invigorating the spleen and removing cancer ingredient combined with chemotherapy treat older advanced gastric carcinoma of 90 cases. Shandong Journal of Chinese Medicine2002;21(9):527‐8. [0257‐358X(2002)09‐0527‐02] ">Wang 2002</a>; <a href="./references#CD005096-fig-0061" title="">Analysis 5.48</a>) (RR 1.24, 95% CI 0.79 to 1.97); </p> </li> <li> <p>22 patients in the intervention group (38 patients) compared with 10 patients in the control group (30 patients) at 30 to 90 days (<a href="./references#CD005096-bbs2-0044" title="WangP . Observation effect in chemotherapy, radiotherapy and Yadanzi oil treating advanced gastric carcinoma. Journal of Practical Oncology2004;19(1):78‐9. [1001‐1692(2004)01‐0078‐02] ">Wang 2004</a>; <a href="./references#CD005096-fig-0062" title="">Analysis 5.49</a>) (RR 1.74, 95% CI 0.98 to 3.08); </p> </li> <li> <p>11 patients in the intervention group (24 patients) compared with 7 patients in the control group (22 patients) at 8 to 12 weeks (<a href="./references#CD005096-bbs2-0045" title="WangR , PanY , YeZ . Clinical observation about Invigorating the spleen and dissolving petechia mixtura combined with chemotherapy treating advanced gastric carcinoma of 24 cases. Jiangsu Traditional Chinese Medicine2004;25(11):22‐3. [1672‐397X(2004)11‐0022‐02] ">Wang 2004a</a>; <a href="./references#CD005096-fig-0063" title="">Analysis 5.50</a>) (RR 1.44, 95% CI 0.68 to 3.05); </p> </li> <li> <p>16 patients in the intervention group (32 patients) compared with 12 patients in the control group (30 patients) at six to eight weeks (<a href="./references#CD005096-bbs2-0052" title="WuY . Analysis of the therapeutic effect of Fuzhenggongjian capsule on the late gastric carcinoma under chemotherapy. Journal of Zhengjiang Medical College2000;10(4):656‐7. ">Wu 2000</a>; <a href="./references#CD005096-fig-0064" title="">Analysis 5.51</a>) (RR 1.25, 95% CI 0.71 to 2.19); </p> </li> <li> <p>12 patients in the intervention group (32 patients) compared with 16 patients in the control group (36 patients) at six to eight weeks (<a href="./references#CD005096-bbs2-0053" title="WuC , LiQ , ZhaoY , LiQ . Controlled observation on Elemene plus chemotherapy treating advanced gastric cancer. Journal of North Sichuan Medical College2000;15(3):12‐3. [1005‐3697(2000)03‐0012‐02] ">Wu 2000a</a>; <a href="./references#CD005096-fig-0063" title="">Analysis 5.50</a>) (RR 0.84, 95% CI 0.47 to 1.50); </p> </li> <li> <p>52 patients in the intervention group (90 patients) compared with 40 patients in the control group (82 patients) at six weeks (<a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a>; <a href="./references#CD005096-fig-0064" title="">Analysis 5.51</a>) (RR 1.19, 95% CI 0.89 to 1.57); </p> </li> <li> <p>28 patients in the intervention group (40 patients) compared with 14 patients in the control group (30 patients) at six weeks (<a href="./references#CD005096-bbs2-0058" title="XuY . Clinical efficacy study Fuzhenghuoxue combined with chemotherapy in treating advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine1999;21(6):329‐31. ">Xu 1999</a>; <a href="./references#CD005096-fig-0065" title="">Analysis 5.52</a>) (RR 1.50, 95% CI 0.97 to 2.31); </p> </li> <li> <p>28 patients in the intervention group (40 patients) compared with 14 patients in the control group (40 patients) at six weeks (<a href="./references#CD005096-bbs2-0069" title="ZhangJ , WangH , ZhangY . Jinlong capsule combined with HFL treat advanced gastric carcinoma. Capital Medicine2005;9(23):33. ">Zhang 2005a</a>; <a href="./references#CD005096-fig-0066" title="">Analysis 5.53</a>) (RR 1.23, 95% CI 0.75 to 2.00); </p> </li> <li> <p>7 patients in the intervention group (40 patients) compared with 6 patients in the control group (40 patients) at six weeks (<a href="./references#CD005096-bbs2-0010" title="DuCJ , WangTL , GuoYS . Clinical observation of quality of life in patients with gastric carcinoma treated by combination of traditional Chinese medicine, chemotherapy and hyperthermia treatment. Hebei Journal of Traditional Chinese Medicine2010;32(9):1299‐301. ">Du 2010</a>) (RR 1.20, 95% CI 0.37 to 3.95); </p> </li> <li> <p>13 patients in the intervention group (24 patients) compared with 11 patients in the control group (23 patients) at three months (<a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a>) (RR 1.29, 95% CI 0.41 to 4.06); </p> </li> <li> <p>16 patients in the intervention group (30 patients) compared with 13 patients in the control group (30 patients) at six to nine weeks (<a href="./references#CD005096-bbs2-0016" title="HuY , HouAJ , ZhangHW , HuangYL , GuWF . Clinical observation of Fuzheng Xiao'ai prescription I combined with OFL regimen for treatment advanced gastric cancer. Journal of New Chinese Medicine2011;43(2):104‐6. ">Hu 2011</a>) (RR 1.31, 95% CI 0.47 to 3.61); </p> </li> <li> <p>10 patients in the intervention group (22 patients) compared with 8 patients in the control group (23 patients) at eight weeks (<a href="./references#CD005096-bbs2-0074" title="ZhangL , WangYF . The effect and immune function of Kanglaite with chemotherapy for advanced or late gastric cancer. Acta Universitatis Medicinalis Nanjin (Natural Science)2010;30(11):1657‐9. ">Zhang 2010a</a>) (RR 1.56, 95% CI 0.47 to 5.19); </p> </li> <li> <p>25 patients in the intervention group (40 patients) compared with 23 patients in the control group (40 patients) at four weeks (<a href="./references#CD005096-bbs2-0009" title="DengZJ , CaoHN , GaoTN . Shenfu Injection with PCF chemotherapy for late or advanced gastric cancer in 40 cases. Contemporary Medicine2011;17(12):116‐8. ">Deng 2011</a>; <a href="./references#CD005096-fig-0070" title="">Analysis 5.57</a>) (RR 1.23, 95% CI 0.50 to 3.02). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0080"> <h5 class="title">Median survival time (MST)</h5> <p>Of the 42 individual trials, only one trial presented the entire data, which showed a significant difference in the MST between the intervention group and the control group. The comparison results were the following: the MST was 24.9 ± 1.36 months (40 patients) in the intervention group and 13.7 ± 0.72 months (40 patients) in the control group (<a href="./references#CD005096-bbs2-0080" title="ZhuJ , SongM , WangL , SunQ , ZhuL , FangC . Immunoregulation and short‐term therapeutic effect of super‐selective intra‐arteral chemotherapy combined with traditional Chinese drugs on gastric cancer patients. Journal of Chinese Integrative Medicine2006;4(5):478‐81. ">Zhu 2006</a>; <a href="./references#CD005096-fig-0072" title="">Analysis 5.59</a>) (WMD 11.20, 95% CI 10.72 to 11.68). </p> </section> <section id="CD005096-sec-0081"> <h5 class="title">Time to progression (TTP)</h5> <p>Of the 42 individual trials, no trial presented specific data on TTP so it could not be appraised. </p> </section> <section id="CD005096-sec-0082"> <h5 class="title">Adverse events</h5> <section id="CD005096-sec-0083"> <h6 class="title">Life threatening</h6> <p>No trial reported adverse events which were life threatening and no patients died of adverse events. </p> </section> <section id="CD005096-sec-0084"> <h6 class="title">Toxic response</h6> <p>Of the 42 individual trials, the common toxic responses included gastrointestinal side effects (such as nausea, vomiting, abdominal pain, diarrhoea, etc), leukopenia, thrombopenia caused by arrest of bone marrow, damage of liver or kidney function, phlebitis, etc. Eighteen trials reported severe adverse events, including leukopenia in 11 trials, thrombopenia in nine trials, diarrhoea in three trials, decrease of haemoglobin in five trials, nausea and vomiting in 10 trials, damage to liver or kidney function in six trials. </p> </section> <section id="CD005096-sec-0085"> <h6 class="title">Leukopenia</h6> <p>Five trials with specific data showed a significant difference in leukopenia between the intervention group and the control group, and the comparison result was the following: 3 patients in the intervention group (38 patients) compared with 11 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0044" title="WangP . Observation effect in chemotherapy, radiotherapy and Yadanzi oil treating advanced gastric carcinoma. Journal of Practical Oncology2004;19(1):78‐9. [1001‐1692(2004)01‐0078‐02] ">Wang 2004</a>; <a href="./references#CD005096-fig-0074" title="">Analysis 5.61</a>) (RR 0.29; 95% CI 0.10 to 0.85). The average score for leukopenia in the intervention group (24 patients) was 3.85 ± 0.57 compared with 3.37 ± 0.47 in the control group (23 patients) (<a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a>) (RR 0.48, 95% CI 0.18 to 0.78); 8 patients in the intervention group (30 patients) compared with 16 patients in the control group (30 patients) at six to nine weeks (<a href="./references#CD005096-bbs2-0016" title="HuY , HouAJ , ZhangHW , HuangYL , GuWF . Clinical observation of Fuzheng Xiao'ai prescription I combined with OFL regimen for treatment advanced gastric cancer. Journal of New Chinese Medicine2011;43(2):104‐6. ">Hu 2011</a>) (RR 0.32, 95% CI 0.11 to 0.94); 8 patients in the intervention group (22 patients) compared with 18 patients in the control group (23 patients) at eight weeks (<a href="./references#CD005096-bbs2-0074" title="ZhangL , WangYF . The effect and immune function of Kanglaite with chemotherapy for advanced or late gastric cancer. Acta Universitatis Medicinalis Nanjin (Natural Science)2010;30(11):1657‐9. ">Zhang 2010a</a>) (RR 0.16, 95% CI 0.04 to 0.59). The leukocyte score was 5.39 ± 1.07 (40 patients) in the intervention group and 3.39 ± 1.08 months (40 patients) in the control group at four weeks (<a href="./references#CD005096-bbs2-0009" title="DengZJ , CaoHN , GaoTN . Shenfu Injection with PCF chemotherapy for late or advanced gastric cancer in 40 cases. Contemporary Medicine2011;17(12):116‐8. ">Deng 2011</a>) (WMD 2.00, 95% CI 1.53 to 2.47). </p> <p>Three trials with specific data showed no significant difference in leukopenia between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0018"> <li> <p>4 patients in the intervention group (51 patients) compared with 12 patients in the control group (45 patients) (<a href="./references#CD005096-bbs2-0057" title="XuD , ZhangX . Clinical observation about Ai‐Fu‐Kang plus chemotherapy treating patients with progressive gastric cancer after operation. Shanxi Traditional Chinese Medicine1993;9(4):14. ">Xu 1993</a>; <a href="./references#CD005096-fig-0075" title="">Analysis 5.62</a>) (RR 0.31, 95% CI 0.10 to 1.01); </p> </li> <li> <p>5 patients in the intervention group (35 patients) compared with 18 patients in the control group (35 patients) (<a href="./references#CD005096-bbs2-0065" title="ZhangF . Clinic research that Shengyutang treats adverse reaction after advanced gastric cancer patients receive chemotherapy. Journal of Changchun College of Traditional Chinese Medicine1997;13(61):18. ">Zhang 1997</a>; <a href="./references#CD005096-fig-0076" title="">Analysis 5.63</a>) (RR 0.28, 95% CI 0.12 to 0.67). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0086"> <h6 class="title">Nausea or vomiting</h6> <p>One trial with specific data showed a significant difference in nausea and vomiting between the intervention group and the control group, and the comparison result was the following: 0 patients in the intervention group (31 patients) compared with 12 patients in the control group (28 patients) (<a href="./references#CD005096-bbs2-0018" title="HuangZ , SiZ , LuoY , HuangN . Clinical efficacy of Toad Venom injection combined with chemotherapy in treating 31 patients with medium and advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine2002;24(3):163‐5. ">Huang 2002</a>; <a href="./references#CD005096-fig-0079" title="">Analysis 5.66</a>) (RR 0.04, 95% CI 0.00 to 0.59). </p> <p>Four trials with specific data showed no significant difference in nausea and vomiting between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0019"> <li> <p>6 patients in the intervention group (61 patients) compared with 7 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0017" title="HuaB , WangA , HouW . Clinical study on treatment of mid‐late stage gastric carcinoma by composite Xiansu capsule combined with chemotherapy. Journal of Combination of Traditional Chinese Medicine with Western Medicine1999;19(8):470‐3. ">Hua 1999</a>; <a href="./references#CD005096-fig-0078" title="">Analysis 5.65</a>) (RR 0.42, 95% CI 0.16 to 1.14); </p> </li> <li> <p>1 patient in the intervention group (35 patients) compared with 4 patients in the control group (33 patients) (<a href="./references#CD005096-bbs2-0024" title="LiS , HeL , SongY . A clinical report of Yiqihuoxue Recipe combinating with FAP regimen for improving the living qualities in patients with gastric cancer in advanced or late stage. Journal of Sichuan of Traditional Chinese Medicine2002;20(12):33‐4. ">Li 2002</a>; <a href="./references#CD005096-fig-0080" title="">Analysis 5.67</a>) (RR 0.24, 95% CI 0.03 to 2.00); </p> </li> <li> <p>4 patients in the intervention group (51 patients) compared with 9 patients in the control group (45 patients) (<a href="./references#CD005096-bbs2-0057" title="XuD , ZhangX . Clinical observation about Ai‐Fu‐Kang plus chemotherapy treating patients with progressive gastric cancer after operation. Shanxi Traditional Chinese Medicine1993;9(4):14. ">Xu 1993</a>; <a href="./references#CD005096-fig-0081" title="">Analysis 5.68</a>) (RR 0.39, 95% CI 0.13 to 1.19); </p> </li> <li> <p>30 patients in the intervention group (36 patients) compared with 34 patients in the control group (36 patients) (<a href="./references#CD005096-bbs2-0071" title="ZhangH , SuZX . Curative effect of Shenling Baizhu powder on chemotherapy‐induced toxicity in advanced gastric cancer. Journal of TCM University of Hunan2008;28(2):51‐3, 56. ">Zhang 2008</a>) (RR 0.29, 95% CI 0.06 to 1.57); </p> </li> <li> <p>5 patients in the intervention group (30 patients) compared with 12 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0011" title="FuJW , DengY , HuangW . Compound matrine injection with chemotherapy in the treatment of pain from advanced or late gastric cancer in 40 patients. Journal of Emergency in Traditional Chinese Medicine2011;20(1):152‐3. ">Fu 2011</a>) (RR 0.30, 95% CI 0.09 to 1.00); </p> </li> <li> <p>12 patients in the intervention group (22 patients) compared with 19 patients in the control group (23 patients) (<a href="./references#CD005096-bbs2-0074" title="ZhangL , WangYF . The effect and immune function of Kanglaite with chemotherapy for advanced or late gastric cancer. Acta Universitatis Medicinalis Nanjin (Natural Science)2010;30(11):1657‐9. ">Zhang 2010a</a>) (RR 0.25, 95% CI 0.06 to 0.99). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0087"> <h6 class="title">Thrombopenia</h6> <p>One trial with specific data showed no significant difference in thrombopenia between the intervention group and the control group, and the comparison result was the following: 2 patients in the intervention group (30 patients) compared with 1 patient in the control group (30 patients) (<a href="./references#CD005096-bbs2-0041" title="WangR , WuD , JinY , ChenJ , LiuY , HuangP , et al. The short‐term effects of Jianpijiandu Decoction plus chemotherapy for advanced gastric cancer. Fujian Journal of Traditional Chinese Medicine1993;24(5):23‐6. ">Wang 1993</a>; <a href="http://archie.cochrane.org/sections/documents/viewdiff?documentpk=605002082719531867%26versionpk1=60169478146336644168111005181544%26versionpk2=80248403963290912963111011190623#fig-74" target="_blank">Figure 74</a>) (RR 2.00, 95% CI 0.19 to 20.90). </p> <p>Four trials with specific data showed a significant difference in thrombopenia between the intervention group and the control group, and the comparison result was the following: 3 patients in the intervention group (30 patients) compared with 10 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0016" title="HuY , HouAJ , ZhangHW , HuangYL , GuWF . Clinical observation of Fuzheng Xiao'ai prescription I combined with OFL regimen for treatment advanced gastric cancer. Journal of New Chinese Medicine2011;43(2):104‐6. ">Hu 2011</a>) (RR 0.22, 95% CI 0.05 to 0.91); the platelet score was 3.89 ± 0.47 (24 patients) in the intervention group and 3.74 ± 0.54 (23 patients) in the control group (<a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a>) (MD 0.15, 95% CI ‐0.14 to 0.44); the platelet score was 132.85 ± 22.45 (40 patients) in the intervention group and 119.58 ± 30.52 (40 patients) in the control group (<a href="./references#CD005096-bbs2-0009" title="DengZJ , CaoHN , GaoTN . Shenfu Injection with PCF chemotherapy for late or advanced gastric cancer in 40 cases. Contemporary Medicine2011;17(12):116‐8. ">Deng 2011</a>; <a href="./references#CD005096-fig-0082" title="">Analysis 5.69</a>) (MD 13.27, 95% CI 1.53 to 25.01); 4 patients in the intervention group (22 patients) compared with 11 patients in the control group (23 patients) (<a href="./references#CD005096-bbs2-0074" title="ZhangL , WangYF . The effect and immune function of Kanglaite with chemotherapy for advanced or late gastric cancer. Acta Universitatis Medicinalis Nanjin (Natural Science)2010;30(11):1657‐9. ">Zhang 2010a</a>; <a href="./references#CD005096-fig-0083" title="">Analysis 5.70</a>) (RR 2.00, 95% CI 0.19 to 20.90). </p> </section> <section id="CD005096-sec-0088"> <h6 class="title">Diarrhoea</h6> <p>One trial with specific data showed no significant difference in diarrhoea between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0020"> <li> <p>25 patients in the intervention group (36 patients) compared with 31 patients in the control group (36 patients) (<a href="./references#CD005096-bbs2-0071" title="ZhangH , SuZX . Curative effect of Shenling Baizhu powder on chemotherapy‐induced toxicity in advanced gastric cancer. Journal of TCM University of Hunan2008;28(2):51‐3, 56. ">Zhang 2008</a>) (RR 0.37, 95% CI 0.11 to 1.19). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0089"> <h6 class="title">Decrease of haemoglobin</h6> <p>One trial with specific data showed no significant difference in the decrease of haemoglobin between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0021"> <li> <p>4 patients in the intervention group (30 patients) compared with 3 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0041" title="WangR , WuD , JinY , ChenJ , LiuY , HuangP , et al. The short‐term effects of Jianpijiandu Decoction plus chemotherapy for advanced gastric cancer. Fujian Journal of Traditional Chinese Medicine1993;24(5):23‐6. ">Wang 1993</a>; <a href="./references#CD005096-fig-0087" title="">Analysis 5.74</a>) (RR 1.33, 95% CI 0.33 to 5.45). </p> </li> </ol> </p> <p>Two trials with specific data showed a significant difference in the decrease of haemoglobin between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0022"> <li> <p>haemoglobin score was 114.25 ± 30.42 (40 patients) in the intervention group and 98.38 ± 26.35 (40 patients) in the control group (<a href="./references#CD005096-bbs2-0009" title="DengZJ , CaoHN , GaoTN . Shenfu Injection with PCF chemotherapy for late or advanced gastric cancer in 40 cases. Contemporary Medicine2011;17(12):116‐8. ">Deng 2011</a>) (MD 15.87, 95% CI 3.40 to 28.34); </p> </li> <li> <p>haemoglobin score was 2.45 ± 0.51 (24 patients) in the intervention group and 1.95 ± 0.42 (23 patients) in the control group (<a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a>) (MD 0.50, 95% CI 0.23 to 0.77). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0090"> <h6 class="title">Damage to liver or kidney function, or both</h6> <p>Four trials with specific data showed no significant difference in damage to the liver or kidney function between the intervention group and the control group. The comparison result was the following: 3 patients in the intervention group (90 patients) compared with 7 patients in the control group (82 patients) (<a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a>; <a href="./references#CD005096-fig-0088" title="">Analysis 5.75</a>) (RR 0.39, 95% CI 0.10 to 1.46); 2 patients in the intervention group (30 patients) compared with 6 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0016" title="HuY , HouAJ , ZhangHW , HuangYL , GuWF . Clinical observation of Fuzheng Xiao'ai prescription I combined with OFL regimen for treatment advanced gastric cancer. Journal of New Chinese Medicine2011;43(2):104‐6. ">Hu 2011</a>) (RR 0.29, 95% CI 0.05 to 1.55); 2 patients in the intervention group (22 patients) compared with 8 patients in the control group (23 patients) (<a href="./references#CD005096-bbs2-0074" title="ZhangL , WangYF . The effect and immune function of Kanglaite with chemotherapy for advanced or late gastric cancer. Acta Universitatis Medicinalis Nanjin (Natural Science)2010;30(11):1657‐9. ">Zhang 2010a</a>) (RR 0.19, 95% CI 0.03 to 1.01); 7 patients in the intervention group (22 patients) compared with 15 patients in the control group (23 patients) (<a href="./references#CD005096-bbs2-0009" title="DengZJ , CaoHN , GaoTN . Shenfu Injection with PCF chemotherapy for late or advanced gastric cancer in 40 cases. Contemporary Medicine2011;17(12):116‐8. ">Deng 2011</a>) (RR 0.35, 95% CI 0.13 to 1.00). </p> </section> <section id="CD005096-sec-0091"> <h6 class="title">Discontinuation of treatment</h6> <p>Of the 42 individual trials, two trials showed a significant difference in discontinuation due to an adverse event during the therapeutic period between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0023"> <li> <p>3 patients in the intervention group (50 patients) compared with 12 patients in the control group (40 patients) (<a href="./references#CD005096-bbs2-0015" title="GuoL , ChenG . Observation of efficacy about association with Western and Traditional Chinese Medicines treats 90 patients with advanced gastric carcinoma. Fujian Medicine Journal1999;11(1):19‐20. ">Guo 1989</a>; <a href="./references#CD005096-fig-0090" title="">Analysis 5.77</a>) (RR 0.20, 95% CI 0.06 to 0.66); </p> </li> <li> <p>5 patients in the intervention group (35 patients) compared with 18 patients in the control group (35 patients) (<a href="./references#CD005096-bbs2-0065" title="ZhangF . Clinic research that Shengyutang treats adverse reaction after advanced gastric cancer patients receive chemotherapy. Journal of Changchun College of Traditional Chinese Medicine1997;13(61):18. ">Zhang 1997</a>; <a href="./references#CD005096-fig-0092" title="">Analysis 5.79</a>) (RR 0.28, 95% CI 0.12 to 0.67). </p> </li> </ol> </p> <p>Two trials showed a significant difference in discontinuation during the therapeutic period between the intervention group and the control group, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0024"> <li> <p>3 patients in the intervention group (90 patients) compared with 7 patients in the control group (82 patients) (<a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a>; <a href="./references#CD005096-fig-0089" title="">Analysis 5.76</a>) (RR 0.39, 95% CI 0.10 to 1.46); </p> </li> <li> <p>4 patients in the intervention group (40 patients) compared with 8 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0058" title="XuY . Clinical efficacy study Fuzhenghuoxue combined with chemotherapy in treating advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine1999;21(6):329‐31. ">Xu 1999</a>; <a href="./references#CD005096-fig-0091" title="">Analysis 5.78</a>) (RR 0.38, 95% CI 0.12 to 1.13). </p> </li> </ol> </p> </section> </section> </section> <section id="CD005096-sec-0092"> <h4 class="title">Type II (western medicine with TCMHs versus the same TCMHs)</h4> <section id="CD005096-sec-0093"> <h5 class="title">Mortality</h5> <p>The six trials could not be pooled for meta‐analysis.</p> <p>One trial showed a significant difference in mortality at six months and one year between the intervention group and the control group, and the comparison result was the following, respectively: </p> <p> <ol id="CD005096-list-0025"> <li> <p>7 patients had died in the intervention group (30 patients) compared with 9 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0026" title="LiuY , ZhouJ . Association with Western and Traditional Chinese Medicines treats 30 patients with advanced gastric cancer. Journal of Shandong Traditional Chinese Medicine2002;21(3):164‐5. [0257‐358X(2002)03‐0164‐02] ">Liu 2002</a>; <a href="./references#CD005096-fig-0113" title="">Analysis 6.5</a>) (RR 0.37, 95% CI 0.18 to 0.74); </p> </li> <li> <p>17 patients had died in the intervention group (30 patients) compared with 27 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0026" title="LiuY , ZhouJ . Association with Western and Traditional Chinese Medicines treats 30 patients with advanced gastric cancer. Journal of Shandong Traditional Chinese Medicine2002;21(3):164‐5. [0257‐358X(2002)03‐0164‐02] ">Liu 2002</a>; <a href="./references#CD005096-fig-0114" title="">Analysis 6.6</a>) (RR 0.63, 95% CI 0.45 to 0.88). </p> </li> </ol> </p> <p>One trial showed a significant difference in mortality at one year between the intervention group and the control group, and the comparison result was the following: 22 patients had died in the intervention group (105 patients) compared with 22 patients in the control group (58 patients) (<a href="./references#CD005096-bbs2-0042" title="WangG , ZhuJ , XuW , WangY , ZhouA . Clinical and experimental studies on Fuzheng granula combined with chemotherapy in advanced gastric cancer. World Chinese Journal of Digestology1998;6(3):214‐8. [ISSN1007‐9319 CN 14‐1218/R] ">Wang 1998</a>; <a href="./references#CD005096-fig-0109" title="">Analysis 6.1</a>) (RR 0.55, 95% CI 0.34 to 0.91). There was no significant difference at two years and three years between the intervention group and the control group, and the comparison result was the following, respectively: 37 patients had died in the intervention group (105 patients) compared with 26 patients in the control group (58 patients) (<a href="./references#CD005096-bbs2-0042" title="WangG , ZhuJ , XuW , WangY , ZhouA . Clinical and experimental studies on Fuzheng granula combined with chemotherapy in advanced gastric cancer. World Chinese Journal of Digestology1998;6(3):214‐8. [ISSN1007‐9319 CN 14‐1218/R] ">Wang 1998</a>; <a href="./references#CD005096-fig-0110" title="">Analysis 6.2</a>) (RR 0.79, 95% CI 0.53 to 1.61); 67 patients had died in the intervention group (105 patients) compared with 42 patients in the control group (58 patients) (<a href="./references#CD005096-bbs2-0042" title="WangG , ZhuJ , XuW , WangY , ZhouA . Clinical and experimental studies on Fuzheng granula combined with chemotherapy in advanced gastric cancer. World Chinese Journal of Digestology1998;6(3):214‐8. [ISSN1007‐9319 CN 14‐1218/R] ">Wang 1998</a>; <a href="./references#CD005096-fig-0111" title="">Analysis 6.3</a>) (RR 0.88, 95% CI 0.71 to 1.09). </p> <p>One trial showed no significant difference in mortality at six months between the intervention group and the control group, and the comparison result was the following: 7 patients had died in the intervention group (22 patients) compared with 12 patients in the control group (19 patients) (<a href="./references#CD005096-bbs2-0004" title="ChenN , JinY , LiuY , ChenY . Observation of effect about hydroxycamptothecin combined with Chinese medicine treating advanced gastric carcinoma of 41 cases. Fujian Journal of Medicine1997;19(2):82. ">Chen 1997a</a>; <a href="./references#CD005096-fig-0112" title="">Analysis 6.4</a>) (RR 0.41, 95% CI 0.19 to 0.86). </p> </section> <section id="CD005096-sec-0094"> <h5 class="title">Quality of life (QOL) (&lt; six months)</h5> <p>Of the six individual trials, only one trial with specific data showed a significant difference in Karnofsky score (&gt; 60 points) between the intervention group and the control group after the trial, and the comparison result was the following: 25 patients in the intervention group (33 patients) compared with 10 patients in the control group (26 patients) at six weeks (<a href="./references#CD005096-bbs2-0076" title="ZhaoZ , LiaoZ , ZhaoX . The clinic research of the effect of Sheng Mai injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Modern Oncology2005;13(3):387‐8. [1672‐4992(2005)03‐387‐02] ">Zhao 2005</a>; <a href="./references#CD005096-fig-0115" title="">Analysis 6.7</a>) (RR 1.97, 95% CI 1.17 to 3.32). </p> </section> <section id="CD005096-sec-0095"> <h5 class="title">Rate of short‐term remission</h5> <p>Of the six individual trials, three trials with specific data showed no significant difference in the rate of short‐term remission between the intervention group and the control group after the trial, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0026"> <li> <p>14 patients in the intervention group (22 patients) compared with six patients in the control group (19 patients) at 40 days (<a href="./references#CD005096-bbs2-0004" title="ChenN , JinY , LiuY , ChenY . Observation of effect about hydroxycamptothecin combined with Chinese medicine treating advanced gastric carcinoma of 41 cases. Fujian Journal of Medicine1997;19(2):82. ">Chen 1997a</a>; <a href="./references#CD005096-fig-0116" title="">Analysis 6.8</a>) (RR 2.02, 95% CI 0.97 to 4.20); </p> </li> <li> <p>14 patients in the intervention group (33 patients) compared with 10 patients in the control group (26 patients) at six weeks (<a href="./references#CD005096-bbs2-0076" title="ZhaoZ , LiaoZ , ZhaoX . The clinic research of the effect of Sheng Mai injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Modern Oncology2005;13(3):387‐8. [1672‐4992(2005)03‐387‐02] ">Zhao 2005</a>; <a href="./references#CD005096-fig-0117" title="">Analysis 6.9</a>) (RR 1.10, 95% CI 0.59 to 2.07); </p> </li> <li> <p>13 patients in the intervention group (30 patients) compared with 11 patients in the control group (30 patients) at 8 to 12 weeks after the therapeutic period (<a href="./references#CD005096-bbs2-0026" title="LiuY , ZhouJ . Association with Western and Traditional Chinese Medicines treats 30 patients with advanced gastric cancer. Journal of Shandong Traditional Chinese Medicine2002;21(3):164‐5. [0257‐358X(2002)03‐0164‐02] ">Liu 2002</a>; <a href="./references#CD005096-fig-0118" title="">Analysis 6.10</a>) (RR 1.18, 95% CI 0.63 to 2.20). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0096"> <h5 class="title">Median survival time (MST)</h5> <p>Of the six individual trials, no trial presented specific data on MST so it could not be appraised. </p> </section> <section id="CD005096-sec-0097"> <h5 class="title">Time to progression (TTP)</h5> <p>Of the six individual trials, no trial presented specific data on TTP so it could not be appraised. </p> </section> <section id="CD005096-sec-0098"> <h5 class="title">Adverse events</h5> <section id="CD005096-sec-0099"> <h6 class="title">Life threatening</h6> <p>No trial reported adverse events which were life threatening and no patients died of adverse events. </p> </section> <section id="CD005096-sec-0100"> <h6 class="title">Toxic response</h6> <p>Of the six individual trials, the common severe toxic responses included arrest of bone marrow and gastrointestinal side effects (such as nausea, vomiting, anorexia, etc). Only two trials reported severe adverse events, including arrest of bone marrow in one trial, nausea or vomiting and anorexia in two trials. </p> </section> <section id="CD005096-sec-0101"> <h6 class="title">Arrest of bone marrow</h6> <p>One trial with specific data showed no significant difference in the arrest of bone marrow between the intervention group and the control group, and the comparison result was the following: 1 patient in the intervention group (33 patients) compared with 4 patients in the control group (26 patients) (<a href="./references#CD005096-bbs2-0076" title="ZhaoZ , LiaoZ , ZhaoX . The clinic research of the effect of Sheng Mai injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Modern Oncology2005;13(3):387‐8. [1672‐4992(2005)03‐387‐02] ">Zhao 2005</a>; <a href="./references#CD005096-fig-0120" title="">Analysis 6.12</a>) (RR 0.20, 95% CI 0.02 to 1.66). </p> </section> <section id="CD005096-sec-0102"> <h6 class="title">Nausea or vomiting</h6> <p>One trial with specific data showed no significant difference in nausea and vomiting between the intervention group and the control group, and the comparison result was the following: 0 patients in the intervention group (33 patients) compared with 1 patient in the control group (26 patients) (<a href="./references#CD005096-bbs2-0076" title="ZhaoZ , LiaoZ , ZhaoX . The clinic research of the effect of Sheng Mai injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Modern Oncology2005;13(3):387‐8. [1672‐4992(2005)03‐387‐02] ">Zhao 2005</a>; <a href="./references#CD005096-fig-0119" title="">Analysis 6.11</a>) (RR 0.26, 95% CI 0.01 to 6.24). </p> </section> <section id="CD005096-sec-0103"> <h6 class="title">Discontinuation of treatment</h6> <p>Of the six individual trials, only one trial with specific data showed a significant difference in discontinuation due to adverse events during the therapeutic period between the intervention group and the control group, and the comparison result was the following: 13 patients in the intervention group (116 patients) compared with 32 patients in the control group (124 patients) (<a href="./references#CD005096-bbs2-0056" title="XuY . The effects of Yangxue decoction plus chemotherapy for late gastric cancer after operation. Journal of Practical Oncology1989;3(1):54‐6. ">Xu 1989</a>; <a href="./references#CD005096-fig-0121" title="">Analysis 6.13</a>) (RR 0.43, 95% CI 0.24 to 0.79). </p> </section> </section> </section> <section id="CD005096-sec-0104"> <h4 class="title">Type III (TCMH versus another TCMH)</h4> <section id="CD005096-sec-0105"> <h5 class="title">Mortality</h5> <p>Two trials could not be pooled for meta‐analysis. One trial with specific data showed a significant difference in mortality at six months between the intervention group and the control group, and the comparison result was the following: 7 patients had died in the intervention group (30 patients) compared with 12 patients in the control group (21 patients) (<a href="./references#CD005096-bbs2-0037" title="ShiL , YeY , LuoS , ChenJ , YanX . Effect on life quality and immune about Huachansu combined with Chinese medical differentiation of symptoms and signs in treating gastric carcinoma. Journal of Zhejiang Chinese Medicine College2004;28(6):20‐1. ">Shi 2004</a>; <a href="./references#CD005096-fig-0122" title="">Analysis 7.1</a>) (RR 0.41, 95% CI 0.19 to 0.86). </p> </section> <section id="CD005096-sec-0106"> <h5 class="title">Quality of life (QOL) (&lt; six months)</h5> <p>Of the two individual trials, only one trial with specific data showed a significant difference in Karnofsky score (&gt; 60 points) between the intervention group and the control group after the trial, and the comparison result was the following: 16 patients in the intervention group (30 patients) compared with 4 patients in the control group (21 patients) at 60 days (<a href="./references#CD005096-bbs2-0037" title="ShiL , YeY , LuoS , ChenJ , YanX . Effect on life quality and immune about Huachansu combined with Chinese medical differentiation of symptoms and signs in treating gastric carcinoma. Journal of Zhejiang Chinese Medicine College2004;28(6):20‐1. ">Shi 2004</a>; <a href="./references#CD005096-fig-0123" title="">Analysis 7.2</a>) (RR 2.80, 95% CI 1.09 to 7.19). </p> </section> <section id="CD005096-sec-0107"> <h5 class="title">Rate of remission (short‐term and long‐term)</h5> <p>Of the two individual trials, no trial presented specific data on rate of remission so it could not be appraised. </p> </section> <section id="CD005096-sec-0108"> <h5 class="title">Median survival time (MST)</h5> <p>Of the two individual trials, no trial presented specific data on MST so it could not be appraised. </p> </section> <section id="CD005096-sec-0109"> <h5 class="title">Time to progression (TTP)</h5> <p>Of the two individual trials, no trial presented specific data on TTP so it could not be appraised. </p> </section> <section id="CD005096-sec-0110"> <h5 class="title">Adverse events</h5> <section id="CD005096-sec-0111"> <h6 class="title">Life threatening</h6> <p>No trial reported life threatening adverse events and no patient died of adverse events.</p> </section> <section id="CD005096-sec-0112"> <h6 class="title">Toxic response</h6> <p>No trial reported a severe toxic response.</p> </section> <section id="CD005096-sec-0113"> <h6 class="title">Discontinuation of treatment</h6> <p>No trial reported the discontinuation of treatment.</p> </section> </section> </section> <section id="CD005096-sec-0114"> <h4 class="title">Type IV (TCMHs versus western medicine)</h4> <section id="CD005096-sec-0115"> <h5 class="title">Mortality</h5> <p>Six trials could not be pooled for meta‐analysis. One trial showed no significant difference in mortality at one year and three years between the intervention group and the control group, and the comparison result was the following, respectively: </p> <p> <ol id="CD005096-list-0027"> <li> <p>13 patients had died in the intervention group (41 patients) compared with 17 patients in the control group (31 patients) (<a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a>; <a href="./references#CD005096-fig-0124" title="">Analysis 8.1</a>) (RR 0.58, 95% CI 0.33 to 1.00); </p> </li> <li> <p>35 patients had died in the intervention group (41 patients) compared with 29 patients in the control group (31 patients) (<a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a>; <a href="./references#CD005096-fig-0125" title="">Analysis 8.2</a>) (RR 0.91, 95% CI 0.78 to 1.07). </p> </li> </ol> </p> <p>One trial showed no significant difference in mortality at 20 months between the intervention group and the control group, and the comparison result was the following: 15 patients had died in the intervention group (24 patients) compared with 8 patients in the control group (12 patients) (<a href="./references#CD005096-bbs2-0078" title='ZhouR , WuL , NiA , XuZ . Clinical observation of intravenous drip of "Anti‐inflammation1" in treating 24 patients with mid and late gastric carcinoma. Shanghai Journal of Traditional Chinese Medicine2000;34(8):15‐6. [1007‐1334(2000)08‐0015‐02] '>Zhou 2000</a>; <a href="./references#CD005096-fig-0126" title="">Analysis 8.3</a>) (RR 0.94, 95% CI 0.57 to1.56). </p> <p>One trial showed no significant difference in mortality at one and two years between the intervention group and the control group, and the comparison result was the following, respectively: 7 patients had died in the intervention group (62 patients) and 7 patients in the control group (56 patients) (<a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>; <a href="#CD005096-fig-0001">Figure 1</a>) (RR 0.90, 95% CI 0.34 to 2.41); 14 patients had died in the intervention group (62 patients) and 18 patients in the control group (56 patients) (<a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>; Figure 2) (RR 0.70, 95% CI 0.39 to 1.28). There was a significant difference in mortality at three, five, and 10 years between the intervention group and the control group, and the comparison result was the following, respectively: 22 patients had died in the intervention group (62 patients) compared with 32 patients in the control group (56 patients) (<a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>) (RR 0.62, 95% CI 0.41 to 0.93); 38 patients had died in the intervention group (62 patients) compared with 56 patients in the control group (56 patients) (<a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>) (RR 0.62, 95% CI 0.51 to 0.75); 57 patients had died in the intervention group (62 patients) compared with 56 patients in the control group (56 patients) (<a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>) (RR 0.92, 95% CI 0.85 to 1.00). </p> <p>One trial showed no significant difference in mortality at one, two, three, four, or five years between the intervention group and the control group, and the comparison result was the following, respectively: </p> <p> <ol id="CD005096-list-0028"> <li> <p>8 patients died in the intervention group (52 patients) compared with 6 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>) (RR 0.77, 95% CI 0.30 to 2.01); </p> </li> <li> <p>18 patients died in the intervention group (52 patients) compared with 12 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>) (RR 0.87, 95% CI 0.49 to1.54); </p> </li> <li> <p>24 patients died in the intervention group (52 patients) compared with 17 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>) (RR 0.81, 95% CI 0.53 to 1.25); </p> </li> <li> <p>32 patients died in the intervention group (52 patients) compared with 22 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>) (RR 0.84, 95% CI 0.62 to 1.14); </p> </li> <li> <p>34 patients died in the intervention group (52 patients) compared with 25 patients in the control group (30 patients) (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>) (RR 0.78, 95% CI 0.61 to 1.01). </p> </li> </ol> </p> <p>One trial showed no significant difference in mortality at six months and one year between the intervention group and the control group, and the comparison result was the following, respectively: 7 patients had died in the intervention group (39 patients) compared with 8 patients in the control group (39 patients) (<a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a>) (RR 0.88, 95% CI 0.35 to 2.18); 10 patients had died in the intervention group (39 patients) compared with 17 patients in the control group (39 patients) (<a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a>) (RR 0.59, 95% CI 0.31 to 1.12). This trial showed a significant difference in mortality at 1.5 years between the intervention group and the control group, and the comparison result was the following: 19 patients had died in the intervention group (39 patients) compared with 28 patients in the control group (39 patients) (<a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a>) (RR 0.68, 95% CI 0.47 to 0.99). </p> </section> <section id="CD005096-sec-0116"> <h5 class="title">Quality of life (QOL) (&lt; six months)</h5> <p>Of the six individual trials, only two trials with specific data showed a significant difference in Karnofsky score between the intervention group and the control group after the trial, and the comparison result was the following: Karnofsky score 70.26 ± 6.68 (39 patients) in the intervention group compared with 63.84 ± 6.73 in the control group (39 patients) at two to three months (<a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a>) (WMD 6.42, 95% CI 3.44 to 9.40); 42 patients in the intervention group (52 patients) compared with 9 patients in the control group (30 patients) at 2 months (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>) (RR 2.69, 95% CI 1.53 to 4.72); 20 patients in the intervention group (35 patients) compared with 9 patients in the control group (30 patients) at three weeks (<a href="./references#CD005096-bbs2-0062" title="YeSF , YeB , WuM . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Journal of Wenzhou Medical College2009;39(2):172‐3. ">Ye 2009</a>) (RR 3.11, 95% CI 1.11 to 8.70); 20 patients in the intervention group (30 patients) compared with 9 patients in the control group (30 patients) at three weeks (<a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a>) (RR 4.67, 95% CI 1.57 to 13.87). </p> <p>Another trial with specific data showed no significant difference in Karnofsky score (&gt; 60 points) between the intervention group and the control group after the trial, and the comparison result was the following: 15 patients in the intervention group (41 patients) compared with 6 patients in the control group (31 patients) at 6 months (<a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a>) (RR 1.89, 95% CI 0.83 to 4.31). </p> </section> <section id="CD005096-sec-0117"> <h5 class="title">Rate of short‐term remission</h5> <p>Of the seven individual trials, three trials showed a significant difference in the rate of short‐term remission between the intervention group and the control group after the trial, and the comparison result was the following: 3 patients in the intervention group (39 patients) compared with 13 patients in the control group (39 patients) at 8 to 12 weeks (<a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a>) (RR 0.23, 95% CI 0.09 to 0.75); 21 patients in the intervention group (35 patients) compared with 10 patients in the control group (30 patients) at three weeks (<a href="./references#CD005096-bbs2-0062" title="YeSF , YeB , WuM . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Journal of Wenzhou Medical College2009;39(2):172‐3. ">Ye 2009</a>) (RR 3.00, 95% CI 1.09 to 8.29); 21 patients in the intervention group (30 patients) compared with 10 patients in the control group (30 patients) at three weeks (<a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a>) (RR 4.67, 95% CI 1.57 to 13.87). </p> <p>Four trials with specific data showed no significant difference in the rate of short‐term remission between the intervention group and the control group after the trial, and the comparison result was the following: </p> <p> <ol id="CD005096-list-0029"> <li> <p>16 patients in the intervention group (41 patients) compared with 5 patients in the control group (31 patients) at six months (<a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a>) (RR 2.42, 95% CI 0.99 to 5.89); </p> </li> <li> <p>3 patients in the intervention group (24 patients) compared with 2 patients in the control group (12 patients) at two months (<a href="./references#CD005096-bbs2-0078" title='ZhouR , WuL , NiA , XuZ . Clinical observation of intravenous drip of "Anti‐inflammation1" in treating 24 patients with mid and late gastric carcinoma. Shanghai Journal of Traditional Chinese Medicine2000;34(8):15‐6. [1007‐1334(2000)08‐0015‐02] '>Zhou 2000</a>) (RR 0.75, 95% CI 0.14 to 3.90); </p> </li> <li> <p>5 patients in the intervention group (62 patients) compared with 6 patients in the control group (56 patients) at four months (<a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>) (RR 0.75, 95% CI 0.24 to 2.33); </p> </li> <li> <p>21 patients in the intervention group (52 patients) compared with 16 patients in the control group (30 patients) at two months (<a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>) (RR 0.76, 95% CI 0.47 to1.21). </p> </li> </ol> </p> </section> <section id="CD005096-sec-0118"> <h5 class="title">Median survival time (MST)</h5> <p>Of the six individual trials, only two trials presented complete data, which showed a significant difference in the median survival time (MST) between the intervention group and the control group, and the comparison results were the following: the MST was 12.68 ± 8.36 months (41 patients) in the intervention group and 7.01 ± 5.32 months (31 patients) in the control group (<a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a>) (MD 5.67, 95% CI 2.50 to 8.84); the MST was 10.51 ± 2.06 months (39 patients) in the intervention group and 7.38 ± 3.24 months (39 patients) in the control group (<a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a>) (MD 3.13, 95% CI 1.93 to 4.33). </p> </section> <section id="CD005096-sec-0119"> <h5 class="title">Time to progression (TTP)</h5> <p>Of the six individual trials, no trial presented specific data on TTP so it could not be appraised. </p> </section> <section id="CD005096-sec-0120"> <h5 class="title">Adverse events</h5> <section id="CD005096-sec-0121"> <h6 class="title">Life threatening</h6> <p>No trial reported life threatening adverse events and no patient died of adverse events.</p> </section> <section id="CD005096-sec-0122"> <h6 class="title">Toxic response</h6> <p>Of the seven individual trials, only one trial mentioned severe toxic response in the patients of the control group (<a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a>) but it could not be appraised due to lack of specific data. </p> <p><b>Leukopenia</b> </p> <p>One trial showed no significant difference in the leukocyte score: 6.1 ± 2.4 (30 patients) in the intervention group and 4.5 ± 2.4 months (30 patients) in the control group at three weeks (<a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a>) (MD 1.60, 95% CI 0.39 to 2.81). </p> <p><b>Thrombopenia</b> </p> <p>One trial showed no significant difference in the platelet score: 163.9 ± 51.2 (30 patients) in the intervention group and 143.4 ± 49.5 (30 patients) in the control group (<a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a>) (MD 20.50, 95% CI ‐4.98 to 45.98). </p> <p><b>Decrease of haemoglobin</b> </p> <p>One trial showed a significant difference in the haemoglobin score: 111.2 ± 17.1 (30 patients) in the intervention group and 101.2 ± 16.8 (30 patients) in the control group (<a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a>) (MD 10.00, 95% CI 1.42 to 18.58). </p> </section> <section id="CD005096-sec-0123"> <h6 class="title">Discontinuation of treatment</h6> <p>No trial reported discontinuation of treatment.</p> <p>The outcomes with a statistically significant difference, from the 51 trials, are listed in the 'Additional tables' (<a href="#CD005096-tbl-0013">Table 9</a>). </p> <div class="table" id="CD005096-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">The outcomes with statistically significant differences from the 53 trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type I (42 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type II (6 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type III (2 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type IV (7 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total number of trials</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median survival time</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to progression</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Result in the discontinuation of treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events (leukopenia)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events (Thrombopenia)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events (Decrease of haemoglobin)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events (nausea/vomiting)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> </tbody> </table> </div> <p>In the 57 trials, follow‐up (from 0.5 to 5 years) was carried out in 16 trials (38.1%, 16/42) in the type I group, three trials (50.0%, 3/6) in the type II group, two trials (100.0%, 2/2) in the type III group, and four trials (57.1%, 4/7) in the type IV group, respectively, but only 13 trials (52%, 13/25) specified the length of follow‐up. All the follow‐ups supported the conclusion that the TCMHs (with western medicine or not) had better long‐term effectiveness (TTP, MST) than the commonly used western medicines for chemotherapy. There were no reports of any toxic effects or side effects of TCMHs and, in fact, one of the curative effects of the TCMHs used in these trials was aimed at the toxic and side effects caused by the chemotherapy itself. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005096-sec-0124" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005096-sec-0124"></div> <section id="CD005096-sec-0125"> <h3 class="title" id="CD005096-sec-0125">Summary of main results</h3> <p>Although the recipes for TCM (including TCMHs) have screened some herbs, such as Radix Astragali seu Hedysari, Rhizoma Atractylodis Macrocephalae, Radix Codonopsis Pilosulae, Rhizoma Zedoariae, etc, the effectiveness of TCM for gastric cancer in an advanced or late stage still needs further confirmation by more trials. </p> <p>Eighty trials with 6857 advanced or late‐stage gastric cancer patients were identified. Most trials were of low quality and used TCMHs plus chemotherapy compared with the same chemotherapy alone (65 trials). Others included TCMHs plus western therapeutic methods compared with the same TCMHs (type II, seven trials), TCMHs compared with another TCMH (type III, two trials), and TCMHs compared with western therapeutic methods (type IV, six trials). Except for four trials of Huachansu, six trials of Aidi, seven trials of Fufangkushen, three trials of Shenqifuzheng, we could not pool the other 57 results because no more than two used the same intervention or outcomes. </p> <p>TCMHs with or without chemotherapy in the 57 trials showed a statistically significant difference for the improvement of mortality in nine trials, quality of life in 16 trials, rate of remission in 11 trials, discontinuation from treatment in three trials, leukopenia in five trials, and vomiting and nausea in one trial. The pooled results from the four injections of TCMHs, Huachansu, Aidi, Fufangkushen, and Shenqifuzheng, showed statistically significant differences for improvement of leukopenia; and Huachansu, Aidi, and Fufangkushen for adverse events in the digestive system; but no significant difference in the rate of short‐term remission. </p> <p>A standard, generally accepted formula of TCM should be used for gastric cancer in an advanced or late stage in large‐scale, randomised, double blind and multi‐centre trials in China. </p> </section> <section id="CD005096-sec-0126"> <h3 class="title" id="CD005096-sec-0126">Overall completeness and applicability of evidence</h3> <p>Although the results, including those of the meta‐analysis and description, implied that TCMHs may have some curative effects for advanced or late‐stage gastric cancer, obtaining more TTP or MST and fewer toxic and side effects than the commonly used western medicine for chemotherapy mentioned above, it is still too early to draw the conclusion that the TCMHs have definitive curative effects for advanced or late‐stage gastric cancer because of the methodological limitations of the data from the trials. Information on allocation concealment, side effects, adverse events, and follow‐up have not been provided adequately for research. All of the primary data should be offered for further analyses, regardless of the positive or negative conclusions of the clinical trials. </p> </section> <section id="CD005096-sec-0127"> <h3 class="title" id="CD005096-sec-0127">Quality of the evidence</h3> <p>The RCTs should be designed strictly, for example to use the same medicine, same dosage, same course in the controlled group; and when including patients with different levels of illness (stage III or IV) the trial should use stratified randomisation. At the same time, the method of allocation concealment for clinical trials should be clarified by the authors. In the 80 included studies, only seven trials (<a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a>; <a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a>; <a href="./references#CD005096-bbs2-0029" title="LiuLH , ZhangCX . Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma. China Modern Doctor2009;47(29):16‐7. ">Liu 2009</a>; <a href="./references#CD005096-bbs2-0042" title="WangG , ZhuJ , XuW , WangY , ZhouA . Clinical and experimental studies on Fuzheng granula combined with chemotherapy in advanced gastric cancer. World Chinese Journal of Digestology1998;6(3):214‐8. [ISSN1007‐9319 CN 14‐1218/R] ">Wang 1998</a>; <a href="./references#CD005096-bbs2-0044" title="WangP . Observation effect in chemotherapy, radiotherapy and Yadanzi oil treating advanced gastric carcinoma. Journal of Practical Oncology2004;19(1):78‐9. [1001‐1692(2004)01‐0078‐02] ">Wang 2004</a>; <a href="./references#CD005096-bbs2-0071" title="ZhangH , SuZX . Curative effect of Shenling Baizhu powder on chemotherapy‐induced toxicity in advanced gastric cancer. Journal of TCM University of Hunan2008;28(2):51‐3, 56. ">Zhang 2008</a>; <a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a>) mentioned that they used a random number table (or drawing straws, envelope concealment), without any special explanation. An urgent mission in the TCM field for gastric cancer is to change the current reporting practices of the study authors. Even if the method of allocation concealment is clear to some, it should be elucidated completely in the article for the purpose of further analysis. </p> </section> <section id="CD005096-sec-0128"> <h3 class="title" id="CD005096-sec-0128">Potential biases in the review process</h3> <p>The journal editors responsible for publication should ask the authors to include information about the methods of the trials and authors should not be permitted to omit these contents. Details of follow‐up and adverse events should also be provided, regardless of whether they occurred or not. </p> <p>It should be noted that although meta‐analysis could not be carried out for most of the trials on Huachansu, because most of the trials were not strictly RCTs, the TCMH Huachansu has been used widely for many years in China. The main components of Huachansu include extracts from the skin of the Chinese toad. </p> </section> <section id="CD005096-sec-0129"> <h3 class="title" id="CD005096-sec-0129">Agreements and disagreements with other studies or reviews</h3> <p>Because the classical therapeutic regimen for advanced or late‐stage gastric cancer is chemotherapy, and almost all of the researchers in TCM circles are aware of this, choosing it as the active comparator in the control group makes the efficacy of TCHMs more convincing than if they had been compared with placebo. The trials were all designed as equivalence trials and no placebo controlled trials were carried out. Some researchers believe their self‐made formulas of TCMHs for gastric cancer in an advanced or late stage to be more effective than some patented TCMHs, so in the type II group some commonly used patented medicines of TCMHs were chosen as the active comparators in the control group. Other relevant reviews about TCMHs for breast cancer (<a href="./references#CD005096-bbs2-0207" title="ZhangM , LiuX , LiJ , HeL , TripathyD . Chinese medicinal herbs to treat the side‐effects of chemotherapy in breast cancer patients. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD004921.pub2] ">Zhang 2007</a>), TCMHs for colorectal cancer (<a href="./references#CD005096-bbs2-0204" title="WuT , MunroA , LiuG . Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD004540] ">Wu 2008</a>), and TCMHs for lung cancer (<a href="./references#CD005096-bbs2-0196" title="RuiD , XiaoC , XTai , GuanJ . Elemene for the treatment of lung cancer. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD006054] ">Rui 2008</a>) all showed that TCMHs may alleviate the chemotherapy‐related side effects or adverse events, but the evidence is too limited to make any confident conclusions. More high quality studies are needed. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005096-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD005096-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Appraisal of the results of Huachansu in the short term, Outcome 1 the rate of complete remission and partly remission." data-id="CD005096-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Appraisal of the results of Huachansu in the short term, Outcome 1 the rate of complete remission and partly remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Appraisal of the results of Huachansu in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy (no special data in trial of Zhang 2006)." data-id="CD005096-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Appraisal of the results of Huachansu in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy (no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Appraisal of the results of Huachansu in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Zhang 2006)." data-id="CD005096-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Appraisal of the results of Huachansu in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Appraisal of the results of Aidi in the short term, Outcome 1 the rate of complete remission and partly remission(no special data in trial of Zhang 2009)." data-id="CD005096-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Appraisal of the results of Aidi in the short term, Outcome 1 the rate of complete remission and partly remission(no special data in trial of Zhang 2009). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Appraisal of the results of Aidi in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy." data-id="CD005096-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Appraisal of the results of Aidi in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Appraisal of the results of Aidi in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Jia 2003, Zhang 2009)." data-id="CD005096-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Appraisal of the results of Aidi in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Jia 2003, Zhang 2009). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Appraisal of the results of Fufangkushen in the short term, Outcome 1 the rate of complete remission and partly remission(no special data in trial of Fu 2011)." data-id="CD005096-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Appraisal of the results of Fufangkushen in the short term, Outcome 1 the rate of complete remission and partly remission(no special data in trial of Fu 2011). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Appraisal of the results of Fufangkushen in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy(no special data in trial of Fu 2011, Liu 2009a, Zhang 2010)." data-id="CD005096-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Appraisal of the results of Fufangkushen in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy(no special data in trial of Fu 2011, Liu 2009a, Zhang 2010). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Appraisal of the results of Fufangkushen in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy." data-id="CD005096-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Appraisal of the results of Fufangkushen in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Appraisal of the results of Shenqifuzheng in the short term, Outcome 1 the rate of complete remission and partly remission." data-id="CD005096-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Appraisal of the results of Shenqifuzheng in the short term, Outcome 1 the rate of complete remission and partly remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Appraisal of the results of Shenqifuzheng in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy." data-id="CD005096-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Appraisal of the results of Shenqifuzheng in the short term, Outcome 2 the toxic and side effects in digestive system after chemotherapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Appraisal of the results of Shenqifuzheng in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy." data-id="CD005096-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Appraisal of the results of Shenqifuzheng in the short term, Outcome 3 the toxic and side effects of leukopenia after chemotherapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 1 mortality 1." data-id="CD005096-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 1 mortality 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 2 mortality 3." data-id="CD005096-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 2 mortality 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 3 mortality 4." data-id="CD005096-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 3 mortality 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 4 mortality 5." data-id="CD005096-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 4 mortality 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 5 mortality 6‐2." data-id="CD005096-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 5 mortality 6‐2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 6 mortality 6‐1." data-id="CD005096-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 6 mortality 6‐1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 7 mortality 6‐3." data-id="CD005096-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 7 mortality 6‐3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 8 mortality 7‐1." data-id="CD005096-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 8 mortality 7‐1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 9 mortality 7‐2." data-id="CD005096-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 9 mortality 7‐2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 10 mortality 7‐3." data-id="CD005096-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 10 mortality 7‐3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 11 mortaliyt 8‐1." data-id="CD005096-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 11 mortaliyt 8‐1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 12 mortality 8‐2." data-id="CD005096-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 12 mortality 8‐2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 13 mortality 8‐3." data-id="CD005096-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 13 mortality 8‐3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 14 quality of life 1." data-id="CD005096-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 14 quality of life 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 15 qualitiy of life 2." data-id="CD005096-fig-0028" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.15</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 15 qualitiy of life 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 16 quality of life 4." data-id="CD005096-fig-0029" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.16</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 16 quality of life 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 17 quality of life 5." data-id="CD005096-fig-0030" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.17</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 17 quality of life 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 18 quality of life 6." data-id="CD005096-fig-0031" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.18</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 18 quality of life 6.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 19 quality of life 7." data-id="CD005096-fig-0032" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.19</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 19 quality of life 7.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 20 quality of life 8." data-id="CD005096-fig-0033" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.20</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 20 quality of life 8.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 21 quality of life 9." data-id="CD005096-fig-0034" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.21</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 21 quality of life 9.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 22 quality of life 10." data-id="CD005096-fig-0035" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.22</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 22 quality of life 10.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 23 quality of life 11." data-id="CD005096-fig-0036" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.23</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 23 quality of life 11.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 24 quality of life 12." data-id="CD005096-fig-0037" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.24</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 24 quality of life 12.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 25 quality of life 13." data-id="CD005096-fig-0038" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.25</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 25 quality of life 13.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 26 quality of life 14." data-id="CD005096-fig-0039" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.26</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 26 quality of life 14.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 27 quality of life 15." data-id="CD005096-fig-0040" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.27</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 27 quality of life 15.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 28 quality of life 16." data-id="CD005096-fig-0041" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.28</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 28 quality of life 16.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 29 quality of life 17." data-id="CD005096-fig-0042" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.29</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 29 quality of life 17.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 30 quality of life 18." data-id="CD005096-fig-0043" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.30</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 30 quality of life 18.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 31 quality of life 19." data-id="CD005096-fig-0044" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.31</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 31 quality of life 19.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 32 quality of life 20." data-id="CD005096-fig-0045" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.32</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 32 quality of life 20.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 33 quality of life 21." data-id="CD005096-fig-0046" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.33</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 33 quality of life 21.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 34 quality of life 22." data-id="CD005096-fig-0047" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.34</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 34 quality of life 22.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 35 quality of life 23." data-id="CD005096-fig-0048" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.35</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 35 quality of life 23.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 36 rate of remission 1." data-id="CD005096-fig-0049" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.36</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 36 rate of remission 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 37 rate of remission 2." data-id="CD005096-fig-0050" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.37</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 37 rate of remission 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 38 rate of remission 4." data-id="CD005096-fig-0051" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.38</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 38 rate of remission 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 39 rate of remission 5." data-id="CD005096-fig-0052" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.39</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 39 rate of remission 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 40 rate of remission 6." data-id="CD005096-fig-0053" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.40</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 40 rate of remission 6.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 41 rete of remission 8." data-id="CD005096-fig-0054" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.41</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 41 rete of remission 8.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 42 rate of remission 9." data-id="CD005096-fig-0055" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.42</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 42 rate of remission 9.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 43 rate of remission 10." data-id="CD005096-fig-0056" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.43</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 43 rate of remission 10.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 44 rate of remission 11." data-id="CD005096-fig-0057" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.44</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 44 rate of remission 11.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 45 rate of remission 12." data-id="CD005096-fig-0058" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.45</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 45 rate of remission 12.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 46 rate of remission 13." data-id="CD005096-fig-0059" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.46</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 46 rate of remission 13.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-47" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-47.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 47 rate of remission 14." data-id="CD005096-fig-0060" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-47.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.47</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 47 rate of remission 14.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-47.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 48 rate of remission 15." data-id="CD005096-fig-0061" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.48</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 48 rate of remission 15.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-48.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-49" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-49.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 49 rate of remission 16." data-id="CD005096-fig-0062" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-49.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.49</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 49 rate of remission 16.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-49.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-50" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-50.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 50 rate of remission 17." data-id="CD005096-fig-0063" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-50.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.50</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 50 rate of remission 17.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-50.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-51" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-51.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 51 rate of remission 18." data-id="CD005096-fig-0064" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-51.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.51</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 51 rate of remission 18.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-51.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-52" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-52.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 52 rate of remission 19." data-id="CD005096-fig-0065" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-52.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.52</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 52 rate of remission 19.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-52.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-53" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-53.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 53 rate of remission 20." data-id="CD005096-fig-0066" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-53.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.53</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 53 rate of remission 20.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-53.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-54" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-54.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 54 rate of remission 21." data-id="CD005096-fig-0067" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-54.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.54</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 54 rate of remission 21.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-54.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-55" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-55.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 55 rate of remission 22." data-id="CD005096-fig-0068" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-55.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.55</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 55 rate of remission 22.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-55.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-56" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-56.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 56 rate of remission 23." data-id="CD005096-fig-0069" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-56.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.56</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 56 rate of remission 23.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-56.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-57" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-57.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 57 rate of remission 24." data-id="CD005096-fig-0070" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-57.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.57</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 57 rate of remission 24.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-57.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-58" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-58.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 58 rate of remission 25." data-id="CD005096-fig-0071" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-58.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.58</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 58 rate of remission 25.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-58.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-59" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-59.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 59 rate of remission 26." data-id="CD005096-fig-0072" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-59.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.59</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 59 rate of remission 26.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-59.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-60" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-60.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 60 rate of remission 27." data-id="CD005096-fig-0073" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-60.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.60</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 60 rate of remission 27.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-60.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-61" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-61.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 61 rate of remission 28." data-id="CD005096-fig-0074" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-61.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.61</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 61 rate of remission 28.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-61.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-62" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-62.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 62 rate of remission 29." data-id="CD005096-fig-0075" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-62.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.62</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 62 rate of remission 29.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-62.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-63" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-63.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 63 rate of remission 30." data-id="CD005096-fig-0076" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-63.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.63</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 63 rate of remission 30.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-63.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-64" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-64.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 64 median survival times 1." data-id="CD005096-fig-0077" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-64.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.64</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 64 median survival times 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-64.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-65" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-65.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 65 leukopenia 2." data-id="CD005096-fig-0078" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-65.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.65</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 65 leukopenia 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-65.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-66" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-66.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 66 leukopenia 3." data-id="CD005096-fig-0079" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-66.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.66</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 66 leukopenia 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-66.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-67" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-67.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 67 leukopenia 4." data-id="CD005096-fig-0080" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-67.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.67</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 67 leukopenia 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-67.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-68" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-68.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 68 leukopenia 5." data-id="CD005096-fig-0081" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-68.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.68</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 68 leukopenia 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-68.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-69" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-69.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 69 leukopenia 6." data-id="CD005096-fig-0082" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-69.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.69</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 69 leukopenia 6.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-69.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-70" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-70.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 70 leukopenia 7." data-id="CD005096-fig-0083" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-70.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.70</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 70 leukopenia 7.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-70.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-71" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-71.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 71 leukopenia 8." data-id="CD005096-fig-0084" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-71.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.71</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 71 leukopenia 8.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-71.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-72" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-72.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 72 nausea/vomiting 2." data-id="CD005096-fig-0085" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-72.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.72</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 72 nausea/vomiting 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-72.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-73" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-73.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 73 nausea/vomiting 3." data-id="CD005096-fig-0086" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-73.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.73</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 73 nausea/vomiting 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-73.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-74" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-74.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 74 nausea/vomiting 4." data-id="CD005096-fig-0087" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-74.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.74</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 74 nausea/vomiting 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-74.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-75" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-75.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 75 nausea/vomiting 5." data-id="CD005096-fig-0088" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-75.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.75</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 75 nausea/vomiting 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-75.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-76" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-76.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 76 nausea/vomiting 6." data-id="CD005096-fig-0089" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-76.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.76</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 76 nausea/vomiting 6.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-76.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-77" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-77.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 77 nausea/vomiting 7." data-id="CD005096-fig-0090" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-77.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.77</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 77 nausea/vomiting 7.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-77.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-78" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-78.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 78 nausea/vomiting 8." data-id="CD005096-fig-0091" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-78.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.78</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 78 nausea/vomiting 8.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-78.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-79" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-79.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 79 thrombopenia 1." data-id="CD005096-fig-0092" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-79.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.79</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 79 thrombopenia 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-79.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-80" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-80.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 80 thrombopenia 2." data-id="CD005096-fig-0093" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-80.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.80</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 80 thrombopenia 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-80.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-81" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-81.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 81 thrombopenia 3." data-id="CD005096-fig-0094" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-81.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.81</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 81 thrombopenia 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-81.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-82" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-82.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 82 thrombopenia 4." data-id="CD005096-fig-0095" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-82.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.82</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 82 thrombopenia 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-82.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-83" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-83.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 83 thrombopenia 5." data-id="CD005096-fig-0096" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-83.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.83</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 83 thrombopenia 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-83.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-84" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-84.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 84 diarrhea 1." data-id="CD005096-fig-0097" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-84.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.84</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 84 diarrhea 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-84.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-85" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-85.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 85 decrease of hemoglobin 1." data-id="CD005096-fig-0098" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-85.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.85</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 85 decrease of hemoglobin 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-85.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-86" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-86.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 86 decrease of hemoglobin 2." data-id="CD005096-fig-0099" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-86.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.86</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 86 decrease of hemoglobin 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-86.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-87" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-87.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 87 decrease of hemoglobin 3." data-id="CD005096-fig-0100" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-87.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.87</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 87 decrease of hemoglobin 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-87.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-88" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-88.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 88 damage of liver and/or kidney function 1." data-id="CD005096-fig-0101" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-88.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.88</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 88 damage of liver and/or kidney function 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-88.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-89" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-89.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 89 damage of liver and/or kidney function 2." data-id="CD005096-fig-0102" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-89.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.89</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 89 damage of liver and/or kidney function 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-89.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-90" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-90.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 90 damage of liver and/or kidney function 3." data-id="CD005096-fig-0103" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-90.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.90</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 90 damage of liver and/or kidney function 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-90.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-91" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-91.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 91 damage of liver and/or kidney function 4." data-id="CD005096-fig-0104" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-91.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.91</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 91 damage of liver and/or kidney function 4. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-91.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-92" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-92.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 92 discontinuation due to adverse event 1." data-id="CD005096-fig-0105" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-92.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.92</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 92 discontinuation due to adverse event 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-92.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-93" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-93.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 93 discontinuation due to adverse event 2." data-id="CD005096-fig-0106" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-93.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.93</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 93 discontinuation due to adverse event 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-93.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-94" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-94.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 94 discontinuation due to adverse event 3." data-id="CD005096-fig-0107" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-94.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.94</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 94 discontinuation due to adverse event 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-94.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-005-95" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-005-95.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Appraisal of the results of type I, Outcome 95 discontinuation due to adverse event 4." data-id="CD005096-fig-0108" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-95.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.95</div> <div class="figure-caption"> <p>Comparison 5 Appraisal of the results of type I, Outcome 95 discontinuation due to adverse event 4. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-005-95.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 1 mortality 1.1." data-id="CD005096-fig-0109" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 1 mortality 1.1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 2 mortality 1.2." data-id="CD005096-fig-0110" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 2 mortality 1.2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 3 mortality 1.3." data-id="CD005096-fig-0111" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 3 mortality 1.3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 4 mortality 2." data-id="CD005096-fig-0112" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 4 mortality 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 5 mortality 3.1." data-id="CD005096-fig-0113" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 5 mortality 3.1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 6 mortality 3.2." data-id="CD005096-fig-0114" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 6 mortality 3.2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 7 quality of life 1." data-id="CD005096-fig-0115" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 7 quality of life 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 8 rate of remission 1." data-id="CD005096-fig-0116" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 8 rate of remission 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 9 rate of remission 2." data-id="CD005096-fig-0117" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 9 rate of remission 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 10 rate of remission 3." data-id="CD005096-fig-0118" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 10 rate of remission 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 11 nausea/vomiting 1." data-id="CD005096-fig-0119" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 11 nausea/vomiting 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 12 arrest of bone marrow." data-id="CD005096-fig-0120" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 12 arrest of bone marrow.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-006-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-006-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Appraisal of the results of type II, Outcome 13 discontinuation due to adverse event." data-id="CD005096-fig-0121" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6 Appraisal of the results of type II, Outcome 13 discontinuation due to adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-006-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Appraisal of the results of type III, Outcome 1 mortality." data-id="CD005096-fig-0122" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Appraisal of the results of type III, Outcome 1 mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Appraisal of the results of type III, Outcome 2 quality of life." data-id="CD005096-fig-0123" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Appraisal of the results of type III, Outcome 2 quality of life.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 1 mortality 1.1." data-id="CD005096-fig-0124" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 1 mortality 1.1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 2 mortality 1.2." data-id="CD005096-fig-0125" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 2 mortality 1.2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 3 mortality 2." data-id="CD005096-fig-0126" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 3 mortality 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 4 mortality 3.1." data-id="CD005096-fig-0127" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 4 mortality 3.1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 5 mortality 3.2." data-id="CD005096-fig-0128" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 5 mortality 3.2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 6 mortality 3.3." data-id="CD005096-fig-0129" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 6 mortality 3.3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 7 mortality 3.4." data-id="CD005096-fig-0130" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 7 mortality 3.4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 8 mortality 3.5." data-id="CD005096-fig-0131" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 8 mortality 3.5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 9 mortality 4.1." data-id="CD005096-fig-0132" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 9 mortality 4.1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 10 mortality 4.2." data-id="CD005096-fig-0133" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 10 mortality 4.2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 11 mortality 4.3." data-id="CD005096-fig-0134" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.11</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 11 mortality 4.3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 12 mortality 5.1." data-id="CD005096-fig-0135" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.12</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 12 mortality 5.1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 13 mortality 5.2." data-id="CD005096-fig-0136" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.13</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 13 mortality 5.2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 14 mortality 5.3." data-id="CD005096-fig-0137" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.14</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 14 mortality 5.3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 15 mortality 5.4." data-id="CD005096-fig-0138" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.15</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 15 mortality 5.4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 16 mortality 5.5." data-id="CD005096-fig-0139" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.16</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 16 mortality 5.5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 17 quality of life 1." data-id="CD005096-fig-0140" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.17</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 17 quality of life 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 18 quality of life 2." data-id="CD005096-fig-0141" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.18</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 18 quality of life 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 19 quality of life 3." data-id="CD005096-fig-0142" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.19</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 19 quality of life 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 20 quality of life 4." data-id="CD005096-fig-0143" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.20</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 20 quality of life 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 21 quality of life 5." data-id="CD005096-fig-0144" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.21</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 21 quality of life 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 22 rate of remission 1." data-id="CD005096-fig-0145" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.22</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 22 rate of remission 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 23 rate of remission 2." data-id="CD005096-fig-0146" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.23</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 23 rate of remission 2.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 24 rate of remission 3." data-id="CD005096-fig-0147" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.24</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 24 rate of remission 3.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 25 rate of remission 4." data-id="CD005096-fig-0148" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.25</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 25 rate of remission 4.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 26 rate of remission 5." data-id="CD005096-fig-0149" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.26</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 26 rate of remission 5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 27 rate of remission 6." data-id="CD005096-fig-0150" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.27</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 27 rate of remission 6.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 28 rate of remission 7." data-id="CD005096-fig-0151" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.28</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 28 rate of remission 7.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 29 Leukopenia 1." data-id="CD005096-fig-0152" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.29</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 29 Leukopenia 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0153"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 30 Thrombopenia 1." data-id="CD005096-fig-0153" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.30</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 30 Thrombopenia 1.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0153">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0154"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 31 Decrease of haemoglobin 1." data-id="CD005096-fig-0154" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.31</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 31 Decrease of haemoglobin 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0154">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0155"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 32 median survival time 1." data-id="CD005096-fig-0155" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.32</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 32 median survival time 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0155">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0156"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-008-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-008-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Appraisal of the results of type IV, Outcome 33 median survival time 2." data-id="CD005096-fig-0156" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.33</div> <div class="figure-caption"> <p>Comparison 8 Appraisal of the results of type IV, Outcome 33 median survival time 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0156">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-008-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0157"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 1 the rate of complete remission and partly remission only for trials with patients in IV stage." data-id="CD005096-fig-0157" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 1 the rate of complete remission and partly remission only for trials with patients in IV stage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0157">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0158"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 2 the toxic and side effects in digestive system only for trials with patients in IV stage(no special data in trial of Zhang 2006)." data-id="CD005096-fig-0158" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 2 the toxic and side effects in digestive system only for trials with patients in IV stage(no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0158">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0159"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 3 the toxic and side effects of leukopenia only for trials with patients in IV stage(no special data in trial of Zhang 2006)." data-id="CD005096-fig-0159" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 3 the toxic and side effects of leukopenia only for trials with patients in IV stage(no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0159">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0160"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 4 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old." data-id="CD005096-fig-0160" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 4 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0160">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0161"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 5 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2006)." data-id="CD005096-fig-0161" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 5 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0161">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0162"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 6 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2006)." data-id="CD005096-fig-0162" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 6 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0162">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0163"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 7 the rate of complete remission and partly remission only for trials with samples&gt;60." data-id="CD005096-fig-0163" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 7 the rate of complete remission and partly remission only for trials with samples&gt;60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0163">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0164"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 8 the toxic and side effects in digestive system only for trials with samples&gt;60(no special data in trial of Zhang 2006)." data-id="CD005096-fig-0164" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 8 the toxic and side effects in digestive system only for trials with samples&gt;60(no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0164">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0165"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 9 the toxic and side effects of leukopenia only for trials with samples&gt;60(no special data in trial of Zhang 2006)." data-id="CD005096-fig-0165" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.9</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 9 the toxic and side effects of leukopenia only for trials with samples&gt;60(no special data in trial of Zhang 2006). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0165">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0166"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 10 the rate of complete remission and partly remission only for trials with dosage of injectio Huachansu=20ml iv gtt Qd." data-id="CD005096-fig-0166" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.10</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 10 the rate of complete remission and partly remission only for trials with dosage of injectio Huachansu=20ml iv gtt Qd. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0166">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0167"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 11 the toxic and side effects in digestive system only for trials with dosage of injectio Huachansu=20ml iv gtt Qd." data-id="CD005096-fig-0167" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.11</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 11 the toxic and side effects in digestive system only for trials with dosage of injectio Huachansu=20ml iv gtt Qd. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0167">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0168"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-009-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-009-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Sensitivity analyses for Huachansu, Outcome 12 the toxic and side effects of leukopenia only for trials with dosage of injectio Huachansu=20ml iv gtt Qd." data-id="CD005096-fig-0168" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.12</div> <div class="figure-caption"> <p>Comparison 9 Sensitivity analyses for Huachansu, Outcome 12 the toxic and side effects of leukopenia only for trials with dosage of injectio Huachansu=20ml iv gtt Qd. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0168">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-009-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0169"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 1 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2009)." data-id="CD005096-fig-0169" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 1 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2009). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0169">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0170"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 2 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old." data-id="CD005096-fig-0170" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 2 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0170">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0171"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 3 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old." data-id="CD005096-fig-0171" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 3 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0171">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0172"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 4 the rate of complete remission and partly remission only for trials with samples&gt;=60." data-id="CD005096-fig-0172" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 4 the rate of complete remission and partly remission only for trials with samples&gt;=60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0172">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0173"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 5 the toxic and side effects in digestive system only for trials with samples&gt;=60." data-id="CD005096-fig-0173" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 5 the toxic and side effects in digestive system only for trials with samples&gt;=60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0173">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0174"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 6 the toxic and side effects of leukopenia only for trials with samples&gt;=60." data-id="CD005096-fig-0174" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 6 the toxic and side effects of leukopenia only for trials with samples&gt;=60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0174">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0175"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 7 the rate of complete remission and partly remission only for trials with dosage of injectio Adi=50ml iv gtt Qd (day12˜21)." data-id="CD005096-fig-0175" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 7 the rate of complete remission and partly remission only for trials with dosage of injectio Adi=50ml iv gtt Qd (day12˜21). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0175">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0176"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 8 the toxic and side effects in digestive system only for trials with dosage of injectio Aidi=50ml iv gtt Qd(day12˜21)." data-id="CD005096-fig-0176" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.8</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 8 the toxic and side effects in digestive system only for trials with dosage of injectio Aidi=50ml iv gtt Qd(day12˜21). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0176">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0177"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-010-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-010-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analyses for Aidi, Outcome 9 the toxic and side effects of leukopenia only for trials with dosage of injectio Aidi=50ml iv gtt Qd(day12˜21)." data-id="CD005096-fig-0177" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.9</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analyses for Aidi, Outcome 9 the toxic and side effects of leukopenia only for trials with dosage of injectio Aidi=50ml iv gtt Qd(day12˜21). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0177">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-010-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0178"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 1 the rate of complete remission and partly remission only for trials with patients in IV stage." data-id="CD005096-fig-0178" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 1 the rate of complete remission and partly remission only for trials with patients in IV stage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0178">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0179"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 2 the toxic and side effects in digestive system only for trials with patients in IV stage." data-id="CD005096-fig-0179" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 2 the toxic and side effects in digestive system only for trials with patients in IV stage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0179">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0180"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 3 the toxic and side effects of leukopenia only for trials with patients in IV stage." data-id="CD005096-fig-0180" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 3 the toxic and side effects of leukopenia only for trials with patients in IV stage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0180">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0181"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 4 the rate of complete remission and partly remission only for trials with samples&gt;60." data-id="CD005096-fig-0181" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 4 the rate of complete remission and partly remission only for trials with samples&gt;60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0181">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0182"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 5 the toxic and side effects in digestive system only for trials with samples&gt;60." data-id="CD005096-fig-0182" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 5 the toxic and side effects in digestive system only for trials with samples&gt;60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0182">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0183"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 6 the toxic and side effects of leukopenia only for trials with samples&gt;60." data-id="CD005096-fig-0183" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 6 the toxic and side effects of leukopenia only for trials with samples&gt;60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0183">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0184"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 7 the rate of complete remission and partly remission only for trials with dosage of injectio Fufangkushen=20ml iv gtt Qd(day10˜14)." data-id="CD005096-fig-0184" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 7 the rate of complete remission and partly remission only for trials with dosage of injectio Fufangkushen=20ml iv gtt Qd(day10˜14). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0184">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0185"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 8 the toxic and side effects in digestive system only for trials with dosage of injectio Fufangkeshen=20ml iv gtt Qd (day10˜14)." data-id="CD005096-fig-0185" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.8</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 8 the toxic and side effects in digestive system only for trials with dosage of injectio Fufangkeshen=20ml iv gtt Qd (day10˜14). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0185">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0186"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-011-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-011-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 9 the toxic and side effects of leukopenia only for trials with dosage of injectio Fufangkeshen=20ml iv gtt Qd (day10˜14)." data-id="CD005096-fig-0186" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.9</div> <div class="figure-caption"> <p>Comparison 11 Sensitivity analyses for Fufangkushen, Outcome 9 the toxic and side effects of leukopenia only for trials with dosage of injectio Fufangkeshen=20ml iv gtt Qd (day10˜14). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0186">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-011-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0187"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 1 the rate of complete remission and partly remission only for trials with patients in IV stage." data-id="CD005096-fig-0187" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 1 the rate of complete remission and partly remission only for trials with patients in IV stage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0187">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0188"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 2 the toxic and side effects in digestive system only for trials with patients in IV stage." data-id="CD005096-fig-0188" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 2 the toxic and side effects in digestive system only for trials with patients in IV stage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0188">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0189"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 3 the toxic and side effects of leukopenia only for trials with patients in IV stage." data-id="CD005096-fig-0189" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 3 the toxic and side effects of leukopenia only for trials with patients in IV stage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0189">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0190"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 4 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old." data-id="CD005096-fig-0190" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 4 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0190">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0191"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 5 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old." data-id="CD005096-fig-0191" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 5 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0191">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0192"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 6 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old." data-id="CD005096-fig-0192" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.6</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 6 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0192">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0193"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 7 the rate of complete remission and partly remission only for trials with samples&gt;60." data-id="CD005096-fig-0193" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.7</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 7 the rate of complete remission and partly remission only for trials with samples&gt;60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0193">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0194"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 8 the toxic and side effects in digestive system only for trials with samples&gt;60." data-id="CD005096-fig-0194" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.8</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 8 the toxic and side effects in digestive system only for trials with samples&gt;60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0194">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0195"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 9 the toxic and side effects of leukopenia only for trials with samples&gt;60." data-id="CD005096-fig-0195" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.9</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 9 the toxic and side effects of leukopenia only for trials with samples&gt;60. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0195">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0196"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 10 the rate of complete remission and partly remission only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14)." data-id="CD005096-fig-0196" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.10</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 10 the rate of complete remission and partly remission only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0196">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0197"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 11 the toxic and side effects in digestive system only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14)." data-id="CD005096-fig-0197" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.11</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 11 the toxic and side effects in digestive system only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0197">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005096-fig-0198"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/urn:x-wiley:14651858:media:CD005096:CD005096-CMP-012-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_t/tCD005096-CMP-012-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 12 the toxic and side effects of leukopenia only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14)." data-id="CD005096-fig-0198" src="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.12</div> <div class="figure-caption"> <p>Comparison 12 Sensitivity analyses for Shenqifuzheng, Outcome 12 the toxic and side effects of leukopenia only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-fig-0198">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/media/CDSR/CD005096/image_n/nCD005096-CMP-012-12.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005096-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Appraisal of the results of Huachansu in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Huachansu in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Huachansu in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Huachansu in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy (no special data in trial of Zhang 2006)</b> <br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.43</b> <br/> (0.28 to 0.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>388 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>589 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>381 per 1000</b> <br/> (286 to 486) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>523 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>320 per 1000</b> <br/> (235 to 420) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission (Copy)</b> <br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.48</b> <br/> (1.01 to 2.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>448 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>401 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>498 per 1000</b> <br/> (403 to 592) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>367 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>462 per 1000</b> <br/> (369 to 557) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Zhang 2006)</b> <br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.32</b> <br/> (0.21 to 0.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>388 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>583 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (227 to 412) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>539 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>272 per 1000</b> <br/> (197 to 369) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in three studies,quasi‐randomised for three trials,and one simple randomisation study. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the seven study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Appraisal of the results of Huachansu in the short term for induction of remission in advanced or late gastric cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005096-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Appraisal of the results of Aidi in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Aidi in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Aidi in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Aidi in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission(no special data in trial of Zhang 2009)</b> <br/> Follow‐up: 6‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.51</b> <br/> (0.94 to 2.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>287 <br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>423 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>525 per 1000</b> <br/> (408 to 638) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>409 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>511 per 1000</b> <br/> (394 to 625) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy</b> <br/> Follow‐up: 6‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.33</b> <br/> (0.2 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>354 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>575 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> <br/> (213 to 422) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>574 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>308 per 1000</b> <br/> (212 to 421) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Jia 2003, Zhang 2009)</b> <br/> Follow‐up: median 6‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.43</b> <br/> (0.23 to 0.8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>242 <br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>675 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>472 per 1000</b> <br/> (323 to 624) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>667 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>463 per 1000</b> <br/> (315 to 616) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in all studies. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the five study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Appraisal of the results of Aidi in the short term for induction of remission in advanced or late gastric cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005096-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Appraisal of the results of Fufangkushen in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Fufangkushen in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Fufangkushen in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Fufangkushen in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission(no special data in trial of Fu 2011)</b> <br/> Follow‐up: 3‐9 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.22</b> <br/> (0.83 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>423 <br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>464 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>514 per 1000</b> <br/> (418 to 608) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>454 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>504 per 1000</b> <br/> (408 to 598) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy(no special data in trial of Fu 2011, Liu 2009a, Zhang 2010)</b> <br/> Follow‐up: 3‐9 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.42</b> <br/> (0.26 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>302 <br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>611 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>397 per 1000</b> <br/> (290 to 520) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>628 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>415 per 1000</b> <br/> (305 to 538) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy</b> <br/> Follow‐up: median 3‐9 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.37</b> <br/> (0.25 to 0.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>503 <br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>699 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>462 per 1000</b> <br/> (367 to 565) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>719 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>486 per 1000</b> <br/> (390 to 589) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in five studies,random number table for one trials, and the method of sequence generation was tossed of a coin in one study. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the seven study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Appraisal of the results of Fufangkushen in the short term for induction of remission in advanced or late gastric cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005096-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Appraisal of the results of Shenqifuzheng in the short term for induction of remission in advanced or late gastric cancer</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Appraisal of the results of Shenqifuzheng in the short term for induction of remission in advanced or late gastric cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in advanced or late gastric cancer <br/> <b>Settings:</b> <br/> <b>Intervention:</b> Appraisal of the results of Shenqifuzheng in the short term </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect <br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants <br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence <br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Appraisal of the results of Shenqifuzheng in the short term</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the rate of complete remission and partly remission</b> <br/> Follow‐up: 4‐8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.48</b> <br/> (0.78 to 2.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>153 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>493 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>590 per 1000</b> <br/> (432 to 732) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>597 per 1000</b> <br/> (438 to 738) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects in digestive system after chemotherapy</b> <br/> Follow‐up: 4‐8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.13</b> <br/> (0.18 to 7.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>153 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>413 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>443 per 1000</b> <br/> (113 to 836) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>533 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>563 per 1000</b> <br/> (170 to 892) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>the toxic and side effects of leukopenia after chemotherapy</b> <br/> Follow‐up: 4‐8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.37</b> <br/> (0.18 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>153 <br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝ <br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>467 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>245 per 1000</b> <br/> (136 to 393) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>182 per 1000</b> <br/> (97 to 307) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence <br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. <br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. <br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The method of sequence generation was not offered by the authors in all studies. <br/> <sup>2</sup> Allocation concealment and blinding of the method were not offered by the seven study authors. <br/> <sup>3</sup> total (cumulative) sample size is lower than the calculated optimal information size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Appraisal of the results of Shenqifuzheng in the short term for induction of remission in advanced or late gastric cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs + medicine versus medicine)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0001" title="CaoY , LiN , ZhangL , HuaL , LiZ . Clinical observation about association with Western and Traditional Chinese Medicines treating 70 patients with advanced gastric cancer. Clinical Journal of Traditional Chinese Medicine1992;2(3):8‐9. ">Cao 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Radix Astragali. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0002" title="CaoJ , XiaoX , TangX . Observation of effect about Elemene plus fluorouracil and acupuncturing Shenque treat advanced gastric carcinoma. Chinese Clinic of Oncology1997;24(7):549‐50. ">Cao 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi, No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0003" title="ChenN , JinY , LaiY . Observation of effect Pingxiao capsule combined chemotherapy treats advanced gastric cancer. Straits Pharmacy1997;9(1):66‐7. ">Chen 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Curcumae, Alumen, Natrii Sulphas, Faeces Trogopterorum, Radix Achyranthis Bidentatae, Semen Strychni Pulveratum, Hebra Agrimoniae, No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0005" title="ChenP , GaoH , SongJ , ZhengW . ELF connected with Cidan capsule treat gastric carcinoma of 64 cases. Chinese Clinic of Oncology2005;32(8):466‐7. ">Chen 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rhizoma Curcumae, Pseudobulbus Cremastrae Seu Pleiones, Fructus Bruceae, Semen Strychni Pulveratum, Nidus Vespae, Radix Astragali, Calculus Bovis. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 22 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0006" title="ChenNJ , WuDH , LaiYQ , ChenYY . Combining AIDI and FOLFOX4 treated advanced gastric cancer. Guangming Journal of Chinese Medicine2008;23(11):1768‐9. ">Chen 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0007" title="ChenHM . The effect of Huachansu with TPF regimen for late gastric cancer. Journal of Emergency in Traditional Chinese Medicine2009;18(1):35‐6. ">Chen 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0008" title="DengW , GuanC . Elemene plus chemotherapy influence on immunity of older progressive gastric carcinoma. Journal of Guangdong Medical College2001;19(5):350. [1005‐4057(2001)‐05‐0350‐01] ">Deng 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0009" title="DengZJ , CaoHN , GaoTN . Shenfu Injection with PCF chemotherapy for late or advanced gastric cancer in 40 cases. Contemporary Medicine2011;17(12):116‐8. ">Deng 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenfu injecta (Radix Ginseng, Radix aconiti lateralis preparata). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0010" title="DuCJ , WangTL , GuoYS . Clinical observation of quality of life in patients with gastric carcinoma treated by combination of traditional Chinese medicine, chemotherapy and hyperthermia treatment. Hebei Journal of Traditional Chinese Medicine2010;32(9):1299‐301. ">Du 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TCMH fomula (Astragalus Mongholicus 30g, Rhizoma Polygonati 20g, Rhizoma atractylodis macrocephala 10g, Poria 10g, Radix Glycyrrhizae 6g, Fructus Ligustri Lucidi 10g, Rhizoma Sanguisorbae 20g, Caulis Spatholobi 30g, Colla Corii Asini 6g, Pericarpium Citri Reticulatae 10g, Rhizoma Pinelliae 6g, Radix Actinidiae Chinensis 20g) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0011" title="FuJW , DengY , HuangW . Compound matrine injection with chemotherapy in the treatment of pain from advanced or late gastric cancer in 40 patients. Journal of Emergency in Traditional Chinese Medicine2011;20(1):152‐3. ">Fu 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0012" title="GaoP , FangXH , ZhangQ , YangF , YangZB , ZhangXC , et al. Clinical Random Control Study on Advanced Gastric Cancer with Mijisan Granule Infusion Combined with FLO Plan. Journal of Zhejiang Chinese Medicine College2008;32(6):756‐8. ">Gao 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mojisankeli (Astragalus Mongholicus, Radix Codonopsitis, Semen Coicis, Fructus Amomi, Ventriculi Galli Mucosa, Sophora Flavescens, Hedyotis Diffusa, Spica Prunellae Vulgaris, Rhizoma Pinelliae, Rhizoma Arisaematis, Kelp, Rhizoma Curcumae Aeruginosae, Rhizoma Sparganii, Radix Curcumae Longae, Scolopendra). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0013" title="GongL , JiangC , ZhaoY . Aidi combining with chemotherapy treat progressive gastric carcinoma. Journal of Oncology2006;12(5):424‐5. ">Gong 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix ginseng, Radix Astragali, Radix Acanthopanacis Senticosi, Chinese Cantharides. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0014" title="GuanC , HeG , YinZ . Effect of elemene emulsion combined chemotherapy on immunity of gastric cancer patients in progressive stage. Chinese Clinic of Oncology2001;28(2):123‐4. [1000‐8179(2001)‐02‐0123‐02] ">Guan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0015" title="GuoL , ChenG . Observation of efficacy about association with Western and Traditional Chinese Medicines treats 90 patients with advanced gastric carcinoma. Fujian Medicine Journal1999;11(1):19‐20. ">Guo 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Largehead Atractylodes, Rhizome Cuscuta Japonica, fructus psoraleae, Fructus Ligustri Lucidi, Fructus Lycii. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0016" title="HuY , HouAJ , ZhangHW , HuangYL , GuWF . Clinical observation of Fuzheng Xiao'ai prescription I combined with OFL regimen for treatment advanced gastric cancer. Journal of New Chinese Medicine2011;43(2):104‐6. ">Hu 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fuzhengxiao'ai I formula (Poria 10g, Radix angelicae seu hemsley 10g, Radix Saposhnikoviae 10g, Rhizoma atractylodis macrocephala 10g, Rhizoma Rehmanniae 10g, Rhizoma Chuanxiong 10g, Cortex Moutan 10g, Radix Actinidiae Chinensis 10g, Radix Pseudoxtellariae 15g, Astragalus Mongholicus 15g, Radix Ophiopogonis 15g, Pseudobulbus Cremastrae Seu Pleiones 15g, Hedyotis Diffusa 30g, Radix Glycyrrhizae 6g, Scolopendra 2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0017" title="HuaB , WangA , HouW . Clinical study on treatment of mid‐late stage gastric carcinoma by composite Xiansu capsule combined with chemotherapy. Journal of Combination of Traditional Chinese Medicine with Western Medicine1999;19(8):470‐3. ">Hua 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>radix ginseng 20g, Radix Astragali 15g, Largehead Atractylodes Rhizome 15g, Prepared Resina Olibani 10g, Prepared Myrrha 10g, Herba Hedyotis Diffusae 30g, Hebra Agrimoniae 30g, Rhizoma Curcumae 15g, Radix Trichosanthis 20g, Venenum Bufonis 0.3g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0018" title="HuangZ , SiZ , LuoY , HuangN . Clinical efficacy of Toad Venom injection combined with chemotherapy in treating 31 patients with medium and advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine2002;24(3):163‐5. ">Huang 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Injecta of Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0019" title="HuangX , SongA . Clinical research on elemene combined chemotherapy treating gastric cancer. Chinese Traditonal Medicine2005;5(3):40‐1. ">Huang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0020" title="JiaL , ZhuS , LiP , ZhangK , WanD , CaiG , et al. Therapeutic effect observation about Aidi, Cisplatin and Fluorouracil treating gastric carcinoma. Journal of China Oncology2003;25(5):517. ">Jia 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Ginseng, Radix Astragali, Radix Acanthopanacis Senticosi. Chinese Cantharides. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0021" title="JiaJW , LiuYQ . The effect of Shenqi Fuzheng injection combined with FOLFOX4 regimen in the treatment of advanced gastric cancer. The Practical Journal of Cancer2009;24(3):273‐5. ">Jia 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0024" title="LiS , HeL , SongY . A clinical report of Yiqihuoxue Recipe combinating with FAP regimen for improving the living qualities in patients with gastric cancer in advanced or late stage. Journal of Sichuan of Traditional Chinese Medicine2002;20(12):33‐4. ">Li 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 40g, Radix Codonopsis Pilosulae 30g, Radix Salviae Miltiorrhizae 30g, Radix Paeoniae Rubra 30g, Radix Rubiae 30g, Rhizoma Sparganii 30g, Ochra Haematitum 30g, Poria 15g, Largehead Atractylodes Rhizome 10g, Radix Glycyrrhizae 10g, Rhizome of Oldworld Arrowhead 10g, Flos Inulae 6g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0025" title="LinCL , GeJH . Clinical research of gastric cancer at the late stage treated with Compound Spophora Flavescens injection combined with chemotherapy. World Journal of Integrated Traditional and Western Medicine2011;6(4):316‐8. ">Lin 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0027" title="LiuH , ZengB , XuL . Observation of decoction of eight ingredients combined with chemotherapy treating advanced gastric carcinoma. Modern Journal of Integrated Traditional Chinese and Western Medicine2006;15(24):3366. ">Liu 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 30g, Radix Codonopsis Pilosulae 20g, Largehead Atractylodes Rhizome 10g, Poria10g, Radix Paeoniae Alba 15g, Radix Angelicae Sinensis 12g, Prepared Radix Rehmanniae 10g, Rhizoma Ligustici Chuanxiong 10g, Prepared Rhizoma Pinelliae 9g, Percarpiu Citri Reticulatae 6g, Carapax Trionycis 30g, Squama Manitis 15g, Caulis Spathoobi 30g, Panax Notoginseng 6g, Radix Glycyrrhizae 5g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0028" title="LiuJ , HuD , FanH , NiuL . Clinical observation of Tianlong treating advanced gastric cancer of 30 cases. Hebei Traditional Chinese Medicine2006;28(10):739‐40. [1002‐2619(2006)10‐739‐02] ">Liu 2006a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gekko Japonicus Dumeril et Bibron 4g, Herba Rabdosiae 30g, Rhizoma Smilacls Chinensis 30g, Radix Actinidiae Chinensis 30g, Radix Ginseng 30g, Radix Astragali 30g, Poria 20g, Dried Semen Coicis 30g, Fructus Crataegi 15g, Rhizoma Curcumae15g, Akebia Trifoliata Koidz 30g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0029" title="LiuLH , ZhangCX . Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma. China Modern Doctor2009;47(29):16‐7. ">Liu 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0030" title="LiuSL , DingC , GuXX . Compound matrine injection with chemotherapy in the treatment of 29 patients with advanced gastric cancer. Chinese Journal of Coal Industry Medicine2009;12(10):1566‐7. ">Liu 2009a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0031" title="LuoPF . The effect of Shenqi Fuzheng injection combined with chemotherapy for advanced gastric cancer. Modern Medicine &amp; Health2011;27(8):1170‐1. ">Luo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5˜6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0032" title="LvB , YangJ . Analysis of efficacy about association Western and Traditional Chinese medicines treating 48 patients with progressive and advanced gastric cancer. Chinese Traditional Treatment1999;2(2):24‐5. ">Lv 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decoction of Taohongsiwu, Decoction of Maimendong. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0033" title="NiuH , MuY . Complex prescription of the TCM and chemotherapy treat 120 patients with advanced gastric carcinoma. Shanxi Traditional Chinese Medicine2006;26(9):1034‐5. ">Niu 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percarpiu Citri Reticulatae, Cortex Magnoliae Officinalis 12g, Ramulus Cinnamomi, Largehead Atractylodes Rhizome, Rhizoma Alismatis10g, Rhizoma Atractylodis 15g, Poria 15g, Umbellate Pore Fungus 9g, Scorpio 5 to 10g, Scolopendra Subspinipes Mutilans L.koch 1 to 3, Fructus Ziziphi Jujubae 10, Radix Glycyrrhizae 6g, Hebra Agastachis, Semen Coicis, Radix Paeoniae Rubra, Radix Codonopsis Pilosulae, Fructus Hordei Germinatus, Fructus Oryzae Germinatus, Faeces Trogopterorum, Pollen Typhae, Rhizoma Polygonati Odorati, Radix Adenophorae, Cortex Cinnamomi, Fructus Evodiae, Panax Notoginseng, Radix Rubiae. No specific dosage of the partly herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0034" title="PengZ , ZhangY , ChenM . Strengthing‐body‐resistance decoction effect on immunity of gastric cancer patients. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1459. [1000‐1719(2006)11‐1459‐01] ">Peng 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 40g, Radix Paeoniae Alba 24g, Rhizoma Corydalis 15g, Fructus Tsaoko 15g, Os Spepiella Seu Sepiae 15g, Poria 15g, PreparedRadix Glycyrrhizae 15g, Baked Concha Arcae 12g, Radix Panacis Quinquefolii 10g, Faeces Trogopterorum 10g, Myrrha 10g, Radix Angelicae Sinensis 10g, Largehead Atractylodes Rhizome 10g, Endothelium Corneum Gigeriae Galli 10g, Panax Notoginseng 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0035" title="RaoF , YuR , HuY , WangY , JinJ , TianZ . Long‐term effect observation Shengxuetang combined with chemotherapy treats advanced gastric cancer. Chinese Journal of Traditional Chinese Medicine1994;14(6):366. ">Rao 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 30g, Radix Pseudostellariae 30g, Caulis Spathoobi 30g, Largehead Atractylodes Rhizome 10g, Poria10g, Fructus Lycii15g, Fructus Ligustri Lucidi 15g, Cuscuta Jjaponica 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0038" title="SiH , ShangG , LuW . Observation of efficacy about TCM and chemo treating advanced gastric cancer. Jiangsu Journal of Traditional Chinese Medicine2004;35(258):40‐1. ">Si 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percarpiu Citri Reticulatae, Prepared Rhizoma Pinelliae, Poria, Radix Glycyrrhizae, Radix Aucklandiae, Semen Sinapis Albae, Radix Codonopsis Pilosulae, Largehead Atractylodes Rhizome, Radix Adenophorae, Radix Ophiopogonis, Rhizoma Polygonati Odorati, Dried Radix Rehmanniae, Prepared Radix Rehmanniae, Radix Angelicae Sinensis, Fructus Meliae Toosendan, Radix Bupleuri, Rhizoma Cyperi, Pericarpium Citri Reticulatae, Percarpiu Citri Reticulatae, Fructus Citri Sarcodactylis, Radix Angelicae Sinensis, Semen Persicae, Radix Paeoniae Alba, Radix Salviae Miltiorrhizae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0039" title="SunG , LiJ . Clinical and experimental research about Qiao‐Wei‐Kang‐Liu dissolved medicines combined with chemotherapy treating advanced gastric cancer. Medical Research Communication1999;28(6):6‐7. ">Sun 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yangweikangliuchongji. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 to 36 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0040" title="TianR , YangJ , ZhangB , LiG . Clinical observations of gastric cancer patients treated with chemotherapy and Lanxiangxiru as a MDR mediator treated with chemotherapy and Elemene as a MDR mediator. Cancer Research on Prevention and Treatment1999;26(3):215‐6. ">Tian 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0041" title="WangR , WuD , JinY , ChenJ , LiuY , HuangP , et al. The short‐term effects of Jianpijiandu Decoction plus chemotherapy for advanced gastric cancer. Fujian Journal of Traditional Chinese Medicine1993;24(5):23‐6. ">Wang 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 15g, Radix Astragali 15g, Largehead Atractylodes Rhizome 15g, Poria 10g, Percarpiu Citri Reticulatae 6g, Rhizoma Pinelliae 6g, Caulis Spathoobi 30g, Fructus Lycii 15g, Fructus Ligustri Lucidi 15g, Radix Paeoniae Alba 15g, Radix Ophiopogonis 12g, Herba Hedyotis Diffusae 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0043" title="WangX , WangR , DaiH . Invigorating the spleen and removing cancer ingredient combined with chemotherapy treat older advanced gastric carcinoma of 90 cases. Shandong Journal of Chinese Medicine2002;21(9):527‐8. [0257‐358X(2002)09‐0527‐02] ">Wang 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Arisaemacum Bile, Rhizoma Pinelliae, Percarpiu Citri Reticulatae, Fructus Aurantii Immaturus, Bulbus Fritillariae Cirrhosae, Semen Sinapis Albae, Scorpio, Endothelium Corneum Gigeriae Galli, Radix Glycyrrhizae. No specific dosage of the herb. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0044" title="WangP . Observation effect in chemotherapy, radiotherapy and Yadanzi oil treating advanced gastric carcinoma. Journal of Practical Oncology2004;19(1):78‐9. [1001‐1692(2004)01‐0078‐02] ">Wang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fructus Bruceae. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0045" title="WangR , PanY , YeZ . Clinical observation about Invigorating the spleen and dissolving petechia mixtura combined with chemotherapy treating advanced gastric carcinoma of 24 cases. Jiangsu Traditional Chinese Medicine2004;25(11):22‐3. [1672‐397X(2004)11‐0022‐02] ">Wang 2004a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 20g, Radix Codonopsis Pilosulae 15g, Largehead Atractylodes Rhizome 12g, Rhizoma Dioscoreae 12g, Semen Coicis 30g, Percarpiu Citri Reticulatae 6g, Radix Salviae Miltiorrhizae 10g, Rhizoma Curcumae 15g, Herba Salviae Chinensis 10g, Herba Solani Nigri 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0046" title="WangZL , ShenHL , ZhouG , LiZY . The effects of Aidi injection to assist selective infusion chemotherapy in treatment of advanced gastric cancer. Journal of Zhejiang Chinese Medical University2009;33(2):219‐20. ">Wang 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0047" title="WangYH . The effect of Huachansu with chemotherapy for advanced or late gastric cancer. Jaingxi Journal of Traditional Chinese Medicine2009;40(4):31‐2. ">Wang 2009a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0048" title="WangJF . The effect of Shenqi Fuzheng injection combined with chemotherapy and radiotherapy for local advanced gastric cancer. Chinese Journal of Traditional Medical Science and Technology2010;17(6):537‐8. ">Wang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0049" title="WangJ , WangKM , WangZX , LuBB , LiJ . Compound matrine injection combined with DCF chemotherapy in the treatment of 25 patients with advanced gastric carcinoma. Chinese Journal of New Drugs2010;19(17):1585‐8. ">Wang 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0050" title="WangWM , LiCF , YaoRJ . The clinical effect of Huachansu with chemotherapy for late gastric cancer. Clinical Journal of Traditional Chinese Medicine2010;22(4):314‐5. ">Wang 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0051" title="WuY , CaiM , ZhuX . Following up of 5 years about Western and Chinese Traditional Medicines treating advanced gastric cancer. Journal of Nanjing University of Traditional Chinese Medicine1999;15(2):124. ">Wu 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Bupleuri 10g, Radix Curcumae 10g, Fructus Aurantii 6g, Rhizoma Cyperi 10g, Radix Codonopsis Pilosulae 20g, Poria 10g, Prepared Radix Rehmanniae 10g, Aspongopus 10g, Nidus Vespae 10g, Herba Scutellariae Barbatae 30g, Rhizoma Zingiberis 6g, Largehead Atractylodes Rhizome 10g, Rhizoma Pinelliae 10g, Chinese Buckeye Seed 10g, Percarpium Citri Reticulatae 6g, Radix Astragali 30g, Radix Paeoniae Alba 10g, Radix Angelicae Sinensis 10g, Pollen Typhae 10g, Faeces Trogopterorum 10g, Rhizoma Ligustici Chuanxiong 6g, Hebra Agrimoniae 30g, Rhizoma Polygonati Odorati 10g, Semen Persicae 10g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0052" title="WuY . Analysis of the therapeutic effect of Fuzhenggongjian capsule on the late gastric carcinoma under chemotherapy. Journal of Zhengjiang Medical College2000;10(4):656‐7. ">Wu 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 300g, Rhizoma Curcumae 150g, Herba Hedyotis Diffusae 150g, Dried Semen Coicis 150g, Herba Salviae Chinensis 150g, Radix Clematidis 100g, Powder of Shark Cartilage 150g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0053" title="WuC , LiQ , ZhaoY , LiQ . Controlled observation on Elemene plus chemotherapy treating advanced gastric cancer. Journal of North Sichuan Medical College2000;15(3):12‐3. [1005‐3697(2000)03‐0012‐02] ">Wu 2000a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emulsion of Lanxiangxi. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0054" title="XieC . Observation of effect Lailikang granula combined with chemotherapy treat advanced gastric carcinoma. Modern Medicine2006;22(6):882‐3. [1009‐5519(2006)‐06‐0882‐02] ">Xie 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Sophorae Subprostratae, Herba Hedyotis Diffusae, Radix Astragali, Pseudobulbus Cremastrae Seu Pleiones, Radix Curcumae, Radix Semiaquilegiae, Spica Prunellae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0055" title="XiongLG . Clinical observation of Yanshu injection combined with paclitaxel and oxaliplatin in the treatment of advanced gastric cancer. The Practical Journal of Cancer2008;23(3):276‐7. ">Xiong 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0057" title="XuD , ZhangX . Clinical observation about Ai‐Fu‐Kang plus chemotherapy treating patients with progressive gastric cancer after operation. Shanxi Traditional Chinese Medicine1993;9(4):14. ">Xu 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mesona Chinensis Benth, DriedPrepared Radix Rehmanniae, Radix Astragali, Radix Codonopsis Pilosulae, Panax Notoginseng, Radix Salviae Miltiorrhizae, Calculus Bovis, Moschus, Hebra Euphorbiae Lunulatae, Herba Solani Nigri, Herba Scutellariae Barbatae £¨No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0058" title="XuY . Clinical efficacy study Fuzhenghuoxue combined with chemotherapy in treating advanced gastric cancer. Hebei Journal of Traditional Chinese Medicine1999;21(6):329‐31. ">Xu 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dried Radix Astragali, Radix Scrophulariae, Fructus Ligustri Lucidi, Umbellate Pore Fungus, Semen Coicis, Hebra Agrimoniae, Caulis Spathoobi, Herba Solani Lyrati, Herba Hedyotis Diffusae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0059" title="YangZ , YuanX , LiG . Shenfu combining with ELFP treat advanced gastric carcinoma of 40 cases. Chinese Medical Science Study2005;18(7):26‐7. ">Yang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Ginseng Rubra, Radix Aconiti Praeparata. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0065" title="ZhangF . Clinic research that Shengyutang treats adverse reaction after advanced gastric cancer patients receive chemotherapy. Journal of Changchun College of Traditional Chinese Medicine1997;13(61):18. ">Zhang 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prepared Radix Rehmanniae 15g, Radix Paeoniae Alba 12g, Rhizoma Ligustici Chuanxiong 15g, Radix Angelicae Sinensis 12g, Radix Codonopsis Pilosulae 15g, Radix Astragali 20g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 22 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0066" title="ZhangC , WangQ . Huachansu combined with chemotherapy treat advanced 35 cases of gastric carcinoma. Journal of Anhui Traditional Chinese Medicine College2001;20(4):18‐9. [1000‐2219(2001)‐04‐0018‐01] ">Zhang 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0067" title="ZhangR , ChenC , ShenB , ZhouD , ZhangG . Clinical observation of Huachansu combined with chemotherapy treating advanced gastric carcinoma. Chinese Clinical Oncology2004;9(3):269‐70. [1009‐0460(2004)‐03‐0269‐02] ">Zhang 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0068" title="ZhangY , ZhuM , CaoT , ZhangP , YaoL , HuangH . Observation of curative effect of Huachansu combined with chemotherapy treating progressive and advanced gastric carcinoma. Henan Journal of Oncology2005;18(5):359‐60. [1003‐1464(2005)05‐0359‐02] ">Zhang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 24 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0069" title="ZhangJ , WangH , ZhangY . Jinlong capsule combined with HFL treat advanced gastric carcinoma. Capital Medicine2005;9(23):33. ">Zhang 2005a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capsule of Jinlong</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0070" title="ZhangZ , WangY , RongD . Late effect of Huachansu combined with hydroxy. Practical Journal of Medicine and Pharmaceuticals2006;23(7):794‐5. ">Zhang 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis. No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0071" title="ZhangH , SuZX . Curative effect of Shenling Baizhu powder on chemotherapy‐induced toxicity in advanced gastric cancer. Journal of TCM University of Hunan2008;28(2):51‐3, 56. ">Zhang 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenlingbaizhusanjiawei (Radix Codonopsitis 20g, Astragalus Mongholicus 30g, Poria 15g, Rhizoma atractylodis macrocephala 15g, Semen Coicis 30g, Dolichos Lablab 10g, Radix Saposhnikoviae 15g, Semen Nelumbinis 10g, Fructus Amomi 9g, Halloysitum Rubrum 20g, Rhizoma Pinelliae 10g, Radix Platycodi 10g,Radix Glycyrrhizae 6g, Red Dates 5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0072" title="ZhangAX . Aidi injection with chemotherapy for advanced or late gastric cancer. Journal of Medical Theory &amp; Practice2009;22(10):1214. ">Zhang 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aidi injecta (Radix Ginseng, Astragalus Mongholicus, Radix Acanthopanacis Senticosi, Chinese Cantharides). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0073" title="ZhangJJ , WeiJH , WeiS , WeiAF , LanC , ZhangF'E . ECF with compound injection of radix sophorae flavescentis for late gastric cancer in 32 patients. Guangji Medical Journal2010;32(5):533‐5. ">Zhang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0074" title="ZhangL , WangYF . The effect and immune function of Kanglaite with chemotherapy for advanced or late gastric cancer. Acta Universitatis Medicinalis Nanjin (Natural Science)2010;30(11):1657‐9. ">Zhang 2010a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kanglaite injecta (Semen Coicis). No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0075" title="ZhangMJ , ZuoCF . Observation of clinical efficacy of Yanshu injection combined with NP chemotherapy in treatment of advanced gastric cancer. Chinese Journal of Clinical Oncology and Rehabilitation2010;17(6):531‐3. ">Zhang 2010b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compound matrine injection (Sophora flavescens, Poria Alba). No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 to 8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0077" title="ZhengL , SunK . Research of efficacy about Western and Traditional Chinese Medicines treating progressing and advanced gastric cancer. Heilongjiang Medicine and Pharmacy1999;22(1):86‐7. ">Zheng 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Astragali 30g, Radix Salviae Miltiorrhizae 20g, Largehead Atractylodes Rhizome 15g, Prepared Radix Rehmanniae 20g, Placenta Hominis 10g, Fructus Lycii 15g, Caulis Spathoobi 30g, Radix Morindae Officinalis 12g, Colla Plastri Testudinis and Colla Cornus Cervi 20g, Radix Polygoni Multiflori Preparata 20g, Colla Corii Asini 10g, Radix Astragali 30g, Radix Salviae Miltiorrhizae 20g, Largehead Atractylodes Rhizome 15g, Prepared Radix Rehmanniae 20g, Placenta Hominis 10g, Fructus Lycii 15g, Caulis Spathoobi 30g, Radix Morindae Officinalis 12g, Colla Plastri Testudinis and Colla Cornus Cervi 20g, Radix Polygoni Multiflori Preparata 20g, Colla Corii Asini 10g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0079" title="ZhuH , ZhuZ , XuL . White Powder of Three Ingredients Medicine treats progressive gastric cancer of 30 cases. Journal of Nanjing Traditional Chinese Medicine University2005;21(5):284‐5. [1000‐5005(2005)05‐0284‐02] ">Zhu 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Semen Crotonis Pulveratum(º¬10 % oil), Bulbus Fritillariae, Radix Platycodi, Prepared Radix Glycyrrhizae, Eupolyphaga Seu Steleophaga, Rhizoma Zedoariae, Moschus, Dried Panax Notoginseng, Dried Semen Coicis, Radix Bupleuri, Radix Aucklandiae, Scorpio, Nidus Vespae, Parched Radix Paeoniae Alba, Radix Codonopsis Pilosulae. No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0080" title="ZhuJ , SongM , WangL , SunQ , ZhuL , FangC . Immunoregulation and short‐term therapeutic effect of super‐selective intra‐arteral chemotherapy combined with traditional Chinese drugs on gastric cancer patients. Journal of Chinese Integrative Medicine2006;4(5):478‐81. ">Zhu 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 15g, Largehead Atractylodes Rhizome 20g, Radix Astragali 30g, Semen Coicis 30g, Herba Solani Lyrati20g, Rhizoma Paridis 30g, Herba Hedyotis Diffusae 30g, fructus psoraleae 10g, Herba Salviae Chinensis 30g, PreparedRadix Glycyrrhizae 5g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs + medicine versus medicine)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0006"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs + medicine versus TCMHs)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0004" title="ChenN , JinY , LiuY , ChenY . Observation of effect about hydroxycamptothecin combined with Chinese medicine treating advanced gastric carcinoma of 41 cases. Fujian Journal of Medicine1997;19(2):82. ">Chen 1997a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decoction of Maimendo, Xiaoyao San, Shixiao San, Decoction of Lizhong ‐ No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0026" title="LiuY , ZhouJ . Association with Western and Traditional Chinese Medicines treats 30 patients with advanced gastric cancer. Journal of Shandong Traditional Chinese Medicine2002;21(3):164‐5. [0257‐358X(2002)03‐0164‐02] ">Liu 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DriedPollen Typhae 10g, Faeces Trogopterorum 10g, Herba Solani Nigri 30g, Dried Leaf of Cycasrevoluta 30g, Radix Actinidiae Chinensis 30g, Hebra Agrimoniae 30g, Herba Taraxaci 30g, Rhizoma Corydalis 10g, Radix Paeoniae Rubra 10g, Semen Persicae 10g, Rhizoma PolygonatiOdorati 20g Hebra Chelidonii 20g Nodus Nelumbinis Rhizomatis 20g, Percarpiu Citri Reticulatae 10g, Rhizoma Pinelliae 10g, Radix Curcumae 10g, Sargassum 10g, Thallus Eckloniae 10g, Bulbus Fritillariae 10g, Poria 15g, Full Fructus Trichosanthis 30g, Dried Concha Ostreae 30g, Radix Glycyrrhizae 6g, Radix Codonopsis Pilosulae 20g, Largehead Atractylodes Rhizome 10g, Radix Aconiti Praeparata 10g, Semen Alpiniae Katsumadai 6g, Rhizoma Zingiberis 6g, Umbellate Pore Fungus 15g, fructus psoraleae 15g, Radix Astragali 30g, Radix Angelicae Sinensis 15g, Rhizoma Ligustici Chuanxiong 10g, Radix Paeoniae Alba 10g, Fructus Aurantii 10g, Prepared Radix Rehmanniae 10g, Cortex Cinnamomi 6g, cuscuta japonica 12g, Fructus Lycii 12g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 22 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0042" title="WangG , ZhuJ , XuW , WangY , ZhouA . Clinical and experimental studies on Fuzheng granula combined with chemotherapy in advanced gastric cancer. World Chinese Journal of Digestology1998;6(3):214‐8. [ISSN1007‐9319 CN 14‐1218/R] ">Wang 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Dried Radix Astragali, Dried Largehead Atractylodes Rhizome, Fructus Psoraleae, Herba Salviae Chinensis, Herba Hedyotis Diffusae, Rhizoma Paridis, Dried Semen Coicis ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0056" title="XuY . The effects of Yangxue decoction plus chemotherapy for late gastric cancer after operation. Journal of Practical Oncology1989;3(1):54‐6. ">Xu 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Ginseng, Cuscuta Japonica, Fructus Psoraleae, Colla Corii Asini, Fructus Lycii, Radix Polygoni Multiflori Preparata, Largehead Atractylodes Rhizome, Fructus Ligustri Lucidi, Radix Paeoniae Alba, Radix Paeoniae Alba, Caulis Spatholobi, Massa Medicata Fermentata, Fructus Hordei Germinatus, Fructus Crataegi, Endothelium Corneum Gigeriae Galli, Fructus Aurantii Immaturus, Pericarpium Citri Reticulatae, Rhizoma Pinelliae, Caulis Bambusae In Taeniam, Radix Astragali, Herba Scutellariae Barbatae, Herba Hedyotis Diffusae ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0064" title="YouJ , ZhaoJ , ZhouL . Clinical study about Fuzhenghewei in treating fourth stage gastric cancer. Jiangsu Chinese Medicine2005;26(11):11‐3. ">You 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 540g, Umbellate Pore Fungus 540g, ParchedLargehead Atractylodes Rhizome 180g, Poria 180g, Folium Eriobotryae 180g, Prepared Rhizoma Pinelliae 108g, Semen Coicis 540g, Fructus Hordei Germinatus 180g, DriedRadix Glycyrrhizae 54g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0076" title="ZhaoZ , LiaoZ , ZhaoX . The clinic research of the effect of Sheng Mai injection combined with the chemotherapy in the elderly patients with advanced gastric cancer. Modern Oncology2005;13(3):387‐8. [1672‐4992(2005)03‐387‐02] ">Zhao 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix ginseng, Radix Ophiopogonis, Fructus Schisandrae Chinensis ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs + medicine versus TCMHs)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0007"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs versus TCMHs)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0036" title="ShaoJ . clinical study of compound Zhenjian liquid in treating advanced gastric cancer. Journal of Traditional Chinese Medicine1998;39(8):479‐80. ">Shao 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lysimachia Pentapetala Bunge, Ramulus Euonymi Alatae, Hirudo, Semen Coicis, Radix Sophorae Flavescentis, Dried Lacquer, Faeces Trogopterorum, Radix Curcumae, Alumen, Hebra Agrimoniae, Potassium Nitrate, Prepared Semen Strychni Pulveratum ‐ No specific dosage of the herbs. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without Blind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0037" title="ShiL , YeY , LuoS , ChenJ , YanX . Effect on life quality and immune about Huachansu combined with Chinese medical differentiation of symptoms and signs in treating gastric carcinoma. Journal of Zhejiang Chinese Medicine College2004;28(6):20‐1. ">Shi 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venenum Bufonis ‐ No specific dosage of the herbs.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without Blind</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs versus TCMHs)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0008"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs versus medicine)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NUMBER OF TRIALS</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HERBS IN REGIMEN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>ROUTE OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PERIOD OF ADMIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RCT AND BLIND METHOD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FOLLOW TIME</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0022" title="JiangY . Clinical observation about invigorating the spleen and removing cancer ingredient treating advanced gastric carcinoma 52 cases. Human Journal of Traditional Chinese Medicine1994;10(4):3‐5. ">Jiang 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae 15g, Poria 15g, Rhizoma Atractylodis Macrocephalae 12g, Radix Astragali sue Hedysari 20g, Rhizoma Zedoariae 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Cyperi 12g, Rhizoma Pinellinae Praeparata 10g, Herba Scutellariae Barbatae 30g, Herba Hedyotis Diffusae 30g, Paris Polyphylla Smith 30g, Herba Salviae Chinensis 50g, Radix Glycyrrhizae 6g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 5 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0023" title="LiX , WeiP . Effect observation about Jinlongshe for oral use treating advanced gastric carcinoma. Hubei Journal of Traditional Chinese Medicine2001;23(11):3‐5. ">Li 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Arisaemacum Bile, Rhizoma Pinelliae, Percarpiu Citri Reticulatae, Fructus Aurantii Immaturus, Bulbus Fritillariae Cirrhosae, Semen Sinapis Albae, Scorpio, Endothelium Corneum Gigeriae Galli, Radix Glycyrrhizae ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0062" title="YeSF , YeB , WuM . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Journal of Wenzhou Medical College2009;39(2):172‐3. ">Ye 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0060" title="YangZ , YouJ . No 3 readjust of Chinese medicine treat advanced gastric carcinoma by differentiation of symptoms and signs. Liaoning Journal of Traditional Chinese Medicine2006;33(11):1434‐5. [1000‐1719(2006)11‐1434‐02] ">Yang 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Radix Codonopsis Pilosulae, Umbellate Pore Fungus, Largehead Atractylodes Rhizome, Rhizoma Dioscoreae, Semen Coicis, Rhizoma Pinelliae, Rhizoma Zingiberis, Endothelium Corneum Gigeriae Galli, Massa Fermentata Medicinalis, Fructus Crataegi, Fructus Hordei Germinatus, Semen Raphani, Prepared Radix Rehmanniae ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0061" title="YangSP , DuB . The effect of Shenqi Fuzheng injection for advanced or late gastric cancer in old patients. Chinese Community Doctors2010;12:87. ">Yang 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shenqifuzheng injecta (Radix Codonopsitis, Astragalus Mongholicus). No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0063" title="YouJ , ZhaoJ . Readjusting and balancing methods of doctor Zhao treat advanced gastric cancer of 176 cases. Jilin Traditional Chinese Medicine2000;20(5):10‐11. ">You 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Umbellate Pore Fungus 30g, Radix Codonopsis Pilosulae 10g, ParchedLargehead Atractylodes Rhizome 10g, Endothelium Corneum Gigeriae Galli 10g, ParchedFructus Oryzae Germinatus 15g, ParchedFructus Hordei Germinatus 15g, Caulis Perillae 10g, Radix Cynanchi Paniculati 15g, Fructus Aurantii Immaturus 10g, Hydrocotyle Sibthorpioides Lam 10g, Dried Radix Rehmanniae 15g, Prepared Radix Rehmanniae 15g, Radix Polygoni Multiflori Preparata 10g, Fructus Corni 10g, Cortex Moutan Radicis 10g, Rhizoma Alismatis 10g, Rhizoma Anemarrhenae 10g, Cortex Phellodendri 10g, Herba Epimedii 15g, Radix Astragali 30g, Rhizoma Polygonati 30g, Radix Ginseng 10g, Fructus Ligustri Lucidi 10g, Fructus Schisandrae Chinensis 10g, Fructus Gardeniae 10g, Radix Bupleuri 6g, Radix Angelicae Sinensis 6g, Radix Salviae Miltiorrhizae 30g, Radix Paeoniae Rubra 30g, Radix Paeoniae Alba 30g, Rhizoma Sparganii 15g, Rhizoma Curcumae 15g </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>oral administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005096-bbs2-0078" title='ZhouR , WuL , NiA , XuZ . Clinical observation of intravenous drip of "Anti‐inflammation1" in treating 24 patients with mid and late gastric carcinoma. Shanghai Journal of Traditional Chinese Medicine2000;34(8):15‐6. [1007‐1334(2000)08‐0015‐02] '>Zhou 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Herba Hedyotis Diffusae, Frucutus Xanthii, Herba Taraxaci ‐ No specific dosage of the herbs </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>intravenous drip</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT without BLIND</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Table of administration of Chinese medicinal herbs (TCMHs versus medicine)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0009"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Summary table of sensitivity analyses for Huachansu</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Huachansu = 20ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Only for trials with dosage of injection Huachansu = 20ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48 [1.01 to 2.13]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48 [1.01 to 2.13]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.15[0.83 to 1.58]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.15[0.83 to 1.58]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.28[1.01 to1.62]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.29 [1.02 to1.62]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.23 [0.99 to 1.54]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.25 [1.01 to 1.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.24 [0.98 to 1.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.26 [1.00 to 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 [0.28 to 0.66]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 [0.22 to 0.84]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 [0.68 to 1.05]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 [0.67 to 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 [0.49 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 [0.40 to 1.30]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62 [0.50 to 0.77]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59 [0.35 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 [0.53 to 0.84]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 [0.32 to 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32 [0.21 to 0.50]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.32 [0.21 to 0.51]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 [0.45 to 0.86]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52 [0.24 to 1.12]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 [0.37 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.52 [0.39 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63 [0.50 to 0.78]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 [0.49 to 0.83]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 [0.53 to 0.84]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.67 [0.50 to 0.89]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Summary table of sensitivity analyses for Huachansu</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0010"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Summary table of sensitivity analyses for Aidi</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Aidi = 50ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Aidi = 50ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.51[0.94 to 2.41]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.50[0.93 to 2.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.69[0.99 to 2.87]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.68[0.98 to 2.88]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.23[0.61 to 2.48]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.23[0.61 to 2.49]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.88[1.03 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.88[1.03 to 3.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33[0.20 to 0.54]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33[0.20 to 0.55]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33[0.20 to 0.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34[0.20 to 0.58]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29[0.15 to 0.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29[0.15 to 0.57]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.20 to 0.65]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.37[0.20 to 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.23 to 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.23 to 0.80]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No specific data just for patients in IV stage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46[0.22 to 0.96]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46[0.22 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.17 to 0.83]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.17 to 0.83]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.46[0.22 to 0.96]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46[0.22 to 0.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Summary table of sensitivity analyses for Aidi</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0011"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Summary table of sensitivity analyses for Fufangkushen</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Fufangkushen = 20ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Fufangkeshen = 20ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06[0.42 to 2.68]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06[0.42 to 2.68]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.22[0.83 to 1.79]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.16[0.75 to 1.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.16[0.75 to 1.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.30[0.86 to 1.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30[0.86 to 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43[0.26 to 0.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.25 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.25 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42[0.25 to 0.71]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42[0.25 to 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.13 to 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.13 to 0.99]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.25 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.23 to 0.59]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.23 to 0.59]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.36[0.24 to 0.56]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36[0.24 to 0.56]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Summary table of sensitivity analyses for Fufangkushen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0012"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Summary table of sensitivity analyses for Shenqifuzheng</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fixed effect model of RR (M‐H, Fixed, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random effects model of RR (M‐H, Random, (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for patients in IV stage, RR (M‐H, Random, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients in IV stage, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with patients' median age&gt;50 years old, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with samples &gt;60, RR (M‐H, Random, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Shenqifuzheng = 250ml IV gtt Qd, RR (M‐H, Fixed, 95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Only for trials with dosage of injection Shenqifuzheng = 250ml IV gtt Qd, RR (M‐H, Random, 95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Rate of complete remission and partly remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48[0.78 to 2.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.48[0.78 to 2.81]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.31[0.39 to 4.39]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.31[0.39 to 4.39]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.49[0.65 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.49[0.65 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47[0.54 to 4.00]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.47[0.54 to 4.00]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.49[0.65 to 3.42]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.49[0.65 to 3.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects in digestive system</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90[0.48 to 1.67]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13[0.18 to 7.24]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.40[2.12 to 61.25]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.40[2.12 to 61.25]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.63[0.72 to 3.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.26[0.11 to 48.60]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.34[0.12 to 0.98]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.63[0.72 to 3.69]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.26[0.11 to 48.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Toxic and side effects of leukopenia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.18 to 0.74]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37[0.18 to 0.74]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12[0.07 to 1.44]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12[0.07 to 1.44]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38[0.14 to 1.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38[0.14 to 1.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.14 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.35[0.14 to 0.97]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38[0.14 to 1.02]</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38[0.14 to 1.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Summary table of sensitivity analyses for Shenqifuzheng</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005096-tbl-0013"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">The outcomes with statistically significant differences from the 53 trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type I (42 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type II (6 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type III (2 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Type IV (7 trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total number of trials</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rate of remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Median survival time</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to progression</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Result in the discontinuation of treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events (leukopenia)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events (Thrombopenia)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events (Decrease of haemoglobin)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events (nausea/vomiting)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">The outcomes with statistically significant differences from the 53 trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/full#CD005096-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Appraisal of the results of Huachansu in the short term</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [1.01, 2.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system after chemotherapy (no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.28, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.21, 0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Appraisal of the results of Huachansu in the short term</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Appraisal of the results of Aidi in the short term</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission(no special data in trial of Zhang 2009) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.94, 2.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system after chemotherapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.20, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia after chemotherapy(no special data in trial of Jia 2003, Zhang 2009) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.23, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Appraisal of the results of Aidi in the short term</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Appraisal of the results of Fufangkushen in the short term</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission(no special data in trial of Fu 2011) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.83, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system after chemotherapy(no special data in trial of Fu 2011, Liu 2009a, Zhang 2010) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.26, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia after chemotherapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.25, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Appraisal of the results of Fufangkushen in the short term</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Appraisal of the results of Shenqifuzheng in the short term</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.78, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system after chemotherapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.18, 7.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia after chemotherapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.18, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Appraisal of the results of Shenqifuzheng in the short term</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Appraisal of the results of type I</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 mortality 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 mortality 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 mortality 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 mortality 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 mortality 6‐2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 mortality 6‐1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 mortality 6‐3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 mortality 7‐1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 mortality 7‐2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 mortality 7‐3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 mortaliyt 8‐1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 mortality 8‐2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 mortality 8‐3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 quality of life 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 qualitiy of life 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 quality of life 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 quality of life 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 quality of life 6 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 quality of life 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 quality of life 8 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 quality of life 9 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 quality of life 10 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 quality of life 11 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 quality of life 12 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 quality of life 13 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 quality of life 14 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 quality of life 15 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 quality of life 16 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 quality of life 17 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 quality of life 18 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 quality of life 19 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 quality of life 20 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.5 [0.43, 10.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 quality of life 21 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.48, 4.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 quality of life 22 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.39 [2.27, 8.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 quality of life 23 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.07 [12.09, 16.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 rate of remission 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 rate of remission 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 rate of remission 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 rate of remission 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 rate of remission 6 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 rete of remission 8 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 rate of remission 9 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 rate of remission 10 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 rate of remission 11 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 rate of remission 12 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 rate of remission 13 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 rate of remission 14 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 rate of remission 15 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49 rate of remission 16 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50 rate of remission 17 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51 rate of remission 18 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52 rate of remission 19 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">53 rate of remission 20 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">54 rate of remission 21 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">55 rate of remission 22 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">56 rate of remission 23 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">57 rate of remission 24 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">58 rate of remission 25 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">59 rate of remission 26 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.37, 3.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">60 rate of remission 27 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.41, 4.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">61 rate of remission 28 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.47, 3.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">62 rate of remission 29 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.47, 5.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">63 rate of remission 30 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.50, 3.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">64 median survival times 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">65 leukopenia 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">66 leukopenia 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">67 leukopenia 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">68 leukopenia 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.18, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">69 leukopenia 6 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.11, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">70 leukopenia 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.04, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">71 leukopenia 8 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.53, 2.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">72 nausea/vomiting 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">73 nausea/vomiting 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">74 nausea/vomiting 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">75 nausea/vomiting 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">76 nausea/vomiting 6 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.06, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">77 nausea/vomiting 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.3 [0.09, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">78 nausea/vomiting 8 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.06, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">79 thrombopenia 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">80 thrombopenia 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.05, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">81 thrombopenia 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.14, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">82 thrombopenia 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.06, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">83 thrombopenia 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.27 [1.53, 25.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">84 diarrhea 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.11, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">85 decrease of hemoglobin 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">86 decrease of hemoglobin 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.87 [3.40, 28.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">87 decrease of hemoglobin 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.23, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">88 damage of liver and/or kidney function 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">89 damage of liver and/or kidney function 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.05, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">90 damage of liver and/or kidney function 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.03, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">91 damage of liver and/or kidney function 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.13, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">92 discontinuation due to adverse event 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">93 discontinuation due to adverse event 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">94 discontinuation due to adverse event 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">95 discontinuation due to adverse event 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Appraisal of the results of type I</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Appraisal of the results of type II</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 mortality 1.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 mortality 1.2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 mortality 1.3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 mortality 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 mortality 3.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 mortality 3.2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 quality of life 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 rate of remission 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 rate of remission 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 rate of remission 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 nausea/vomiting 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 arrest of bone marrow <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 discontinuation due to adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Appraisal of the results of type II</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Appraisal of the results of type III</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Appraisal of the results of type III</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Appraisal of the results of type IV</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 mortality 1.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 mortality 1.2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 mortality 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 mortality 3.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 mortality 3.2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 mortality 3.3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 mortality 3.4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 mortality 3.5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 mortality 4.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 mortality 4.2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 mortality 4.3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 mortality 5.1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 mortality 5.2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 mortality 5.3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 mortality 5.4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 mortality 5.5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 quality of life 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 quality of life 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 quality of life 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 quality of life 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.11 [1.11, 8.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 quality of life 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.67 [1.57, 13.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 rate of remission 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 rate of remission 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 rate of remission 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 rate of remission 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 rate of remission 5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 rate of remission 6 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [1.09, 8.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 rate of remission 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.67 [1.57, 13.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Leukopenia 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.39, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Thrombopenia 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.5 [‐4.98, 45.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Decrease of haemoglobin 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.0 [1.42, 18.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 median survival time 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 median survival time 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Appraisal of the results of type IV</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Sensitivity analyses for Huachansu</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission only for trials with patients in IV stage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.83, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system only for trials with patients in IV stage(no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.68, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia only for trials with patients in IV stage(no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.24, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.02, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.40, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.39, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 the rate of complete remission and partly remission only for trials with samples&gt;60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.99, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 the toxic and side effects in digestive system only for trials with samples&gt;60(no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.50, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 the toxic and side effects of leukopenia only for trials with samples&gt;60(no special data in trial of Zhang 2006) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.49, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 the rate of complete remission and partly remission only for trials with dosage of injectio Huachansu=20ml iv gtt Qd <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.98, 1.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 the toxic and side effects in digestive system only for trials with dosage of injectio Huachansu=20ml iv gtt Qd <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.32, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 the toxic and side effects of leukopenia only for trials with dosage of injectio Huachansu=20ml iv gtt Qd <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.53, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Sensitivity analyses for Huachansu</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Sensitivity analyses for Aidi</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old(no special data in trial of Zhang 2009) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.98, 2.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.20, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.22, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 the rate of complete remission and partly remission only for trials with samples&gt;=60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.61, 2.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 the toxic and side effects in digestive system only for trials with samples&gt;=60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.15, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 the toxic and side effects of leukopenia only for trials with samples&gt;=60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.17, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 the rate of complete remission and partly remission only for trials with dosage of injectio Adi=50ml iv gtt Qd (day12˜21) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [1.03, 3.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 the toxic and side effects in digestive system only for trials with dosage of injectio Aidi=50ml iv gtt Qd(day12˜21) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.20, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 the toxic and side effects of leukopenia only for trials with dosage of injectio Aidi=50ml iv gtt Qd(day12˜21) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.22, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Sensitivity analyses for Aidi</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Sensitivity analyses for Fufangkushen</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission only for trials with patients in IV stage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.42, 2.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system only for trials with patients in IV stage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.12, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia only for trials with patients in IV stage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.13, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 the rate of complete remission and partly remission only for trials with samples&gt;60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.75, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 the toxic and side effects in digestive system only for trials with samples&gt;60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.25, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 the toxic and side effects of leukopenia only for trials with samples&gt;60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.23, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 the rate of complete remission and partly remission only for trials with dosage of injectio Fufangkushen=20ml iv gtt Qd(day10˜14) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.86, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 the toxic and side effects in digestive system only for trials with dosage of injectio Fufangkeshen=20ml iv gtt Qd (day10˜14) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.25, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 the toxic and side effects of leukopenia only for trials with dosage of injectio Fufangkeshen=20ml iv gtt Qd (day10˜14) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.24, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Sensitivity analyses for Fufangkushen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005096-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Sensitivity analyses for Shenqifuzheng</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 the rate of complete remission and partly remission only for trials with patients in IV stage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.39, 4.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 the toxic and side effects in digestive system only for trials with patients in IV stage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.40 [2.12, 61.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 the toxic and side effects of leukopenia only for trials with patients in IV stage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.07, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 the rate of complete remission and partly remission only for trials with patients' median age&gt;50 years old <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.65, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 the toxic and side effects in digestive system only for trials with patients' median age&gt;50 years old <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.72, 3.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 the toxic and side effects of leukopenia only for trials with patients' median age&gt;50 years old <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.14, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 the rate of complete remission and partly remission only for trials with samples&gt;60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.54, 4.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 the toxic and side effects in digestive system only for trials with samples&gt;60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.12, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 the toxic and side effects of leukopenia only for trials with samples&gt;60 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.12, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 the rate of complete remission and partly remission only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.65, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 the toxic and side effects in digestive system only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.72, 3.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 the toxic and side effects of leukopenia only for trials with dosage of injectio Shenqifuzheng=250ml iv gtt Qd(day10˜14) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.14, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Sensitivity analyses for Shenqifuzheng</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005096.pub4/references#CD005096-tbl-0025">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005096.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005096-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005096-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005096-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD005096-note-0001">日本語</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005096\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005096\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005096\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005096\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005096\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005096.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005096.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005096.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005096.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005096.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718243949"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005096.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718243953"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005096.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcb967861f3fd',t:'MTc0MDcxODI0NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 